<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2406394-B1" country="EP" doc-number="2406394" kind="B1" date="20140108" family-id="42244601" file-reference-id="318276" date-produced="20180826" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146588486" ucid="EP-2406394-B1"><document-id><country>EP</country><doc-number>2406394</doc-number><kind>B1</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-10708682-A" is-representative="NO"><document-id mxw-id="PAPP154850678" load-source="docdb" format="epo"><country>EP</country><doc-number>10708682</doc-number><kind>A</kind><date>20100311</date><lang>EN</lang></document-id><document-id mxw-id="PAPP220366083" load-source="docdb" format="original"><country>EP</country><doc-number>10708682.9</doc-number><date>20100311</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140548008" ucid="US-2010027011-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>2010027011</doc-number><kind>W</kind><date>20100311</date></document-id></priority-claim><priority-claim mxw-id="PPC140547301" ucid="US-20256509-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>20256509</doc-number><kind>P</kind><date>20090312</date></document-id></priority-claim></priority-claims><dates-of-public-availability><intention-to-grant-date><date>20130724</date></intention-to-grant-date></dates-of-public-availability><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1989325791" load-source="docdb">C12Q   1/68        20060101AFI20101001BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-2122401584" load-source="docdb" scheme="CPC">C12Q   1/6806      20130101 FI20150109BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2122404117" load-source="docdb" scheme="CPC">C12Q   1/6853      20130101 LI20150109BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132370091" lang="DE" load-source="patent-office">REAGENTIEN UND VERFAHREN FÜR PCR</invention-title><invention-title mxw-id="PT132370092" lang="EN" load-source="patent-office">REAGENTS AND METHODS FOR PCR</invention-title><invention-title mxw-id="PT132370093" lang="FR" load-source="patent-office">RÉACTIFS ET PROCÉDÉS POUR PCR</invention-title><citations><patent-citations><patcit mxw-id="PCIT370958907" load-source="docdb" ucid="WO-2004090153-A2"><document-id format="epo"><country>WO</country><doc-number>2004090153</doc-number><kind>A2</kind><date>20041021</date></document-id><sources><source name="EXA" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT370960229" load-source="docdb" ucid="WO-2007008728-A2"><document-id format="epo"><country>WO</country><doc-number>2007008728</doc-number><kind>A2</kind><date>20070118</date></document-id><sources><source name="EXA" created-by-npl="N"/></sources></patcit></patent-citations></citations></technical-data><related-documents><relation type="division-into"><child-doc ucid="EP-13195156.8"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>13195156.8</doc-number><date>20131129</date></document-id></child-doc><parent-doc ucid="EP-10708682-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>10708682</doc-number><kind>A</kind><date>20100311</date></document-id><parent-grant-document ucid="EP-2406394-B1"><document-id><country>EP</country><doc-number>2406394</doc-number><kind>B1</kind><date>20140108</date></document-id></parent-grant-document></parent-doc></relation></related-documents><parties><applicants><applicant mxw-id="PPAR919505324" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>UNIV BRANDEIS</last-name><address><country>US</country></address></addressbook></applicant><applicant mxw-id="PPAR919510333" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>BRANDEIS UNIVERSITY</last-name></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919534943" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>WANGH LAWRENCE J</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919523743" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>WANGH, LAWRENCE, J.</last-name></addressbook></inventor><inventor mxw-id="PPAR919023342" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>WANGH, LAWRENCE, J.</last-name><address><street>20 Duffield Road</street><city>Auburndale, MA 02466</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919537295" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>RICE JOHN</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919527194" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>RICE, JOHN</last-name></addressbook></inventor><inventor mxw-id="PPAR919023341" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>RICE, JOHN</last-name><address><street>268 Common Street</street><city>Quincy, MA 02169</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919520542" load-source="docdb" sequence="3" format="epo"><addressbook><last-name>RICE NICHOLAS</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919530726" load-source="docdb" sequence="3" format="intermediate"><addressbook><last-name>RICE, NICHOLAS</last-name></addressbook></inventor><inventor mxw-id="PPAR919023343" load-source="patent-office" sequence="3" format="original"><addressbook><last-name>RICE, NICHOLAS</last-name><address><street>268 Common Street</street><city>Quincy, MA 02169</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919537458" load-source="docdb" sequence="4" format="epo"><addressbook><last-name>JIA YANWEI</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR919544393" load-source="docdb" sequence="4" format="intermediate"><addressbook><last-name>JIA, YANWEI</last-name></addressbook></inventor><inventor mxw-id="PPAR919023344" load-source="patent-office" sequence="4" format="original"><addressbook><last-name>JIA, YANWEI</last-name><address><street>17 Prospect Street, Apartment 4</street><city>Waltham, MA 02543</city><country>US</country></address></addressbook></inventor></inventors><assignees><assignee mxw-id="PPAR919023346" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>BRANDEIS UNIVERSITY</last-name><iid>101074643</iid><address><street>415 South Street</street><city>Waltham, MA 02254</city><country>US</country></address></addressbook></assignee></assignees><agents><agent mxw-id="PPAR919023345" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Ford, Hazel</last-name><iid>101191443</iid><address><street>J A Kemp 14 South Square Gray's Inn</street><city>LONDON WC1R 5JJ</city><country>GB</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="US-2010027011-W"><document-id><country>US</country><doc-number>2010027011</doc-number><kind>W</kind><date>20100311</date><lang>EN</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2010105074-A1"><document-id><country>WO</country><doc-number>2010105074</doc-number><kind>A1</kind><date>20100916</date><lang>EN</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS549786231" load-source="docdb">AT</country><country mxw-id="DS549875756" load-source="docdb">BE</country><country mxw-id="DS549880292" load-source="docdb">BG</country><country mxw-id="DS549924240" load-source="docdb">CH</country><country mxw-id="DS549870710" load-source="docdb">CY</country><country mxw-id="DS549786232" load-source="docdb">CZ</country><country mxw-id="DS549893510" load-source="docdb">DE</country><country mxw-id="DS549870711" load-source="docdb">DK</country><country mxw-id="DS549870712" load-source="docdb">EE</country><country mxw-id="DS549803212" load-source="docdb">ES</country><country mxw-id="DS549880293" load-source="docdb">FI</country><country mxw-id="DS549880298" load-source="docdb">FR</country><country mxw-id="DS549875757" load-source="docdb">GB</country><country mxw-id="DS549870713" load-source="docdb">GR</country><country mxw-id="DS549875762" load-source="docdb">HR</country><country mxw-id="DS549786245" load-source="docdb">HU</country><country mxw-id="DS549924241" load-source="docdb">IE</country><country mxw-id="DS549875763" load-source="docdb">IS</country><country mxw-id="DS549880299" load-source="docdb">IT</country><country mxw-id="DS549870722" load-source="docdb">LI</country><country mxw-id="DS549893511" load-source="docdb">LT</country><country mxw-id="DS549786246" load-source="docdb">LU</country><country mxw-id="DS549893512" load-source="docdb">LV</country><country mxw-id="DS549893517" load-source="docdb">MC</country><country mxw-id="DS549786036" load-source="docdb">MK</country><country mxw-id="DS549786041" load-source="docdb">MT</country><country mxw-id="DS549875764" load-source="docdb">NL</country><country mxw-id="DS549880300" load-source="docdb">NO</country><country mxw-id="DS549875765" load-source="docdb">PL</country><country mxw-id="DS549924242" load-source="docdb">PT</country><country mxw-id="DS549875770" load-source="docdb">RO</country><country mxw-id="DS549875771" load-source="docdb">SE</country><country mxw-id="DS549924243" load-source="docdb">SI</country><country mxw-id="DS549893518" load-source="docdb">SK</country><country mxw-id="DS549893519" load-source="docdb">SM</country><country mxw-id="DS549870723" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data><office-specific-data><eptags><ep-no-a-document-published>*</ep-no-a-document-published></eptags></office-specific-data></bibliographic-data><description mxw-id="PDES63960907" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><heading id="h0001"><b>Cross-Reference for Related Patent Applications</b></heading><p id="p0001" num="0001">This application claims benefit to <patcit id="pcit0001" dnum="US61202565A"><text>U.S. provisional patent application no. 61/202,565, filed March 12, 2009 to Zhang</text></patcit>,</p><heading id="h0002"><b>Field</b></heading><p id="p0002" num="0002">Nucleic acid amplification reactions and assays including both real-time and end point homogeneous polymerase chain reaction (PCR) monoplex and multiplex amplification assays are provided.</p><heading id="h0003"><b>Background</b></heading><p id="p0003" num="0003">Amplification and amplification assays using DNA primers and a DNA polymerase are well-known for amplifying and for detecting nucleic acid target sequences. Methods for exponential amplification include the polymerase chain reaction (PCR), strand displacement amplification (SDA), nucleic acid sequence based amplification (NASBA), transcriptionmediated amplification (TMA), and rolling circle amplification (RCA). Certain of these primer-dependent amplification methods, such as PCR, include thermal cycling, while others, such as NASBA, are isothermal. Among numerous DNA polymerases commonly used are <i>Thermus aquaticus</i> DNA polymerase (Taq polymerase) and reverse transcriptase. The design of linear DNA oligonucleotide amplification primers is generally accomplished with the aid of a computer program designed for that purpose. Among the available programs that can be utilized are PRIDE (<nplcit id="ncit0001" npl-type="s"><text>Haas et al., Nucl. Acids Res. 26:3006-3012 1998</text></nplcit>); OLIGO (<nplcit id="ncit0002" npl-type="s"><text>Rychlik et al., Nucl. Acids Res 17(21):8543-51 1989</text></nplcit>); OSP (<nplcit id="ncit0003" npl-type="s"><text>Hilber et al., OSP: a computer program for choosing PCR and DNA sequencing primers. PCR Methods Appl. 1(2):124-128 1991</text></nplcit>); Primo (<nplcit id="ncit0004" npl-type="s"><text>Li et al., Genomics 40(3):476-85 1997</text></nplcit>); and Primer Master (<nplcit id="ncit0005" npl-type="s"><text>Proutski et al., Comput Appl Biosci 12(3):253-5 1996</text></nplcit>).</p><p id="p0004" num="0004">Nucleic acid amplification employing PCR is well known, as are assays that include PCR amplification. See <patcit id="pcit0002" dnum="US4683202A"><text>U.S. Patents 4,683,202</text></patcit>,<patcit id="pcit0003" dnum="US4683195A"><text>4,683,195</text></patcit> and<patcit id="pcit0004" dnum="US4965188A"><text> 4,965,188</text></patcit>, and, generally, <nplcit id="ncit0006" npl-type="b"><text>PCR PROTOCOLS, a guide to Methods and Applications, Innis et al. eds., Academic Press<!-- EPO <DP n="2"> --> (San Diego, CA (USA) 1990</text></nplcit>). Homogeneous PCR assays that do not require washing to remove unbound detector reagents or probes and thus can be performed without opening amplification reaction vessels are also well known. Homogeneous PCR assays include both end-point assays, in which amplified product is detected at the end of the amplification reaction, and real-time assays, in which amplified product is detected during some or all of the thermal cycles as the reaction proceeds. See <patcit id="pcit0005" dnum="US5994056A"><text>U.S. Patents 5,994,056</text></patcit>, <patcit id="pcit0006" dnum="US5487972A"><text>5,487,972</text></patcit>, <patcit id="pcit0007" dnum="US5925517A"><text>5,925,517 </text></patcit>and <patcit id="pcit0008" dnum="US6150097A"><text>6,150,097</text></patcit>.</p><p id="p0005" num="0005">PCR amplification reactions, like other amplification methods referred to above, are generally designed to be symmetric, that is, to make double-stranded amplicons by utilizing a forward primer and a reverse primer that are "matched"; that is, they have melting temperatures that are as close as possible, and they are added to the reaction in equimolar concentrations. A technique that has found limited use for making single-stranded DNA directly in a PCR reaction is "asymmetric PCR." <nplcit id="ncit0007" npl-type="s"><text>Gyllensten and Erlich, "Generation of Single-Stranded DNA by the Polymerase Chain Reaction and Its Application to Direct Sequencing of the HLA-DQA Locus," Proc. Natl. Acad. Sci. (USA) 85: 7652-7656 (1988</text></nplcit>); and <patcit id="pcit0009" dnum="US5066584A"><text>U.S. Patent 5,066,584</text></patcit>. Asymmetric PCR differs from symmetric PCR in that one of the primers is added in limiting amount, typically 1-20 percent of the concentration of the other primer.</p><p id="p0006" num="0006">A more recently developed non-symmetric PCR amplification method is known as "Linear-After-The-Exponential" PCR or, for short, "LATE-PCR." See <nplcit id="ncit0008" npl-type="s"><text>Sanchez et al. (2004) PNAS 101: 1933-1938</text></nplcit>, <nplcit id="ncit0009" npl-type="s"><text>Pierce et al. (2005) PNAS 102: 8609-8614</text></nplcit>, and published international patent application <patcit id="pcit0010" dnum="WO03054233A"><text>WO 03/054233 (3 July 2003</text></patcit>). LATE-PCR takes into account the actual, concentration-adjusted melting temperatures of PCR primers at the start of amplification, referred to as Tm<sub>[0]</sub>. Tm<sub>[0]</sub> can be determined empirically, as is necessary when non-natural nucleotides are used, or calculated. A variety of fluorescent probes can be used with LATE-PCR, including, among others: molecular beacons, which are single-strands capable of forming a stem-loop structure that can close when not bound to target thereby bringing near to each other a fluorophore on one end and a quencher on the other end; linear single-stranded probes having a fluorophore on one end and a quencher on the other end; FRET probe pairs, which are two labeled, single-stranded probes that hybridize adjacently on a target sequence, permitting their labels to pass<!-- EPO <DP n="3"> --> energy between them by FRET; fluorophore-labeled linear probes that FRET with a DNA dye; and linear double-stranded probes in which the fluorophore is on the strand that binds to target and the quencher is on a complementary strand that binds to the probe at an equivalent Tm in the absence of a target.</p><p id="p0007" num="0007">An undesirable feature of symmetric PCR amplifications is that, following the exponential phase of amplification, fluorescence curves obtained by monitoring replicate amplifications in real time diverge and plateau at different levels. Scatter indicates that replicates do not have the same reaction efficiency and reduces detection accuracy. This is a problem for PCR assays generally, but is particularly undesirable in the case of end-point assays. Scatter among replicates is considerably reduced but still present in LATE-PCR assays and asymmetric PCR assays, both of which have an exponential phase and a linear phase. The scatter in the linear phase in part reflects the scatter in the plateau at the end of the exponential amplification when the limiting primer runs out.</p><p id="p0008" num="0008">Another significant problem with primer-dependent amplification reactions, including PCR amplifications, is mispriming, which we consider to be manifested in several distinct types: Type 1, mispriming that occurs during preparation of reaction mixtures prior to the start of amplification; Type 2, mispriming that occurs during amplification if the temperature (which in PCR amplifications means the temperature in any thermal cycle) is for any reason reduced below the melting temperature of a primer; and Type 3, mispriming that occurs in the late stages of amplification, including a PCR amplification, that is continued after a high concentration of amplicon has been made. When Type 3 mispriming occurs in LATE-PCR and asymmetric reactions, the 3'end of a single-stranded amplicon primes on another ss-DNA molecule, thereby converting ss-DNA into ds-DNA. Mispriming in a reaction can also result in scatter among replicate reactions. Mispriming includes primer-dimer formation, which can occur during any stage of amplification.</p><p id="p0009" num="0009">Several approaches have been used to address Type 1 mispriming. One approach is to modify the polymerase chemically so that it is inactive until heated to a high temperature such as 95 °C. See <patcit id="pcit0011" dnum="US5677152A"><text>U.S. Patents 5,677,152</text></patcit> and <patcit id="pcit0012" dnum="US5773258A"><text>5,773,258</text></patcit>. Another approach is to bind an antibody to the polymerase to inhibit the polymerase until the reaction is heated to a high temperature such as 95 °C to irreversibly denature the antibody. See <patcit id="pcit0013" dnum="US5338671A"><text>U.S. Patent 5,338,671</text></patcit>. Chemically modified and antibody-bound DNA polymerases are commonly referred to as<!-- EPO <DP n="4"> --> "hot start" DNA polymerases. Yet another "hot start" approach is to include an aptamer in the reaction mixture. See <nplcit id="ncit0010" npl-type="s"><text>Doug and Jayasena (1996), J. Mol. Biol. 264: 268 - 278</text></nplcit> and <patcit id="pcit0014" dnum="US6020130A"><text>U.S. patent 6,020,130</text></patcit>. An aptamer is a single-stranded oligonucleotide approximately 30 nucleotides in length that binds to a polymerase and inhibits its ability to extend a recessed 3' end at low temperatures. Aptamers are not irreversibly denatured at 95 °C, a typical highest temperature for a PCR cycle. Eppendorf-5 Prime, Inc. markets a proprietary ligand that is said to bind to Taq polymerase in a temperature-dependent manner and to inhibit its binding to double-stranded DNA at temperatures below about 50°C. Despite these many attempts, mispriming remains a problem with PCR amplifications.</p><p id="p0010" num="0010">Another type of mispriming during primer-dependent amplification reactions, including PCR amplifications, is known as primer-dimer formation and primer-dimer amplification. According to this phenomenon one primer hybridizes to the other primer or to another copy of itself and then undergoes extension of the 3' end to generate a small double-stranded amplicon, which can then amplify further or can multimerize and amplify further. Primer-dimer formation can occur in the absence of target.</p><p id="p0011" num="0011">Quantitative analysis of amplification reactions, including PCR amplifications, has been enabled by real-time detection methods. In PCR amplifications the PCR cycle at which fluorescent signal becomes visible above the threshold cycle or C<sub>T</sub> of reactions is indicative of starting target concentrations. End-point analyses are semi-quantitative at best, due in part to scatter among replicates as the reaction exits exponential amplification. Electrophoretic analysis of double-stranded amplicons is semi-quantitative, and may utilize fluorescently labeled primers. End-point analysis utilizing fluorescently labeled probes, either allele-discriminating probes or mismatch-tolerant probes, are also semi-quantitative at best. By reducing scatter and producing single-stranded product, LATE-PCR offers significant improvement in end-point analysis, but scatter among replicates is often not completely eliminated, leaving quantitative and multiplex detection less accurate and more problematic than desired.</p><p id="p0012" num="0012">Design and construction of multiplex PCR assays often encounters the problem of mispriming, because the use of multiple pairs of primers in a single reaction geometrically increases the number of possible unintended interactions of primers and target sequences or other DNA strands that may be present. Indeed, in symmetric multiplex PCR assays it is very<!-- EPO <DP n="5"> --> difficult to design all primer pairs to have the same melting temperature, and in a asymmetric or LATE-PCR multiplex PCR assay to design all of the limiting primers to have a single melting temperature and all of the excess primers to have a single melting temperature. It therefore follows that in a multiplex PCR assay the particular annealing temperature used for one or more thermal cycles is not likely to be optimal for all pairs of primers. If the primer annealing step of a PCR cycle is set to permit hybridization of the lowest Tm primer, the reaction will have reduced stringency for primers with Higher Tm's, which increases the chance for mispriming to occur. Moreover, in LATE-PCR assays the limiting primers used (whether in a monoplex or a multiplex) typically have melting temperatures 5°C or more above the melting temperatures of the excess primers, again making it impossible to match a single primer annealing temperature to the melting temperature of both primers.</p><p id="p0013" num="0013">A property of DNA polymerases in primer-dependent amplifications, including PCR amplifications, is a nominal amount of selectivity, particularly a nominal ability to discriminate between a target sequence that is perfectly complementary to a primer and a sequence that is perfectly complementary except for a mismatch at the 3' terminal nucleotide of the primer. It has been attempted to take advantage of this nominal selectivity to detect single-nucleotide mutations, or SNPs, by designing primers having their 3' terminal nucleotide complementary to the target nucleotide that is subject to mutation. The amplification assay method known as the amplification refractory mutation system (ARMS) attempts to do that (<nplcit id="ncit0011" npl-type="s"><text>Newton et al., Nucl. Acids Res. 17, 2503-2516 (1989</text></nplcit>);<nplcit id="ncit0012" npl-type="s"><text> Wu et al., Proc. Natl. Acad. Sci. USA 86:2757-2760 (1989</text></nplcit>)). ARMS assays are prone to generation of false-positive signals due to mispriming and primer-dimer formation. Certain mispriming events may involve a primer that hybridizes incorrectly such that there is a 3' mismatched nucleotide. Primer-dimer formation may also involve a mismatched 3' nucleotide. In the last phase of a LATE-PCR amplification mispriming of a single-stranded amplicon on another single strand in the reaction mixture may also involve a mismatched 3' nucleotide. Therefore, enhancing a polymerase's discrimination against a 3' terminal mismatch can, among other effects, reduce mispriming. Attempts have been made to improve selectivity during amplification beyond the foregoing nominal selectivity by making amplification primers themselves more selective. For example, Tyagi et al. added to the 5' end of a primer a sequence complementary to the 3' end of the primer to form a stem-loop structure wherein<!-- EPO <DP n="6"> --> the loop and the 3' portion of the stem are complementary to the target strand (<patcit id="pcit0015" dnum="US6277607B"><text>U.S. patent 6,277,607</text></patcit>). This approach is not seen to reduce the difficulty, described above, of designing primers for multiples assays. Making primers more selective does not, of course, improve the selectivity of DNA polymerases.</p><p id="p0014" num="0014">To improve selectivity, an alternative to modifying primers is to affect the DNA polymerase itself. U.S. patent application <patcit id="pcit0016" dnum="US11242506B"><text>US 11/242,506</text></patcit> describes a class of reagent additives that somewhat improve product specificity and that greatly reduce or in some cases practically eliminate the effects of mispriming in PCR amplification reactions. This class of reagents is comprised of single oligonucleotides molecules that are able to fold into hairpin structures having a stem and a loop when the temperature is lowered below the melting temperature of the stem. Although the double-stranded stem closes, the nucleotides at the 3' and 5' ends tend to unwind. Therefore, these additive reagents are chemically modified at both their 3' and 5' ends to keep the ends closed. End closure in this way effectively increases the melting temperature of the stem. In the closed configuration these reagent additives interact with DNA polymerase so as to improve selectivity. In the closed configuration they also inhibit polymerase activity of DNA polymerases. While these additives out-perform existing "hot-start" methodologies in all types of PCR and can be used to prevent the accumulation of undesired products, including primer-dimers and misprimed amplicons, both at early stages of the reaction and during LATE-PCR reactions having many cycles (typically 60 cycles and more), they do have their limitations which are inherent to their being comprised of a single oligonucleotide. Specifically, the length of the stem cannot be greater than about 12 nucleotides, because, if it is, and is also chemically modified at its ends, its melting temperature becomes so high that it does not readily open when the PCR is heated to the extension temperature. Even when added at low concentration, hairpin molecules with long stems and high Tm tend to inhibit the reaction. Yet another difficulty inherent to these additives is that they are not linearly symmetric, i.e. one end of the closed hairpin is open while the other end is a loop. As described in U.S. patent application <patcit id="pcit0017" dnum="US11242506B"><text>US 11/242,506</text></patcit>, molecules with loops comprised of 3-22 nucleotides tend to inhibit amplification more readily than molecules in which the loop is formed by use of a 3 carbon or 6 carbon linker. It would be desirable to have reagents which are structurally symmetrical end-to-end.<!-- EPO <DP n="7"> --></p><p id="p0015" num="0015"><nplcit id="ncit0013" npl-type="s"><text>Kainz et al. (2000) Biotechniques 28: 278-282</text></nplcit> reported that DNA fragments, double-stranded DNA oligonucleotides, having lengths of 16-21 nucleotides can inhibit mispriming that occurs at or just below the optimal annealing temperature of symmetric PCR reactions and thereby prevent amplification of non-specific products. The DNA oligomers are reversibly denatured during the melting step of the PCR cycling. In all cases the assays that Kainz et al. employed revealed the presence of, and inhibition of, mispriming that takes place when the temperature is descending to the optimal annealing temperature after the first melting event at 95°C. This does not address Type 1 mispriming, as Kainz et al. acknowledged, and their data reveal that double-stranded fragments that are only double- stranded when Type 1 mispriming occurs (that is, with melting temperatures &gt; 5°C below the annealing temperature of the reaction) fail to prevent mispriming. From Kainz et al. one infers that their method will likely be even more unreliable in multiplex reactions because, as explained above, the annealing temperature cannot simultaneously be optimized for all pairs of primers. Kainz et al. also acknowledged that, although they did not observe it in their particular experiments, double-stranded DNA oligonucleotides may trigger mispriming, if they become the target for hybridization of one or more primers in the reaction.</p><p id="p0016" num="0016"><patcit id="pcit0018" dnum="WO2006044994A"><text>WO 2006/044994</text></patcit> describes the use of fluorophore-labelled oligonucleotide primers and probes to allow detection during or following PCR amplification, particularly in LATE-PCR. <patcit id="pcit0019" dnum="WO2007008728A"><text>WO 2007/008728</text></patcit> describes methods of inhibiting the polymerase activity of a DNA polymerase enzyme by contacting the enzyme with a second enzyme that modifies a binding partner that is bound to the polymerase enzyme, thereby inhibiting the polymerase activity of the polymerase enzyme. The binding partner may be a single-stranded or double-stranded nucleic acid. <patcit id="pcit0020" dnum="WO2004090153A"><text>WO 2004/090153</text></patcit> describes nucleic acid based polymerase inhibitors including double-stranded nucleic acid portions recognised by a polymerase enzyme as a template for extension but incapable of being extended by the polymerase enzyme.</p><heading id="h0004"><b>Summary</b></heading><p id="p0017" num="0017">The invention provides a reaction mixture for suppressing mispriming in a primer-dependent DNA amplification reaction, preferably a PCR amplification reaction, said reaction mixture comprising (a) at least one primer pair, (b) a thermally stable DNA polymerase, (c) dNTP's, and (d) at least one double-stranded oligonucleotide additive that has terminal regions on each of its strands, that comprises two nucleic acid strands of 6-50 nucleotides in length, that is at least 50% double-stranded at 32°C, that has blunt ends or overhangs of 1-8 nucleotides and that includes 1-4 modifying groups, preferably two, three or four modifying groups, each covalently attached to a different terminal region, preferably to a terminal nucleotide, said modifying groups being polycyclic moieties that do not have bulky portions that are non-planar, wherein said at least one double-stranded oligonucleotide additive is included at a concentration of up to 2000 nM. Preferably the double-stranded oligonucleotide additive is included at a concentration that is<!-- EPO <DP n="8"> --> effective for at least one of the functions of suppressing mispriming, increasing polymerase selectivity against hybrids having recessed 3' terminal sequences that are not perfectly complementary, increasing polymerase selectivity against hybrids having recessed 3' terminal sequences that are AT-rich, reducing scatter among replicate reactions, inhibiting polymerase 5' exonuclease activity, and inhibiting polymerase activity. In one embodiment, if the additive is a primer or detection probe for any target sequence, it includes at least three modifying groups.</p><p id="p0018" num="0018">A reaction mixture as described in the preceding paragraph may include a mixture of two such double-stranded additives.</p><p id="p0019" num="0019">A reaction mixture may be a reaction mixture as described above wherein the additive includes a first strand that is a primer or probe for said at least one target sequence and a reverse complement strand that is partially complementary to the first strand, and wherein the additive includes three of the described modifying groups.</p><p id="p0020" num="0020">Primer-dependent amplification of DNA (including cDNA) targets, preferably PCR amplification, may be carried out using reaction mixtures described above and, where necessary reverse transcribing RNA to obtain the DNA target sequence to be amplified.</p><p id="p0021" num="0021">Homogeneous detection assays, both real-time and end-point assays, may include such primer-dependent amplifications plus fluorescence detection of amplification products.</p><p id="p0022" num="0022">Reagent kits may contain primers for at least one DNA target sequence, dNTPs, a thermally stable DNA polymerase, and at least one modified double- stranded oligonucleotide additive as describe above.</p><p id="p0023" num="0023">Such reagent kits may also include at least one fluorescence detection reagent for detecting amplification reaction products homogeneously.</p><p id="p0024" num="0024">Modified double-stranded oligonucleotides may have terminal regions on each of their strands, may have a hybrid length of 6-50 nucleotides long, may be at least 50% double-stranded at 40°C, preferably, but at least at 32°C, and may include 2-4 modifying groups, each covalently attached to a different terminal region, preferably to a terminal nucleotide, said modifying groups being polycyclic moieties that do not have bulky portions that are non-planar, said modified oligonucleotide being capable of binding to the 5' exonuclease domains of DNA polymerases.</p><p id="p0025" num="0025">A primer-dependent DNA amplification reaction mixture including primer extension by a DNA polymerase for amplifying at least one DNA target sequence, may include (a) at least one primer pair, (b) a DNA polymerase, and (c) dNTP's, wherein at least one double-stranded oligonucleotide additive is included in the reaction mixture prior to the start of amplification that comprises two nucleic acid strands of 6-50 nucleotides in length, that is at least fifty percent double-stranded at 32°C, that has blunt ends or overhangs of 1-8 nucleotides, that has terminal regions on each of its strands and includes 1-4 modifying groups, each covalently attached to a different terminal region, said modifying groups being polycyclic moieties that do not have bulky<!-- EPO <DP n="9"> --> portions that are non-planar, wherein said at least one double-stranded oligonucleotide additive is included at a concentration of up to 2000 nM. Preferably the concentration of said DNA polymerase is effective for at least one of the functions of suppressing mispriming, increasing polymerase selectivity against hybrids having recessed 3' terminal sequences that are not perfectly complementary, increasing polymerase selectivity against hybrids having recessed 3' terminal sequences that are AT-rich, reducing scatter among replicate reactions, inhibiting polymerase 5' exonuclease activity, and inhibiting polymerase activity. If the additive is a primer or detection probe for any target sequence, it may include at least three modifying groups.</p><p id="p0026" num="0026">An amplification assay may include amplification and fluorescence detection of single-stranded products of the reaction, double-stranded products of the reaction, or both, either in real time during amplification or end point following amplification, wherein double-stranded products of the reaction are detected with a fluorescent DNA dye, single-stranded products of the reaction are detected with at least one fluorescently labeled hybridization probe, or both.</p><p id="p0027" num="0027">Described herein is a modified double-stranded oligonucleotide that has terminal regions on each of its strands, that has a hybrid length of 6-50 nucleotides long, that is at least fifty percent double-stranded at 32°C, and that includes 2-4 modifying groups, each covalently attached to a different terminal region, said modifying groups being polycyclic moieties that do not have bulky portions that are non-planar, said modified oligonucleotide being capable of inhibiting the 5' exonuclease domains of DNA polymerases. The modified double-stranded oligonucleotide may have from one to four single-stranded overhangs, and, when not hybridized in the double-stranded oligonucleotide structure, it may comprise either<!-- EPO <DP n="10"> --> one or two single strands that form a stem-loop (hairpin) structure, in which case the stem is 6 or fewer base-pairs long.</p><heading id="h0005"><b>Brief Description of the Drawings</b></heading><p id="p0028" num="0028"><ul><li><figref idrefs="f0001">FIG. 1</figref> presents melt curves for replicates of a LATE-PCR amplification described in Example 1 utilizing additive 16merA at a concentration of 300 nM.</li><li><figref idrefs="f0002">FIG. 2</figref> presents melt curves for replicates of a LATE-PCR amplification described in Example 1 utilizing additive 16merB at a concentration of 300 nM.</li><li><figref idrefs="f0003">FIG. 3</figref> presents melt curves for replicates of a LATE-PCR amplification described in Example 1 utilizing additive EP049 at a concentration of 600 nM.</li><li><figref idrefs="f0004">FIG. 4</figref> presents melt curves for replicates of a LATE-PCR amplification described in Example 1 utilizing additive EP027 at a concentration of 100 nM.</li><li><figref idrefs="f0005">FIG. 5</figref> is a graph of SYBR Green fluorescence as a function of amplification cycle number for replicates of a LATE-PCR amplification described in Example 1 utilizing additive EP027 at concentrations of 100, 300, 600 and 1000 nM.</li><li><figref idrefs="f0006">FIG. 6</figref> presents melt curves for replicates of a LATE-PCR amplification described in Example 2 utilizing additive 22merA at a concentration of 100 nM and additive EP003 at a concentration of 100 nM.</li><li><figref idrefs="f0007">FIG. 7A</figref> is a graph of SYBR Green fluorescence as a function of amplification cycle number for replicates of a LATE-PCR amplification described in Example 4 utilizing three-strand additive mixture EP043 at a total concentration of 600 nM and strand concentrations of 25/600/575 nM.</li><li><figref idrefs="f0008">FIG 7B</figref> is a graph of SYBR Green fluorescence as a function of amplification cycle number for replicates of a LATE-PCR amplification described in Example 4 utilizing three-strand additive mixture EP043 at a total concentration of 600 nM and strand concentrations of 50/600/550 nM.</li><li><figref idrefs="f0009">FIG 7C</figref> is a graph of SYBR Green fluorescence as a function of amplification cycle number for replicates of a LATE-PCR amplification described in Example 4 utilizing three-strand additive mixture EP043 at a total concentration of 600 nM and strand concentrations of 75/600/525 nM.<!-- EPO <DP n="11"> --></li><li><figref idrefs="f0010">FIG. 7D</figref> is a graph of SYBR Green fluorescence as a function of amplification cycle number for replicates of a LATE-PCR amplification described in Example 4 utilizing three-strand additive mixture EP043 at a total concentration of 600 nM and strand concentrations of 100/600/500 nM.</li><li><figref idrefs="f0011">FIG. 8A</figref> is a graph of SYBR Green fluorescence as a function of amplification cycle number for replicates of a LATE-PCR amplification described in Example 4 utilizing three-strand additive mixture EP045 at a total concentration of 600 nM and strand concentrations of 25/600/575 nM.</li><li><figref idrefs="f0012">FIG. 8B</figref> is a graph of SYBR Green fluorescence as a function of amplification cycle number for replicates of a LATE-PCR amplification described in Example 4 utilizing three-strand additive mixture EP045 at a total concentration of 600 nM and strand concentrations of 50/600/550 nM.</li><li><figref idrefs="f0013">FIG. 8C</figref> is a graph of SYBR Green fluorescence as a function of amplification cycle number for replicates of a LATE-PCR amplification described in Example 4 utilizing three-strand additive mixture EP045 at a total concentration of 600 nM and strand concentrations of 75/600/525 nM.</li><li><figref idrefs="f0014">FIG. 8D</figref> is a graph of SYBR Green fluorescence as a function of amplification cycle number for replicates of a LATE-PCR amplification described in Example 4 utilizing three-strand additive mixture EP046 at a total concentration of 600 nM and strand concentrations of 100/600/500 nM.</li><li><figref idrefs="f0015">FIG. 9A</figref> is a graph of fluorescences from two probes as a function of amplification cycle number for replicates of a LATE-PCR duplex amplification described in Example 5 utilizing no additive and an annealing temperature of 65°C.</li><li><figref idrefs="f0016">FIG 9B</figref> is a graph of fluorescences from two probes as a function of amplification cycle number for replicates of a LATE-PCR duplex amplification described in Example 5 utilizing additive EP020 at a concentration of 400 nM and an annealing temperature of 65°C.</li><li><figref idrefs="f0017">FIG. 9C</figref> is a graph of fluorescences from two probes as a function of amplification cycle number for replicates of a LATE-PCR duplex amplification described in Example 5 utilizing additive EP020 at a concentration of 400 nM and an annealing temperature of 60.7°C.<!-- EPO <DP n="12"> --></li><li><figref idrefs="f0018">FIG. 9D</figref> is a graph of fluorescences from two probes as a function of amplification cycle number for replicates of a LATE-PCR duplex amplification described in Example 5 utilizing additive EP013 at a concentration of 300 nM and an annealing temperature of 66. °C.</li><li><figref idrefs="f0019">FIG. 9E</figref> is a graph of fluorescences from two probes as a function of amplification cycle number for replicates of a LATE-PCR duplex amplification described in Example 5 utilizing additive EP013 at a concentration of 300 nM and an annealing temperature of 64.2°C.</li><li><figref idrefs="f0020">FIG. 9F</figref> is a graph of fluorescences from two probes as a function of amplification cycle number for replicates of a LATE-PCR duplex amplification described in Example 5 utilizing additive EP013 at a concentration of 300 nM and an annealing temperature of 60.7 °C.</li><li><figref idrefs="f0021">FIG. 10</figref> is a graph of probe fluorescence as a function of the number of temperature oscillation cycles for a primer-independent probe-cleavage assay described in Example 6 utilizing any of several additives or no additive.</li><li><figref idrefs="f0022">FIG. 11A</figref> presents melt curves for probe-amplicon hybrids resulting from replicates of a LATE-PCR amplification described in Example 7 with no additive, and for probe alone.</li><li><figref idrefs="f0023">FIG. 11B</figref> presents melt curves for probe-amplicon hybrids resulting from replicates of a LATE-PCR amplification described in Example 7 with additive EP013 at 600 nM concentration, and for probe alone.</li><li><figref idrefs="f0024">FIG. 12</figref> is an electrophoretic gel showing products of a 12-plex LATE-PCR amplification described in Example 8 starting with 1000 copies of mitochondrial genomic DNA (target sequences) with no additive, with additive EP011 at a concentration of 300 nM, and with additive EP011 at a concentration of 600 nM.</li><li><figref idrefs="f0025">FIG. 13</figref> is a graph of SYBR Green fluorescence as a function of amplification cycle number for replicates of a LATE-PCR amplification described in Example 9 utilizing Taq DNA polymerase with no additive, Taq DNA polymerase and antibody with no additive, Taq DNA polymerase with additive EP046 at a concentration of 600 nM, and Taq DNA polymerase and antibody with additive EP046 at a concentration of 600 nM.</li><li><figref idrefs="f0026">FIG. 14A</figref> is a graph of fluorescence from a probe as a function of amplification cycle number for replicates of a LATE-PCR amplification with a low-temperature detection<!-- EPO <DP n="13"> --> step described in Example 10 utilizing additive EP010 at a concentration of 600 nM, starting with 1000, 100 and 10 copies of target.</li><li><figref idrefs="f0027">FIG. 14B</figref> presents melt curves for probe-amplicon hybrids after 40 cycles of a LATE-PCR ColdStop amplification described in Example 10 utilizing additive EP010 at a concentration of 600 nM. starting with 1000, 100 and 10 copies of target.</li><li><figref idrefs="f0028">FIG 14C</figref> presents melt curves for probe-amplicon hybrids after 70 cycles of a LATE-PCR ColdStop amplification described in Example 10 utilizing additive EP010 at a concentration of 600 nM. starting with 1000, 100 and 10 copies of target.</li><li><figref idrefs="f0029">FIG. 15A</figref> is a graph of SYBR Green fluorescence as a function of amplification cycle number for replicates of a LATE-PCR amplification described in Example 13 utilizing additive mixture EP043 at a total concentration of 600 nM and strand concentrations of 50/600/550 nM, with untailed primer and tailed primer.</li><li><figref idrefs="f0030">FIG 15B</figref> shows the melt curves of the six amplification products with additive EP043, where the downward pointing arrow indicates the melting temperature, 86°C, of the correct double-stranded DNA product. Circle 153 identifies the one replicate with untailed primer that showed the correct peak with no product evolution (flat plateau) in <figref idrefs="f0029">FIG 15A</figref>, and circle 154 identifies the two replicates with tailed primer also showed no product evolution (flat plateau) in <figref idrefs="f0029">FIG. 15A</figref>.</li><li><figref idrefs="f0031">FIG. 16A</figref> presents melt curves for replicates of a LATE-PCR amplification described in Example 14 utilizing a 5'-Dabcylated primer but no reverse complement sequence.</li><li><figref idrefs="f0032">FIG. 16B</figref> presents melt curves for replicates of a LATE-PCR amplification described in Example 14 utilizing a 5'-Dabcylated primer plus a reverse complement sequence at a concentration of 100 nM.</li><li><figref idrefs="f0033">FIG. 16C</figref> presents melt curves for replicates of a LATE-PCR amplification described in Example 14 utilizing a 5'-Dabcylated primer plus a reverse complement sequence at a concentration of 200 nM.</li><li><figref idrefs="f0034">FIG. 16D</figref> presents melt curves for replicates of a LATE-PCR amplification, described in Example 14 utilizing a 5'-Dabcylated primer plus a reverse complement sequence at a concentration of 300 nM.<!-- EPO <DP n="14"> --></li><li><figref idrefs="f0035">FIG. 17A</figref> is a graph of probe fluorescence as a function of cycle number for replicates of a LATE-PCR amplification with reverse transcription for an RNA target, described in Example 15, utilizing additive EP020 at a concentration of 2000 nM.</li><li><figref idrefs="f0036">FIG. 17B</figref> is a graph of probe fluorescence as a function of cycle number for replicates of a LATE-PCR amplification with reverse transcription for an RNA target, described in Example 15, utilizing additive EP010 at a concentration of 200 nM.</li><li><figref idrefs="f0037">FIG. 17C</figref> is a graph of probe fluorescence as a function of cycle number for replicates of a LATE-PCR amplification with reverse transcription for an RNA target, described in Example 15, utilizing additive EP003 at a concentration of 400 nM.</li><li><figref idrefs="f0038">FIG. 17D</figref> is a graph of probe fluorescence as a function of cycle number for replicates of a LATE-PCR amplification with reverse transcription for an RNA target, described in Example 15, utilizing an mixture of additive EP010 at a concentration of 400 nM and additive EP020 at a concentration of 1000 nM.</li><li><figref idrefs="f0039">FIG. 17E</figref> is a graph of probe fluorescence as a function of cycle number for replicates of a LATE-PCR amplification with reverse transcription for an RNA target, described in Example 15, utilizing a mixture of additive EP003 at a concentration of 400 nM and additive EP020 at a concentration of 1000 nM.</li><li><figref idrefs="f0040">FIG. 17F</figref> is a graph of probe fluorescence as a function of cycle number for replicates of a LATE-PCR amplification with reverse transcription for an RNA target, described in Example 15, utilizing no additive.</li><li><figref idrefs="f0041">FIG. 18A</figref> is a schematic depiction of a modified double-stranded additive according to this invention formed from two linear (random coil) oligonucleotides and having single-stranded overhangs.</li><li><figref idrefs="f0041">FIG. 18B</figref> is a schematic depiction of a modified double-stranded additive as in <figref idrefs="f0041">FIG 18A</figref>, but formed from one linear oligonucleotide and one hairpin-forming oligonucleotide.</li><li><figref idrefs="f0041">FIG 18C</figref> is a schematic depiction of a modified double-stranded additive as in <figref idrefs="f0041">FIG. 18A</figref>, but formed from two hairpin-forming oligonucleotides.</li><li><figref idrefs="f0042">FIG. 19A</figref> presents melt curves for products of LATE-PCR amplifications with Taq polymerase plus antibody, with and without additive SL04, as described in Example 16.</li><li><figref idrefs="f0042">FIG. 19B</figref> presents melt curves for products of LATE-PCR amplifications with Taq polymerase plus antibody, with and without additive SL07, as described in Example 16.<!-- EPO <DP n="15"> --></li><li><figref idrefs="f0043">FIG. 19C</figref> presents melt curves for products of LATE-PCR amplifications with Taq polymerase plus antibody, with and without additive SL08, as described in Example 16.</li><li><figref idrefs="f0043">FIG. 19D</figref> presents melt curves for products of LATE-PCR amplifications with Taq polymerase plus antibody, with and without additive SL09, as described in Example 16.</li><li><figref idrefs="f0044">FIG. 20</figref> is a graph of probe fluorescence as a function of the number of temperature oscillation cycles for a primer-independent probe-cleavage assay described in Example 18 utilizing additive SL06 at different concentartions.</li><li><figref idrefs="f0045">FIG. 21</figref> is a schematic representation showing the action of a blocker oligonucleotide to create a 3' terminal mismatch between a limiting primer and a target to which the primer is perfectly complementary.</li><li><figref idrefs="f0046">FIG 22A</figref> is a graph of threshold cycle (C<sub>T</sub>) versus starting concentration of target (Copy Number) for a dilution series of amplifications without blocker as described in Example 19.</li><li><figref idrefs="f0046">FIG. 22B</figref> is a graph of threshold cycle (C<sub>T</sub>) versus starting concentration of target (Copy Number) for a dilution series of amplifications with blocker as described in Example 19.</li><li><figref idrefs="f0047">FIG 23A</figref> is a graph of SYBR Green fluorescence versus amplification Cycle Number showing the effect of antibody in amplifications described in Example 20.</li><li><figref idrefs="f0047">FIG 23B</figref> is a graph of SYBR Green fluorescence versus amplification Cycle Number showing the effect of additive EP010 in amplifications described in Example 20.</li><li><figref idrefs="f0048">FIG 23C</figref> is melt curves of products described in Example 20 made with DNA polymerase only and product made with antibody added after the first incubation step of the assay.</li><li><figref idrefs="f0048">FIG. 23D</figref> is melt curves of product described in Example 20 made with antibody added prior to the first incubation step of the assay.</li><li><figref idrefs="f0049">FIG. 23E</figref> is melt curves of products described in Example 20 made with additive EP010 added before and after the first incubation step of the assay.</li></ul><!-- EPO <DP n="16"> --></p><heading id="h0006"><b>Detailed Description</b></heading><p id="p0029" num="0029">References are made to melting temperatures (Tm) of double-stranded additives, primers and probes. By definition, Tm means the temperature at which a double-stranded oligonucleotide is 50% double-stranded and 50% single-stranded. For additives, Tm means a calculated Tm of a double-stranded oligonucleotide not accounting for any effect of substituent modifiers. Tms of double-stranded additives presented in this specification were calculated according to <nplcit id="ncit0014" npl-type="s"><text>Markhan and Zuker (2005) DINAMELT web server for nucleic acid melting prediction, Nucleic Acids Res. 33:W577-W581</text></nplcit>, and <nplcit id="ncit0015" npl-type="b"><text>Markham and Zuker (2008) UNAFOLD: software for nucleic acid folding and hybridization. In Keith, J.M., ed., BIOINFORMATICS, vol. II, Structure, Functions and Applications, No. 453</text></nplcit> in <nplcit id="ncit0016" npl-type="b"><text>Methods in Molecular Biology, Ch. 1, pages 3-31 (Humana Press, Totowa, New Jersey. ISBN 978-1-60327-428-9</text></nplcit>. In utilizing the referenced web server, the following inputs were made: concentration of each strand, in µM, as reported in the Examples; 70 mM for salt concentration; and 3 mM for magnesium concentration. Tms of probes and primers in LATE-PCR amplification reactions the start of amplification are referred to as Tm<sub>[0]</sub>. Tm<sub>[0]</sub> can be determined empirically, as is necessary when structured probes are used, or calculated according to the "nearest neighbor" method (<nplcit id="ncit0017" npl-type="s"><text>Santa Lucia, J. (1998) PNAS (USA) 95: 1460-1465</text></nplcit>; and <nplcit id="ncit0018" npl-type="s"><text>Allawi, H. T. and Santa Lucia, J. (1997) Biochem. 36: 10581-10594</text></nplcit>) which is herein incorporated by reference in its entirety using a salt concentration adjustment. In our work, we use 0.07 M monovalent salt concentration, although other concentrations can be used.</p><p id="p0030" num="0030">References are made to modifying groups being located on terminal regions oligonucleotide strands. By "terminal regions" it is meant attached to a terminal 5' or 3' nucleotide or to an internal nucleotide not more than five, not more than three, or not more than two nucleotides from a 5' or 3' end. In some embodiments, terminal modifiers are attached to a 5' or 3' terminal nucleotide.</p><p id="p0031" num="0031">References are made to selectivity. By "selectivity" it is meant generally the preference of DNA polymerase to extend recessed 3' ends when certain conditions are met. Generally speaking, recessed 3'ends bound to a target sequence are thermodynamically unstable, that is they alternately bind to and partially unwind from the strand to which they are hybridized. These ends can be said to be stable when binding to the target is favored by<!-- EPO <DP n="17"> --> formation of more hydrogen bonds and unstable when they form fewer hydrogen bonds. According to this view, recessed 3' ends that are perfectly complementary to their targets are more stable than recessed 3' ends that are not perfectly complementary to their targets. Similarly, recessed 3' ends that are GC rich are generally more stable than recessed 3' ends that are AT rich, since GC dinucleotide pairs form three hydrogen bonds while AT dinucleotide pairs form two hydrogen bonds.</p><p id="p0032" num="0032">In accord with this understanding, one type of selectivity is the preference of a DNA polymerase to extend a recessed 3' end of a hybrid when the 3' terminal region, particularly including the terminal 3' nucleotide, of the recessed 3' end is perfectly complementary, that is, is hybridized with no mismatch. Stated another way, this type of selectivity is selectivity against a 3' terminal priming sequence that is not perfectly matched to its target. Selectivity against 3' terminal-region mismatches applies to primer-target hybrids, where it signifies the preference of a polymerase for a primer-target hybrid that is perfectly complementary at the 3' end of the primer over a primer-target hybrid having a mismatch at, for example, the 3' terminal nucleotide. Selectivity against 3' terminal-region mismatches also applies more generally to hybrids having recessed, extendable 3' ends formed by any two DNA strands in an amplification reaction mixture, such as may occur when one amplicon strand hybridizes to (that is, primes on) another amplicon strand.</p><p id="p0033" num="0033">A second type of selectivity is the preference of a DNA polymerase for a primer (or priming strand) having a 3' terminal region that is GC-rich rather than AT-rich, or stated another way, selectivity against a primer or other priming strand whose terminal region is AT-rich.</p><p id="p0034" num="0034">For selectivity of either type, the measure of selectivity is the difference (ΔC<sub>T</sub>) between the threshold cycle (C<sub>T</sub>) of the signal from amplification of the non-preferred hybrid, for example the hybrid formed by a primer and a mismatched target and the C<sub>T</sub> of the signal from amplification of the preferred hybrid, for example the hybrid formed by a primer and a matched target. Improvement in selectivity due to the use of an additive is the net C<sub>T</sub> difference obtained by subtracting the (ΔC<sub>T</sub>) without any additive from the (ΔC<sub>T</sub>) that results with the additive.</p><p id="p0035" num="0035">Additives for use in the present invention suppress mispriming in a primer-dependent DNA amplification reaction. Additives that reduce mispriming, inhibit DNA polymerase activity, increase DNA polymerase selectivity of either type, inhibit DNA polymerase exonuclease activity, or reduce scatter among replicate reactions, or any combination of the foregoing in primer-dependent DNA amplification reactions and nucleic acid detection assays employing such reactions, including PCR amplification reactions and PCR amplification assays can be included.</p><p id="p0036" num="0036">Chemical reagents that are soluble in DNA amplification buffer and include from one to four or from two to four, covalently bound moieties, which are referred to as modifying groups or, for short, modifiers, suppress mispriming and enhance polymerase selectivity for hybrids<!-- EPO <DP n="18"> --> between primers and fully complementary target sequences. The covalently bound modifying groups are polycyclic (including but not limited to aromatic) moieties which, if bulky, are planar and can be configured to bind to a DNA polymerase having an exonuclease domain (active or inactivated) so as to suppress mispriming and enhance polymerase selectivity for hybrids between primers and fully complementary target sequences.</p><p id="p0037" num="0037">In some embodiments, the quencher Dabcyl can be used as a modifying group for these reagents.</p><p id="p0038" num="0038">These polycyclic moieties can be solubilized by attaching them to double-stranded oligonucleotides. Certain double-stranded oligonucleotides with from 1-4 polycyclic moieties, as described above, can be useful as additives for reducing mispriming, inhibiting DNA polymerase activity, increasing DNA polymerase selectivity, inhibiting DNA polymerase exonuclease activity, reducing scatter among replicates, or any combination of the foregoing in primer-dependent DNA amplification reactions and nucleic acid detection assays employing such reactions, including PCR amplification reactions and PCR amplification assays. The modified double-stranded oligonucleotides may comprise natural nucleotides, that is, they may be DNA, RNA, or mixtures of DNA and RNA. The modified double-stranded oligonucleotides may also comprise non-natural nucleotides, for example, LNA's and 2'O-methyl ribonucleotides. The amplification reactions may be symmetric or non-symmetric, including asymmetric PCR amplification reactions and, preferably, LATE-PCR reactions.</p><p id="p0039" num="0039">The additives for use in the invention are modified linear double-stranded DNA oligonucleotides in which the complementary nucleic acid strands are from 6-50, preferably 12-30, and more preferably 16-26, nucleotides in length. The modified double-stranded oligonucleotides are blunt ended or contain short overhangs of 1-8 nucleotides, preferably 1-5 nucleotides,<!-- EPO <DP n="19"> --> on one or both ends. <figref idrefs="f0041">FIGS. 18A-18C</figref> depict several different embodiments with non-complementary terminal regions in the strands at one or both ends of an additive's double-stranded region. For purposes of illustration, all the constructions are shown with three modifying groups, M, having a particular placement, but it will be appreciated that embodiments such as these are not limited to the placement shown or to the inclusion of three modifier groups. <figref idrefs="f0041">FIG. 18A</figref> shows two partially complementary, random coil oligonucleotides 181, 182 that hybridize to form double-stranded additive 183, which includes double-stranded region 184 and single-stranded overhangs 185, 186. The melting temperature, Tm, of hybrid 184 can be adjusted by changing its length and GC content. <figref idrefs="f0041">FIG. 18B</figref> similarly shows two partially complementary oligonucleotides 187, 188 that hybridize to form double-stranded additive 189, which includes double-stranded region 190 and single-stranded overhangs 191, 192. Overhangs 191, 192 may comprise sequences that do not hybridize to one another even at low temperatures. Alternatively, the overhangs may comprise sequences that hybridize to one another only at low temperatures (Tm below the Tm of double-stranded region 184, as determined by degree of complementarity and GC content). The embodiment depicted in <figref idrefs="f0041">FIG. 18B</figref> differs from the embodiment shown in <figref idrefs="f0041">FIG. 18A</figref> in that one ologonucleotide, namely, oligonucleotide 187, when not hybridized to oligonucleotide 188, assumes a hairpin structure that includes a double-stranded stem 193 up to six nucleotides in length. <figref idrefs="f0041">FIG. 18C</figref> similarly shows two partially complementary oligonucleotides 194, 195 that hybridize to form double-stranded additive 196, which includes double-stranded region 197 and single-stranded overhangs 198-201. In the embodiment shown in <figref idrefs="f0041">FIG. 18C</figref> both oligonucleotides 194 and 195, when not hybridized to one another, assume hairpin structures that include stems 202 and 203, respectively. Examples 16 and 17 utilize the structures shown in <figref idrefs="f0041">FIG. 18C</figref>. For additives in which either or both strands form a hairpin, or stem-loop, structure, the Tm of each stem is higher than the Tm of the double-stranded region, to ensure formation of the hairpin during use, but not so high as to prevent formation of the double-stranded conformation of the additive in a reasonable period of time when the temperature of the reaction is decreased during use. In some embodiments, in which neither oligonucleotide strand serves as an amplification primer or as a probe, both 3' ends are blocked to prevent extension by a DNA polymerase. Blocking may be achieved by covalently linking a modifying group to the 3' terminal nucleotide of a strand or otherwise<!-- EPO <DP n="20"> --> blocking extension, as, for example, by including a 3' terminal phosphate group. Additives can include double-stranded oligonucleotides that are at least 50% double-stranded at 32°C, which is as high a temperature as is likely to be encountered during assembly of an amplification reaction mixture.</p><p id="p0040" num="0040">From 1-4 modifying groups, preferably 2, 3 or 4 groups, are included in the linear double-stranded oligonucleotides. The modifiers are covalently attached to additive strands in their terminal regions, that is, at a terminal nucleotide or at a nucleotide that is not more than five, preferably not more than two, nucleotides from a terminal nucleotide. Some embodiments utilize modifiers attached to terminal nucleotides of the double-stranded oligonucleotides. The modifiers can be covalently linked to oligonucleotide strands. Covalent linking of modifying groups is well known in the art for incorporating fluorophores and quenchers, for example.</p><p id="p0041" num="0041">The modifying groups can be moieties that are polycyclic, including but not limited to polyaromatic, and, if bulky, have an overall planar aspect. Examples include digoxigenin, a plant steroid; coumarin, a bicyclic aromatic; QSY-21, a small polyaromatic compounds used as quenchers, that are not planar. Fulvic and humic acids are believed to be included. In some embodiments, the modifying group is the well-known quencher Dabcyl, which is polyaromatic, bulky and planar. Thus, modifying groups can be polycyclic moieties that do not have bulky portions that are non-planar, and preferably are polyaromatic.</p><p id="p0042" num="0042">Additives can include a linear double-stranded DNA oligonucleotide with various possible configurations of one, two, three and four modifying groups. With one terminal modifying group, there are four possible configurations: the modifier may be attached to the 3' or 5' terminal nucleotide of either strand. With two terminal modifying groups, there are six possible configurations; with three terminal modifying groups there are four possible configurations; and with four modifying groups there is only one possible configuration. Attachment of modifiers to internal nucleotides of terminal regions creates additional possible configurations. In all cases in which a strand is not a primer and a modifying group is not attached to a strand's 3' terminal nucleotide, that nucleotide is otherwise blocked, as by a phosphate group (identified in sequences in the Examples as "p").</p><p id="p0043" num="0043">In certain embodiments, one strand serves also as a primer, and its 3' terminus is not blocked. In certain other embodiments, one strand serves as a detection probe, in which case<!-- EPO <DP n="21"> --> its 3' end can be blocked, for example by a terminal modifying group, a terminal fluorophore, or a terminal phosphate group. For primer embodiments, a single-stranded amplification primer can be converted into an additive by including a single-stranded oligonucleotide that is complementary to the primer, which we call the reverse complement sequence, so that it forms a double-stranded hybrid with the primer. The hybrid can function as an additive when it is double-stranded. The hybrid can include three modifiers, such as Dabcyl groups. The Tm of the reverse complement sequence to the primer strand can be designed to be 5-30°C, preferably 15-25°C, lower than the Tm of the primer strand to its amplification target sequence. To achieve the difference in Tm's, the reverse complement sequence may be rendered partially complementary to the primer strand by making it either shorter or mismatched at one or more nucleotide, or both. For probe embodiments, a labeled, single-stranded hybridization probe can be converted to an additive similarly to the conversion of a primer and has a Tm that is similarly lower than the Tm of the probe-target hybrid. Preferred probe embodiments include a probe strand having a fluorophore and a quencher and a reverse complement sequence having two terminal quenchers.</p><p id="p0044" num="0044">Primer-dependent amplification reaction mixtures for amplifying at least one DNA or cDNA target can be included. The reaction mixtures include at least one of the foregoing additives as well as target nucleic acid and amplification reagents that include primers, a DNA polymerase, dNTP's and, generally, amplification buffer. If the amplification mixture is for an amplification assay that includes both amplification and homogeneous detection of double-stranded amplification products, single-stranded amplification products, or both, the reaction mixture can include at least one reagent for product detection, preferably fluorescence detection. Preferred reagents for detecting double-stranded amplification products are DNA dyes, such as SYBR Green. Preferred reagents for detecting single-stranded products are fluorescently labeled detection probes whose hybridization to single-stranded products causes a detectable fluorescent signal change or whose hybridization to single-stranded products during amplification leads to a detectable fluorescent signal change. Numerous homogeneous detection reagents are known in the art, and any suitable detection reagent or reagents can be used. Other reagents can also be used. If target nucleic acid that is included is an RNA target sequence, the reaction mixture will include reverse transcriptase.<!-- EPO <DP n="22"> --></p><p id="p0045" num="0045">Reaction mixtures can include multiple primer pairs for multiple targets for multiplex amplifications and assays. Example 5 illustrates a reaction mixture for a duplex LATE-PCR assay for two target sequences that includes two primer pairs and a fluorescent probe for each amplified product. Example 8 illustrates a reaction mixture for a highly multiplexed amplification, a twelve-plex that contains twelve primer pairs for twelve different targets. If an additive includes one of the primer strands, the reaction mixture can further include the appropriate reverse complement sequence. Reaction mixtures can be PCR reaction mixtures, and in some embodiments LATE-PCR reaction mixtures. Reaction mixtures may include a combination, or mixture, of two additives. Such a mixture may comprise four strands or, if two additives share a common strand, three strands. Reaction mixtures include at least one modified, double-stranded additive at a total concentration of up to 2000 nM, preferably up to 1000 nM and more preferably up to 600 nM. If the reaction mixture includes a mixture of additives, the total concentration of additives remain as stated.</p><p id="p0046" num="0046">Methods for primer-dependent amplification of one or more DNA or cDNA target sequences and primer-dependent amplification of one or more DNA or cDNA target sequences with homogeneous detection of amplification products (that is, amplification assays with homogeneous detection) utilizing reaction mixtures described above are provided. Amplification methods and amplification assay methods may include isothermal amplification reactions or thermal cycling amplification reactions. In one embodiment, the amplification method can PCR and in some embodiments, LATE-PCR The additive or combination of additives selected to be used in a particular amplification or amplification assay, and its or their amount(s), depends on the effect desired and on the temperatures to be utilized during amplification. Isothermal amplifications may include only a reaction mixture preparation temperature, typically room temperature, followed by an isothermal amplification reaction at a single reaction temperature, for example, 37°C. PCR and other thermal cycling amplification methods include a reaction mixture preparation temperature followed by numerous thermal cycles that include a primer annealing temperature (annealing temperature), a primer extension temperature (extension temperature), and a strand denaturation temperature (melting temperature). Although the annealing temperature and the extension temperature may be the same, it is more common for the annealing temperature to<!-- EPO <DP n="23"> --> be 5-20 degrees Celsius (°C) below the extension temperature. LATE-PCR assays may further include a low-temperature detection step in some or all of the thermal cycles, during which the temperature of the reaction mixture is reduced below the annealing temperature to permit low-temperature probes to bind to their target sequences. Amplification reactions may be interrupted at an intermediate point for performing some operation that may include low temperature (below the annealing temperature), after which the amplification reaction can be resumed. Amplifications may take advantage of other ways of reducing mispriming. For example, the DNA polymerase that is used may be a hot-start polymerase. Further, the primers that are used may be designed to have AT-rich 5' ends, including where necessary by adding extensions. Additionally or alternatively, the 3' ends of primers can be designed to be either GC-rich or AT-rich so as to alter polymerase inhibition in amplifications and amplification assays. Products of amplification reactions can be suitable for sequencing, including but not limited to dideoxy sequencing.</p><p id="p0047" num="0047">Amplification assays may include real-time homogeneous detection of single-stranded products, double-stranded products, or both, at multiple times during amplification of DNA target sequences, for example, during some or all cycles of a PCR amplification reaction. As stated above, fluorescence detection can be used. Alternatively, amplification assays may include homogeneous detection at end-point following completion of an amplification reaction. Detection may include melting amplification products and detecting fluorescence change as a function of temperature. Detection may be qualitative or quantitative. For targets that are RNA, assays can include reverse transcription.</p><p id="p0048" num="0048">Reagent kits for performing amplifications and amplification assays are provided. Such kits can include reagents needed to prepare reaction mixtures, including primers for at least one target sequence, dNTPs, a DNA polymerase, and at least one modified double-stranded additive, as described above. Kits for amplification assays can also include at least one detection reagent, such as, a DNA fluorescent dye or a fluorescently labeled hybridization probe. Amplification kits and amplification assay kits may also include reagents for sample preparation, for example, cell lysing reagents, reagents for nucleic acid isolation, and reverse transcriptase. Amplification assay kits may include control target sequences and primers for their amplification.<!-- EPO <DP n="24"> --></p><p id="p0049" num="0049">Selection of an additive or mixture of additives can take into account their properties of DNA polymerase inhibition, selectivity against 3' terminal primer mismatches, selectivity against AT-rich primer 3' terminal regions, inhibition of polymerase exonuclease activity, mispriming suppression, and reduction of scatter among replicates. An additive's effect depends, in turn, on the inherent properties of the additive, its concentration, its melting temperature, and its concentration. For example, inherent polymerase inhibition tends to increase with the number of modifiers included in the additive, and the effective inhibition of an additive increases with its concentration. Selectivity against a 3' terminal primer mismatch has been found to correlate with blocking Exonuclease activity of DNA polymerases that have that activity or at least have an exonuclease site. This may be due to blocking the exonuclease site of the enzyme by the additive.</p><p id="p0050" num="0050">Additives can be added to amplification reaction mixtures in concentrations that are effective for one or more of the functions of suppressing mispriming, increasing polymerase selectivity against hybrids having recessed 3' terminal sequences that are not perfectly complementary, increasing polymerase selectivity against hybrids having recessed 3' terminal sequences that are AT-rich, reducing scatter among replicate reactions, inhibiting polymerase 5' exonuclease activity, and inhibiting polymerase activity. Because additives interact with DNA polymerases, the concentration required will vary with the concentration of DNA polymerase that is included in an amplification reaction mixture. Determination of the additive concentration required to be effective for one or more of the foregoing functions, as well a determination of an optimum concentration, can be determined routinely by trying several concentrations in the amplification reaction or amplification assay for which an additive is intended, as demonstrated in the Examples below. Example 3, for instance, reports empirical trials of several additives at several concentrations to determine the effects of the additives at various concentrations to aid in selection of a preferred additive, to ascertain the effective concentration, and to determine an optimum concentration for a particular purpose in a particular LATE-PCR assay. For Taq DNA polymerases, which are the most commonly used polymerases for amplification reactions and assays, a typical polymerase concentration can be 1.25 units in 25 microliters (µl0r ul) of reaction mixture. In some embodiments, no more than 2000 nanomolar (nM) of additive is required, in some embodiments, no more than 1000 nM, and in some emboduiments, not more than 600nM.<!-- EPO <DP n="25"> --> For Tfi DNA polymerases, which can be included in reaction mixtures at higher concentrations than Taq DNA polymerases, the same concentrations of additives are generally effective.</p><p id="p0051" num="0051">For an additive to act as a "hot start" reagent, it is preferred that the additive nearly or completely inhibit the polymerase activity of the polymerase being used, for example, Taq DNA polymerase, at temperatures below the reaction temperature of an isothermal amplification and below the annealing temperature of a thermal cycling reaction such as PCR. For this purpose, the additive can have a high inhibitory effect on polymerase activity and a melting temperature (Tm) that is at least 32°C and equal to or below, preferably, 1-15°C below, more preferably 1-5°C below, the isothermal reaction temperature or the PCR , and at a concentration sufficiently high to completely or at least substantially inhibit the polymerase activity. As additives are not irreversibly denatured by being melted apart at temperatures above their Tm, the additives will function during the isothermal reaction of PCR thermal cycling every time the temperature is lowered sufficiently for the additive to become double-stranded, for example, during a low-temperature detection step, as is sometimes used in a LATE-PCR assay.</p><p id="p0052" num="0052">An additive can also act to reduce mispriming and increase polymerase selectivity at the reaction temperature of an isothermal amplification or at temperatures above the annealing temperature of a PCR amplification, particularly at the extension temperature. For this purpose, an additive can have low to modest inhibitory effect on polymerase activity and a melting temperature that is not more than 2°C below, preferably at least equal to, and more preferably above, the isothermal reaction temperature or the PCR extension temperature, and at a concentration that is only as high as necessary to achieve the desired effect without unduly inhibiting the efficiency of the reaction. Here again, because the additives are not irreversibly denatured during the strand-melting step of PCR cycles, the additives can function to increase polymerase selectivity during every PCR cycle as the temperature is lowered for the strand-melting temperature to the annealing temperature or below.</p><p id="p0053" num="0053">Additives may be used singly or in combination. A mixture of two modified double-stranded oligonucleotides may include four strands or, if the two additives share a common strand, three strands. Three-strand mixtures insert one less strand into a reaction mixture, which can be advantageous in embodiments wherein the additive is neither a primer nor a<!-- EPO <DP n="26"> --> probe for any target sequence in an amplification reaction mixture. Using additives in combination imparts flexibility of design. For example, to suppress Type I mispriming, one may include a first additive that, by its inherent nature, Tm and concentration, is very inhibitory of polymerase activity below the primer annealing temperature of an amplification reaction, but that is single-stranded during amplification so as not to inhibit the polymerization reaction. In combination with such an additive, to suppress Type II mispriming and where applicable, Type III mispriming during amplification, one may include an additive that is double-stranded during primer annealing but that minimally inhibits polymerase activity during primer extension.</p><p id="p0054" num="0054">Oligonucleotide reagents that interact directly with a DNA polymerase enzyme used in either an isothermal DNA amplification reaction or a thermal cycling DNA amplification reaction, such as a PCR reaction, are provided. Oligonucleotide reagents can act in amplification reactions during all steps in which they are double-stranded. They can have the effect of both suppressing mispriming and increasing polymerase selectivity, including the preference of the DNA polymerase to extend recessed 3' ends that are perfectly complementary to the strands to which they hybridize in comparison to recessed 3' ends that are imperfectly complementary to the strands to which they hybridize. Mispriming may be considered according to different types. Type I is mispriming that occurs whenever the temperature of the reaction mixture is below the primer annealing temperature. It occurs during preparation of reaction mixtures prior to the start of amplification. It may also occur during amplification, if the temperature is reduced below the primer annealing temperature. Type II is mispriming that occurs during amplification whenever the temperature of the reaction mixture is at or above the primer annealing temperature but below the melting temperature of a primer that is present. Type III is mispriming that occurs during amplification that continues after a high concentration of amplification product (amplicon) has been made. Yet another manifestation of mispriming is primer-dimer formation, wherein one primer hybridizes to another primer or to itself and then undergoes extension to generate a short double-stranded amplicon, which can then amplify further or even multimerize and amplify further. It is useful to divide an amplification reaction into stages to consider mispriming possibilities. Mispriming creates an amplifiable product, so a mispriming event that occurs early in an amplification reaction will be amplified almost as if it were a target<!-- EPO <DP n="27"> --> molecule. The following general description is for PCR reactions, but persons skilled in the art will appreciate its application to other amplification reactions. This general description of PCR is for illustration purposes only and is not intended to limit the types of amplication reactions that can be used.</p><p id="p0055" num="0055">Pre-Stage: Reagents are prepared and mixed at 25°C or lower (for example, on-ice). The concentration of primers is highest during the Pre-Stage, which typically lasts for minutes. Usually, the number of targets is low or very low during Pre-Stage, and some or all of those targets may be single-stranded, depending on how the sample was prepared and whether or not it is a cDNA. Indeed, synthesis of cDNA using an enzyme such as reverse transcriptase is also a part of Pre-Stage when the reaction mixture used for cDNA synthesis also contains primers and a DNA polymerase, since these components of the reaction mixture can misprime under the conditions required cDNA synthesis, typically 5-30 minutes at temperatures in the range of 40-60°C. The Pre-Stage is terminated by heating to high temperature, for example, 95°C, to denature all double-stranded DNA in the reaction mixture. If the DNA polymerase has been added in an inactivated form, for example, antibody-bound DNA polymerase, this heating step activates the polymerase, a process known as "hot start."</p><p id="p0056" num="0056">Type I mispriming occurs during the Pre-Stage. Chances of Type I mispriming are enhanced, if the DNA polymerase is not a hot-start enzyme and if no other inhibitor of polymerase activity is included in the reaction mixture. Also, Type I mispriming occurs, if the hot-start modification of the polymerase or added inhibitors used to block polymerase activity fail to do so completely. Both primer-dimer formation and Type I mispriming are favored during the Pre-Stage because the temperature is low. Products of Pre-Stage mispriming will be amplified.</p><p id="p0057" num="0057">Early-Stage: This stage of the reaction is typically 10-15 thermal cycles of a PCR amplification. The thermal profile of each cycle of 3-step PCR includes a strand-melting temperature, a primer annealing temperature, and primer extension temperature. For 2-step PCR, primer annealing and primer extension are performed at the same temperature. The amount of time allotted for each step in the thermal cycles is typically seconds long. During the first and second thermal cycles primers first anneal to their target sequences within the full-length target and are intended to selectively extend only when on fully complementary target sequences. Primers anneal to and extend on both strands of the target and, if all goes<!-- EPO <DP n="28"> --> perfectly, generate and then exponentially amplify two complementary strands of defined length. The tendency of product strands to hybridize to each other is low, because their concentrations are low.</p><p id="p0058" num="0058">Type II mispriming can occur during the Early-Stage if primers extend on allelic targets to which they are not fully complementary. It is not atypical for primers to have Tms several degrees or even more above the annealing temperature, which invites Type II mispriming. Shorter annealing times and higher annealing temperatures (relative to the primer Tms) are more stringent than longer annealing times and lower annealing temperatures and therefore decrease Type II mispriming and increase polymerase selectivity. Products of Type II mispriming can be amplified during the remainder of amplification. Hot-start polymerase modifications do not apply here, because the first heating to high temperature irreversibly inactivates the hot-start antibody or enzyme alkylation. Thermally stable inhibitors, including those described here, will be functional during the first and subsequent annealing steps, because they are not irreversibly denatured by high temperature.</p><p id="p0059" num="0059">Middle-Stage: This stage of a PCR reaction is typically comprised of 10-25 thermal cycles and includes melting, primer annealing, and primer extension. The amount of time allotted for each step in the thermal cycle is typically seconds long. Primers anneal to and extend on both strands of the target and, under optimal conditions generate and then exponentially amplify two complementary strands of defined length that is determined by primer pairs.</p><p id="p0060" num="0060">In the case of real-time symmetric PCR assays, Middle-Stage typically includes product detection during either the annealing step or the extension step of the reaction. In the case of LATE-PCR reactions, the Middle-Stage may include product detection at a temperature that is lower than the annealing temperature and occurs after the extension step. Fluorescent signals using a hybridization probe typically become detectable late in the exponential phase of both symmetric and LATE-PCR.</p><p id="p0061" num="0061">Toward the end of the Middle-Stage in symmetric PCR, the concentration of the exponentially accumulating product strands grows high enough for hybridization of product strands during the primer-annealing step. Exponential amplification slows down and plateaus, because, it is believed, the polymerase binds to the double-stranded product of the reaction. In the case of LATE-PCR, the limiting primer runs out and terminates the<!-- EPO <DP n="29"> --> exponential phase of the reaction before the concentration of the product strands becomes high enough to slow the reaction.</p><p id="p0062" num="0062">In LATE-PCR amplifications that include a low-temperature detection step, Type I and Type II mispriming can occur in the Middle-Stage, just as in the Early Stage. This is particularly a risk during the low temperature detection step in real-time LATE-PCR. Type III mispriming can also occur during the Middle Stage as the concentration of product strands increases. Mispriming of any type, whether during Pre-Stage, Early-Stage or Middle-Stage results in scatter among replicate reactions, which is particularly manifest as exponential amplification slows down.</p><p id="p0063" num="0063">Late-Stage: The Late-Stage of amplification is generally found only in LATE-PCR because symmetric PCR has reached plateau and been terminated by this stage. This stage of a LATE-PCR amplification is typically comprised of 10-25 thermal cycles that include steps of melting, primer annealing (excess primer only), and primer extension (excess primer only). The amount of time allotted for each step in the thermal cycle is typically seconds long. Each excess primer anneals to and extends on the extension product made by extension of its corresponding limiting primer (its Limiting-Primer Strand) and, if all goes perfectly, efficiently generates the Excess-Primer Strand, which accumulates linearly until it begins to out-compete the excess primer itself. Thus, LATE-PCR reactions slow down but do not plateau as do symmetric PCR reactions.</p><p id="p0064" num="0064">In the case of real-time LATE-PCR assays, this stage may include product detection at the primer annealing temperature or at a temperature that is lower than the annealing temperature and occurs after the extension phase. Fluorescent signals using a hybridization probe typically increase with approximately linear kinetics during this stage.</p><p id="p0065" num="0065">Type III mispriming can occur during the Late-Stage after a number of linear cycles, because the 3' end of the Excess Primer strand can misprime anywhere along another molecule of the Excess Primer strand. Thus, the probability of Type III mispriming increases as: 1) the concentration of single-stranded product increases; 2) the number of different single-stranded products in a multiplex reaction increases; 3) the temperature of the reaction is lowered; 4) the 3' ends, or bases near the 3' ends of the Excess Primer Strands are GC-rich and hybridize (misprime) more readily. Type III mispriming results in conversion of single-stranded DNA back into double-stranded DNA, which we refer to as "product evolution"<!-- EPO <DP n="30"> --> (although products are incomplete or abnormal). Product evolution is manifest as a sudden late increase in the fluorescence using dyes that detect double-stranded products (an increase in slope after plateau), or a sudden decrease in fluorescence from probes that detect single-stranded DNA. Thus, Type III mispriming is similar to Type II mispriming in that the error can occur above the annealing temperature, but Type III mispriming is also similar to Type I mispriming in that the error can occur below the annealing temperature. Type II mispriming can, of course, occur during this stage as well, as can Type I mispriming, if a low-temperature step is included.</p><p id="p0066" num="0066">End-Stage: End-Stage in LATE-PCR does not involve additional amplification because double-stranded products are no longer melted apart. End-Stage is a post-amplification stage in which some operation is carried out. Most commonly the temperature is lowered below the annealing temperature to permit probe target hybridization (signal generation = anneal signal) and then the temperature is raised over time to melt probe-target complexes apart (loss of signal = melting). We refer to this as "Probe Anneal-Melt Analysis". Probe Anneal-Melt Analysis at End-Stage can be carried with or without real-time analysis during LATE-PCR amplification. Typically Probe Anneal-Melt Analysis after a Late-Stage of 10-15 cycles generates quantitative information about the number of target copies present at the start of the reaction.</p><p id="p0067" num="0067">Typically, mispriming does not occur during End-Stage or, if it does, it is not followed by additional amplification needed to make products of mispriming visible. And, as shown in Example 10, it is possible using the "ColdStop" protocol to carry out Probe Anneal-Melt Analysis during Late-Stage, then to resume amplification for additional cycles until End-Stage is reached, at which time Probe Anneal-Melt Analysis can be repeated. As shown in Example 10, there is less scatter among replicates when real-time analysis is not used before Probe Anneal Melt Analysis, because the frequency of Type III mispriming is reduced by omission of a detection step in each thermal cycle.</p><p id="p0068" num="0068">Although not intending to be bound by any theory, we theorize that modified double-stranded oligonucleotides, as described herein, interact directly with DNA polymerases to suppress all types of mispriming, that is, Type I, Type II, Type III and primer-dimers. We believe that the additives, when double-stranded, preferentially bind to the 5' exonuclease domains of DNA polymerases but also bind to the polymerase domains of DNA<!-- EPO <DP n="31"> --> polymerases, if added in sufficient concentration to more than saturate the 5' exonuclease domains. Empirically, 300-600 nM concentration of additive per 1.25 Units of Taq DNA polymerase in a 25 µL reaction volume can be sufficient to saturate both the 5' nuclease domain and the polymerase domain.</p><p id="p0069" num="0069">Although not intending to be bound by any theory, we theorize that by saturating both domains at temperatures below the primer annealing temperature, additives, as described herein, prevent Type I mispriming by effectively shutting down the polymerase by a combination of mass action and binding due to the modifying groups. At temperatures above the primer annealing temperature, additives can be used in concentrations which do not saturate both the 5'exonuclease domain and the polymerase domain. At these temperatures, additives preferentially bind to and selectively inhibit the activity of the 5' exonuclease domain while leaving the polymerase domain largely free to carry out extension of correctly hybridized primers. By selectively binding to the 5' exonuclease domain, additives increase the selectivity of the polymerase domain by an allosteric effects.</p><p id="p0070" num="0070">Although not intending to be bound by any theory, we theorize that modifying groups, for example Dabcyl groups, contribute to the functioning of additives in ways that can be used in selecting one or more additives for a particular purpose. Even one 3' terminal modifying group can suppress mispriming that is potentially caused by the additive itself. However, 3' terminal modifying groups, whether one or two on a double-stranded oligonucleotide, do not function to increase polymerase selectivity against a mismatch at the 3' terminus of a primer. On the other hand, 5' terminal modifying groups, particularly two 5' modifying groups, can significantly enhance that polymerase selectivity. Inclusion of modifiers on both strands at one end of the double-stranded oligonucleotide (that is, one 5' modifier and one 3' modifier) can significantly enhance that selectivity even if the double-stranded oligonucleotide is not blunt-ended. Having two modifiers on both ends of a double-stranded oligonucleotide can be better for selectivity enhancement than having two modifiers on just one end, but double-stranded oligonucleotides with four modifying groups tend to lower the efficiency of the polymerization reaction more than do double-stranded oligonucleotides with one, two or three modifying groups. We theorize that the cause for this is that additives with four modifying groups bind more efficiently to polymerase domains than do additives with fewer modifying groups.<!-- EPO <DP n="32"> --></p><heading id="h0007"><u>Suppression of Type I Mispriming</u></heading><p id="p0071" num="0071">Additives include double-stranded oligonucleotides that are modified by the addition of 1, 2, 3 or 4 modifying groups, for example Dabcyl modifying groups, at or near the termini of the strands, that is, in the terminal regions of the strands. In some embodiments, there are 2-4 such groups, and in some embodiments, the groups are covalently attached to terminal nucleotides. In the Examples, additives as described herein, whether single additives or mixtures, are denoted by the prefix "EP" to distinguish them from other additives described for purposes of comparison. Example 1 demonstrates that additives suppress Type I mispriming without causing additional mispriming. In this example, a LATE-PCR amplification that produced incorrect product (product other than that defined by the primer pair, as determined by melt analysis) was used. Production of the wrong product indicates Type I mispriming. Two different additives comprising unmodified double-stranded oligonucleotides having the same length (16 nucleotides) but different sequences were tried as control additives in this amplification. One, 16merA, added at a concentration of at least 300 nM caused the reaction to produce the correct product (<figref idrefs="f0001">FIG. 1</figref>). The other, 16merB, did not (<figref idrefs="f0002">FIG. 2</figref>), even when added at concentrations of 600 nM or1000 nM, and in fact caused mispriming. This inconsistency was in accord with the teaching of Kainz et al. that double-stranded oligonucleotides could suppress mispriming or could cause mispriming. The assay was repeated with additives that were modifications of the mispriming-causing oligonucleotide, 16merB, the modifications being the inclusion of either one or two terminal Dabcyl modifiers. Inclusion of a single Dabcyl modifier, additive EP048 (<figref idrefs="f0003">FIG. 3</figref>) or additive EO049 at 600 nM concentration, suppressed mispriming as compared to 16merB (<figref idrefs="f0002">FIG.2</figref>), including mispriming caused by the unmodified oligomer. Inclusion of two Dabcyl modifiers, additive EP027, did so at only 300 nM concentration and gave quite an improvement when added at only 100 nM concentration (<figref idrefs="f0004">FIG 4</figref>). As shown by the kinetic analysis of reactions containing additive EP027 at different concentrations (<figref idrefs="f0005">FIG. 5</figref>), additive EP027 at 300 nM concentration eliminated scatter among replicates, and 300 nM was judged to be the optimum concentration in this assay.</p><p id="p0072" num="0072">The assay of Example 1 was repeated with several other unmodified double-stranded oligonucleotides having lengths from 12 to 30 nucleotides. Results, reported in Example 1, confirmed that unmodified oligonucleotides were inconsistent regarding<!-- EPO <DP n="33"> --> suppressing or causing Type I mispriming. As reported in Example 1, the assay was also repeated with a number of double-stranded oligonucleotides having lengths in the range of 8-22 nucleotides and having two modifiers that were Dabcyl, two modifiers that were digoxigenin, four modifiers that were Dabcyl, or four modifiers that were digoxigenin. Results confirmed that additives, as described herein, suppressed Type I mispriming. These results also demonstrate the influence of Tm for additives. (In this application the Tm of an additive means the calculated Tm of its unmodified double-stranded sequence, as defined above. Modifiers tend to increase actual Tm slightly, perhaps 1-2°C, which the reader can take into account). To suppress Type I mispriming, it is preferred that additives remain double-stranded up to, or nearly up to, the primer annealing temperature and the primer Tm's. In Example 1, the primer annealing temperature for the first 10 cycles was 55°C. While good results were obtained in all cases at 600 nM concentration with additives having Tms ranging from 37°C to 63°C in Example 1, it was only additive EP021, the additive with the lowest Tm, that did not also give good results at 300 nM. The additives that performed best at concentrations of 100 nM and 50 nM had Tm's of at least 60°C. For suppression of Type I mispriming in PCR amplification reactions, additives can have Tms of at least 32°C, more typically at least 50°C, and more preferably at least 60°C.</p><p id="p0073" num="0073">As a further check on the consistency with which additives as described herein suppress Type I mispriming, we performed a LATE-PCR assay for a different target sequence using different primers. In this assay, as reported in Example 2, we compared twelve additives to the unmodified double-stranded oligonucleotide, oligonucleotide 22merA, that performed well in the assay of the first part of Example 1. The additives all had lengths of 22 nucleotides, several different sequences, and several different configurations of two, three or four terminal Dabcyl modifiers. All were at least as good as additive 22mer A in suppressing mispriming at 300 nM concentration, and nearly half did so at a lower concentration of only 100 nM. <figref idrefs="f0006">FIG 6</figref> is melt curves for additive EP003 and additive 22merA, showing that only the additive suppressed mispriming at 100 nM concentration.</p><p id="p0074" num="0074">Example 9 illustrates a quantitative LATE-PCR assay to measure polymerase activity of a DNA polymerase prior to the first thermal cycle. This same assay can be used to quantify and compare the DNA polymerase inhibitory capacities of additives, which can be assayed over a broad range of concentations, temperatures, and incubation times. The initial<!-- EPO <DP n="34"> --> reaction mixture includes a high concentration of two oligonucleotides (62 and 75 base pairs, respectively) capable of annealing to each other at their 3' ends to form a hybrid that is 27 base pairs long and has a calculated Tm of 60°C. They also have priming sites at their 5' ends. Amplification primers are not included in the initial reaction mixture. The thermal profile of the reaction begins with an isothermal soak at 50°C for 10 minutes. During this step the overlapping oligonucleotides can prime themselves, that is, hybridize and be extended by active DNA polymerase. To the extent that this occurs, there will be created copies of a double-stranded target for the primers, which are added to the reaction mixture prior to thermal cycling. Inhibition of the activity of the polymerase activity during the long incubation at 50°C will reduce the number of copies of target formed during this step.</p><p id="p0075" num="0075">After the long 50°C incubation, high Tm primers are added, and a 2-step LATE-PCR amplification is performed to amplify whatever targets had been made. The primer annealing temperature use for amplification (72°C) is well above the Tm of the overlapping nucleotides so that additional double-stranded targets are not generated. In this assay, the number of cycles required to generate a detectable level of product (observed with either SYBR Green or a probe to the Excess-Primer-Strand) depends on how many full length strands were generated during the initial isothermal incubation of the partially complementary oligomers. This, in turn, depends on how active the DNA polymerase was during isothermal incubation due to the presence/absence of any potential enzyme inhibitor(s), such inhibitors, of known composition and concentration, having been added to the reaction mixture when it was first assembled on ice and prior to addition of the (overlapping oligonucleotides.</p><p id="p0076" num="0076">We tested additives in this quantitative assay, including additives having Tm's at or below the 50°C incubation temperature (EP020, Tm 50°C; EP022, Tm 45°C) and an additive having a Tm substantially above the incubation temperature (EP046, Tm 67°C). The additives having the lower Tm's would have been at least substantially single-stranded during the 50°C incubation, while high-Tm additive EP046 would have been double-stranded. Incorporation of the low-Tm additives into the reaction mixture resulted in no delay of the C<sub>T</sub>, but incorporation of EP046 at a concentration of 600 nM did delay the C<sub>T</sub>, whether the polymerase was Taq or Taq-plus-antibody. Kinetic curves for additive EP046 are shown in <figref idrefs="f0025">FIG. 13. FIG. 13</figref> reveals that in the absence of any DNA polymerases inhibitor the 3'ends of the overlapping oligonucleotides hybridized to each other and extended. Addition of the<!-- EPO <DP n="35"> --> antibody with the polymerase for hot-start partially inhibited Type I mispriming, by about 1000- fold, but further addition of 600 nM EP046 inhibited Type I mispriming an additional 10-fold.</p><p id="p0077" num="0077">Example 16 reports similar tests with additives having single-stranded overhangs six nucleotides in length and a double-stranded region of 22 base pairs. The additives all contained the same strand sequences but differed in the number and placement of modifiers, which were Dabcyl groups in the example. Both individual strands were hairpin-forming as depicted in <figref idrefs="f0041">FIG. 18C</figref>. The method of the tests included and isothermal soak at 50 °C for one minute (rather than for 10 minutes as in Example 9), followed by incubation on ice and then the LATE-PCR amplification. Melt-curve analysis showed that additives with two modifiers (<figref idrefs="f0042">FIG 19A</figref>) and three modifiers (<figref idrefs="f0042">FIGS. 19B</figref>, <figref idrefs="f0043">19C</figref>) reduced generation of incorrect product, and the additive with four modifiers (<figref idrefs="f0043">FIG 19D</figref>) completely suppressed its generation.</p><p id="p0078" num="0078">Example 20 reports a test according to Example 9 that more strictly isolates Type I mispriming during the Pre-Stage. By using an additive that becomes single-stranded at the PCR annealing/extension temperature, possible Type II mispriming is eliminated. Based on the results reported in Example 20, we conclude that: a) hot-start antibody does not suppress DNA synthesis completely and that most products generated in the presence of the antibody result from Type I mispriming; b) products synthesized during incubation on ice are largely the result of Type I mispriming; c) additive EP010 acts to increase the specificity of product extension on ice, and because most products generated on ice are the result of Type I mispriming, EP010 inhibits most primer extension events on ice. Because melt curves of the amplified product containing additive EP010 (<figref idrefs="f0049">FIG. 23E</figref>) show that the double-stranded form is no longer present at 72°C, the temperature at which primer annealing and extension was carried out during amplification, the effects of EP010 observed in Example 20 are entirely due to the activity of EP010 during incubation at 50 °C and on ice, prior to the start of amplification. The same analysis of the additives used in Example 9 revealed that they have melt peaks (not shown) that are higher than that of EP010 and, therefore, the effects of the additives in Example 9 are due not strictly to steps prior to amplification, but also to steps during amplification.</p><heading id="h0008"><u>Suppression of Type II Mispriming and Increasing Polymerase Selectivity in PCR Reactions</u></heading><!-- EPO <DP n="36"> --><p id="p0079" num="0079">Additives can suppress Type II mispriming and increase the selectivity of DNA polymerase for hybridized 3' terminal nucleotides of primers. To determine the selectivity against a mismatch at the 3' terminal nucleotide of the limiting primer during amplification in a LATE-PCR assay, we amplify a target that is perfectly complementary to both primers (matched target), and we separately amplify a target that is perfectly complementary to the excess primer but that contains a single mismatch to the 3' terminal nucleotide of the limiting primer. Alternately, as described below and demonstrated in Example 19, a 3' terminal mismatch can be created by use of a blocker oligonucleotide. We detect double-stranded product by DNA dye. "Selectivity" is the difference (ΔC<sub>T</sub>) between the C<sub>T</sub> of the signal from amplification of the mismatched target and the C<sub>T</sub> of the signal from amplification of the matched target. When performed on a sample containing no additive, this assay can demonstrate the basic selectivity of the polymerase for the primer/matched-target over primer/mismatched target, as well as the basic efficiency of amplification of the primer/matched target. For Taq DNA polymerase, the ΔC<sub>T</sub> can be less than two amplification cycles. Improvement in selectivity caused by an additive is the gain in AC<sub>T</sub> resulting from the inclusion of the additive in the amplification reaction mixture.</p><p id="p0080" num="0080">We tested unmodified double-stranded oligonucleotide and a number of additives in this selectivity assay. Results of assays run in triplicate are reported in Example 3. The C<sub>T</sub> differences (ΔC<sub>T</sub>) that are reported are the improvement in selectivity based on averages of the three replicates. Unmodified double-stranded oligonucleotide 22merA, despite having a Tm slightly above the primer annealing temperature of the assay, improved the basic selectivity of the Taq DNA polymerase itself by fewer than two C<sub>T</sub> units at concentrations up to 300 nM. We tested numerous additives having the same length, 22 nucleotides, with various configurations of two, three, or four Dabcyl modifiers. As reported in Example 3, most configurations of two, three, or four Dabcyl modifiers improved the selectivity of the polymerase substantially, thereby reducing its tendency for Type II mispriming. As further reported in Example 3, we also tested three other modifiers useful in additives and fluorescein (FAM), not useful as a modifying group in additives. In at least some double-stranded oligonucleotides, each of the modifiers digoxigenin, coumarin and the quencher QSY 21 significantly improved selectivity as compared to additive 22merA and as compared to a 22 nucleotide-long oligonucleotide with four FAM modifiers.<!-- EPO <DP n="37"> --></p><p id="p0081" num="0081">As reported in Example 17, we similarly tested amplification with various amounts of three additives having a double-stranded region of 22 base pairs and single-stranded overhangs six nucleotides in length. The sequences of the additives are given in Example 16. The additives comprised two strands that were hairpin-forming, as shown in <figref idrefs="f0041">FIG 18C</figref>. Such additives with two and three Dabcyl groups as modifiers showed moderate improvement in selectivity (ΔC<sub>T</sub>) of greater than three C<sub>T</sub> units. The largest gain in selectivity was achieved with the additive having four Dabcyl groups as modifiers, namely, greater than six C<sub>T</sub> units.</p><p id="p0082" num="0082">Additives can also suppress Type II mispriming and increase polymerase selectivity in conventional symmetric PCR amplifications. Example 11 reports a symmetric PCR assay for two target sequences, one that was perfectly complementary to both primers and one that was perfectly complementary to one primer but contained a mismatch opposite the 3' terminal nucleotide of the other primer. The assay was run with no additive in the reaction mixture and also with a combination of two additives in the reaction mixture. That combination, designated EP043, included two double-stranded oligonucleotides with Dabcyl modifiers at combined concentration of 300 nM. In the assay of Example 11 the combination of Platinum Taq DNA polymerase, a hot-start DNA polymerase, and a highly discriminating allele-specific primer pair preferentially amplified the matched target by 7.84 C<sub>T</sub> values relative to the mismatched target. This detection specificity would be equivalent to detection of 1 matched target in an excess of 229 mismatched targets (i.e., 0.43% intended target) in a theoretical mixed population of both DNA targets. In comparison, addition of additive EP043 to the same symmetric PCR assay increased the specificity in favor of the matched target by another 4.75 C<sub>T</sub> values to 12.59 C<sub>T</sub> values, which would be equivalent to detection of 1 matched target in an excess of 6,615 mismatched targets (i.e., 0.02%), corresponding to a 26.7-fold increase in detection specificity.</p><p id="p0083" num="0083">In the experiment reported in Example 5, we performed a series of LATE-PCR amplifications with no additive, with a low-Tm additive, EP020 (Tm 51°C), and with a higher-Tm additive, EP013 (Tm 62°C). The experiment included the use of different primer annealing temperatures to test the amplification reaction under highly stringent conditions (high annealing temperature), moderately stringent conditions, and rather unstringent conditions (low annealing temperature as compared to the primer Tm's). Mispriming<!-- EPO <DP n="38"> --> problems typically worsen as stringency is reduced. The assays were duplex assays for two target sequences, each having its own primer pair and its own detection probe.</p><p id="p0084" num="0084">The probes were molecular beacon probes that fluoresced upon hybridization to correct amplicons. Kinetic curves of probe fluorescences over the first 50 cycles are reported in <figref idrefs="f0015 f0016 f0017 f0018 f0019 f0020">FIGS. 9A-9F</figref>.</p><p id="p0085" num="0085"><figref idrefs="f0015">FIG 9A</figref> shows that in this amplification reaction, Platinum Taq DNA polymerase, a hot-start polymerase, was not able to suppress Type I and Type II mispriming even under stringent conditions: 65°C annealing temperature for all cycles. In contrast, both additives were able to do so (<figref idrefs="f0016">FIGS. 9B</figref> and <figref idrefs="f0018">9D</figref>) at the concentrations used. With low stringency during the first 20 cycles (annealing temperature 60.7°C), low-Tm additive EP020, which was not double-stranded at the annealing temperature, did not suppress Type II mispriming during amplification (<figref idrefs="f0017">FIG. 9C</figref>), but higher-Tm additive EP013 did (<figref idrefs="f0020">FIG. 9F</figref>). This shows that to suppress a type of mispriming occurring at a particular temperature, the additive should be double-stranded at that temperature. Comparison of <figref idrefs="f0018 f0019 f0020">FIGS. 9D-9F</figref> shows that with additive EP013 the least scatter among replicates was achieved using a stringent annealing condition for the first 20 cycles (66.5°C), and that scatter was less at the least stringent condition (60.7°C) than at an intermediate stringency (64.2°C). This latter result is explained by the fact that the concentration of double strands, that is the functional concentration of the additive, was higher at the lower annealing temperature, illustrating the interrelationship between additive concentration and primer annealing temperature. It will be noted from <figref idrefs="f0018 f0019 f0020">FIGS. 9D-9F</figref> that with additive EP013, one target sequence amplified significantly less efficiently in the reaction than the other product sequence. We found that the difference could be much reduced by increasing the limiting primer concentration for the less efficient amplification from 50 nM to 100 nM.</p><heading id="h0009"><u>Suppression of Type III Mispriming</u></heading><p id="p0086" num="0086">Additives can suppress Type III mispriming. Example 13 reports an experiment in which a LATE-PCR reaction was carried out to 65 cycles, long enough for Type III mispriming to occur and generate long double-stranded products resulting from the priming of one amplicon strand by another amplicon strand. We tested amplification with no additive; amplification with an additive having a Tm very close to the 58°C primer annealing temperature (additive EP047, Tm 59.1°C); and with a mixture of additives in which we<!-- EPO <DP n="39"> --> replaced a minor amount, only about one-tenth, of additive EP047 with an additive that is double-stranded at temperatures above the annealing temperature. In this example, we used a higher Tm additive having a Tm (67.4°C) substantially above the annealing temperature. A melt curve for three replicate amplifications with no additive showed that after 65 cycles of amplification the detected products had higher Tm's than the intended product, indicating that product evolution occurred. Kinetic curves showed that during the plateau phase there occurred a rise in the SYBR signal, also indicating that product evolution occurred. When the 5' end of the limiting primer was modified by the addition of a pair of A-nucleotides, the result remained the same: the melt curves showed products having higher Tm's than the desired amplicon. Inclusion of EP047 at 600 nM concentration with the unmodified limiting primer helped a little: it delayed product evolution by several cycles, and some detected products in two of three replicates had the correct Tm. Inclusion of EP047 at 600 nM and the use of the modified limiting primer decreased product evolution significantly and prevented it entirely in one of three replicates. Inclusion of additive mixture EP043 at 600 nM total concentration when used with the unmodified limiting primer decreased product evolution significantly and prevented it entirely in one of three replicates. Inclusion of EP043 at 600 nM and use of the modified limiting primer significantly decreased product evolution and prevented it entirely in two of three replicates. Thus, low concentrations of additives that are designed to have a Tm above the primer annealing temperature can suppress Type III mispriming. Further, the effect can be enhanced, if the 3' ends of amplicon strands are rendered AT-nucleotide rich, which can be accomplished, where necessary, by modification of the 5' ends of limiting primers.</p><p id="p0087" num="0087">Example 15 includes a no-additive control amplification assay for an RNA target sequence that showed severe Type III mispriming. It also shows that inclusion of additives, both double-stranded oligonucleotides and four-strand mixtures of double-stranded oligonucleotides, can suppress the Type III mispriming seen in the control. Example 15 demonstrates that additives, reaction mixtures, and methods do not inhibit reverse transcriptase used to convert RNA target into cDNA target.</p><heading id="h0010"><u>Multiplexing</u></heading><p id="p0088" num="0088">Additives can enable highly multiplexed reaction for numerous target sequences with numerous primer pairs. Example 8 reports a 12-plex reaction, that is, multiplexed<!-- EPO <DP n="40"> --> amplification of twelve target sequences using twelve primer pairs in a single reaction mixture. The amplification reaction was a LATE-PCR amplification of 65 cycles. The target sequences were included as human mitochondrial genomic DNA, which was included in the reaction mixtures with starting copy numbers of 1000, 100 and 10. In addition to a control amplification with no additive, additive EP011 was included in the reaction mixtures at concentrations of 300 nM and 600 nM. Following amplification, the reaction mixture was subjected to electorphoretic separation to ascertain whether or not the twelve intended products were made. In addition, dideoxy sequencing was performed to evaluate the amplicons. A photograph of the electrophoretic gel, <figref idrefs="f0024">FIG 12</figref>, shows that amplification starting with 1000 copies, but with no additive, failed to produce the intended set of twelve products, but amplification starting with 1000 copies plus additive EP011 at 300 nM and 600 nM concentrations did produce the twelve products. The gel revealed that in this reaction EP011 at 300 nM concentration did not completely suppress mispriming, as evidenced by a band of lightweight product. Mispriming products were not seen in the gel when additive EP011 was included in the reaction mixture at 600 nM concentration. As a further analysis on this last product, it was sequenced. Sequencing results showed that a sufficient amount of each of the twelve amplicons had been generated to permit dideoxy sequencing by the simplified Dilute'N'Go protocol. That was found not to be the case when the starting numbers of target were reduced to 100 and 10 copies. The results with 1000 copies of mitochondrial DNA show that mispriming was suppressed successfully both prior to amplification and during amplification.</p><heading id="h0011"><u>Additive Mixtures</u></heading><p id="p0089" num="0089">A mixture of additives, additive mixture EP043, is discussed above in connection with Example 13. A reason to use a mixture can be understood by reference to Example 1, for example. The results show that suppression of Type I mispriming typically requires a moderately high concentration of additives. The kinetic curves in <figref idrefs="f0005">FIG 5</figref> show, however, that efficiency of the polymerization reaction tends to decrease as one increases the concentration of an additive having a Tm significantly above the primer annealing temperature. Yet Example 13 shows that a high-Tm additive can be needed to suppress Type III mispriming. A mixture of additives can be designed to suppress both types of mispriming while minimizing the reduction in amplification efficiency. In one embodiment, use a mixture that includes a<!-- EPO <DP n="41"> --> higher concentration (300 nM to 1000 nM) of an additive that has a Tm close to the annealing temperature and a lower concentration (25 nM to 300 nM) of an additive that is double-stranded at temperatures above the annealing temperature, specifically, an additive that has a Tm several degrees above the annealing temperature (or the higher annealing temperature, if two are used in the reaction) can be used to suppress both types of mispriming. A mixture of additives may comprise four different strands, that is, two double-stranded additives that do not share a common strand. Alternatively, a mixture of additives may comprise three strands, that is, two double-stranded additives that share a common strand. The latter approach reduces the number of different strands included in an amplification mixture.</p><p id="p0090" num="0090">We tested mixtures of additives in the polymerase selectivity assay described in Example 3, both mixtures of unmodified double-stranded oligonucleotides and mixtures of additives. Experimental results are reported in Example 4. The mixtures tested were all three-strand mixtures in which two additives share a common strand. The mixtures all included a high-Tm additive having a Tm of 67.4°C, several degrees above the primer annealing temperature, which in this experiment was 62°C, and a low-Tm additive having a Tm in the range of 57.4-59.1°C, that is, slightly below the annealing temperature. Two of the mixtures, additive 041 and additive 042, contained unmodified double-stranded oligonucleotides. Both mixtures with unmodified oligonucleotides improved selectivity of the polymerase only relatively slightly, less than two amplification cycles, when added at concentrations of 75 nM for the higher Tm hybrid and 325 nM for the lower Tm hybrid. We also tested four mixtures of additives. In two (EP041, EP042), both double-stranded oligonucleotides contained three Dabcyl modifiers; in one (EP043), the higher Tm oligonucleotide contained three Dabcyls, while the lower Tm oligonucleotide contained four Dabcyls; and in one (EP045), both oligonucleotides contained four Dabcyls. All four mixtures improved selectivity more than did additives 041 and 042. <figref idrefs="f0007 f0008 f0009 f0010">FIGS. 7A-7D</figref> and <figref idrefs="f0011 f0012 f0013 f0014">8A-8D</figref> are kinetic curves for mixtures EP043 and EP045, respectively, at the same total concentration of 600 nM but with the amount of the higher Tm hybrid varying from 25 nM to 100 nM. These curves reveal inhibition caused by additives and also scatter among replicates. The ΔC<sub>T</sub> results and the kinetic curves taken together show that for each mixture there may be an optimum amount of the higher Tm hybrid in the mixture. For mixture EP043, (a) even the lowest concentration (25 nM) of the high-Tm component increases<!-- EPO <DP n="42"> --> polymerase selectivity, (b) polymerase selectivity is not increased more by increasing the proportion of the high-Tm component up to 100 nM, and (c) none of the formulations significantly inhibits the efficiency of amplification of the primer to its matched target. For mixture EP045, (a) even the lowest concentration (25 nM) of the high-Tm component increases polymerase selectivity to a greater extent than EP043, (b) polymerase selectivity increases in proportion of the concentration of the high-Tm component, (c) all of the formulations inhibit the efficiency of amplification of the primer to its matched target, and (d) the extent of inhibition increases with the proportion of the high-Tm component. We judged the optimal formulation of mixture EP043 to be 75/600/525 nM, and we judged the optimal formulation of mixture EP045 to be 50/600/550 nM, as these formulations had low scatter among replicates.</p><p id="p0091" num="0091">We also tested, in Example 19, additive mixture EP043 in an assay in which a 3' terminal mismatch is created by use of a blocker oligonucleotide. The scheme for that assay is illustrated generally in <figref idrefs="f0045">FIG. 21 A </figref>and <figref idrefs="f0045">FIG. 21B. FIGS. 21A, 21 B</figref> depict two double-stranded targets 231, 232, which differ by one base pair (either a G or an A in the excess-primer strand) shortly downstream from the binding site for limiting primer, arrow 233. The binding site for the excess primer, arrow 234, is also conserved between the two targets. Oligonucleotide blocker 235 is complementary to, and binds to, target 231 (<figref idrefs="f0045">FIG. 21A</figref>), which is the "mismatched" target to be selected against. Blocker 235 is allele-discriminating and mismatched against target 232 (<figref idrefs="f0045">FIG. 21B</figref>) and does not bind to it. Accordingly, primer 233 binds fully to target 232 and is extended, but the 3' terminus of primer 233 cannot bind to target 231, preventing extension. In <figref idrefs="f0045">FIG. 21A</figref> dashed line 242 is the limiting primer strand that would be created were primer 233 extended. In <figref idrefs="f0045">FIG. 21B</figref> dashed line 243 is the limiting primer strand created by extension of primer 233. Blocker 235 is shown with a terminal fluorophore 236 and a terminal quencher 237, but all that is required is that blocker 235 have a blocked 3' terminal nucleotide so as not to be extendable by a DNA polymerase during amplification. In the particular embodiment shown in <figref idrefs="f0045">FIGS. 21A, 21B</figref>, targets 231,232 are shown to differ by another base pair (either a G in excess primer strand 241 in <figref idrefs="f0045">FIG. 21 A</figref> or a C in excess primer strand primer strand 244 in <figref idrefs="f0045">FIG. 2 1 B</figref>) downstream from blocker 235 and downstream from excess primer 234. A sequence-specific probe 238, labeled with fluorophore 239 and quencher 240, binds to the product of amplification of target 231 (the<!-- EPO <DP n="43"> --> "mismatched" target) but not to the product of amplification of target 232, and signals upon hybridization. Probe 238 is optional in the sense that it is not used to enhance polymerase selectivity. It can be used, for example, for a melt analysis of the amplification product. Example 19 shows that in the case of induced-Type II mis-priming, when the additive reduces amplification efficiency, amplification is delayed in a thermal-cycle-dependent manner, and when the magnitude of the enhancement of selectivity due to the presence of an additive is also thermal-cycle dependent, the apparent enhancement of selectivity needs to be corrected for the thermal-cycle-dependent decrease in efficiency. A way to make that correction using a series of target dilution reactions in the presence of the blocker plus the presence/absence of the additive is demonstrated in Example 19.</p><p id="p0092" num="0092">We utilized additive mixture EP043 in the 12-plex of Example 8, discussed above, to see if sufficient amounts of all twelve products could be generated for sequencing. For these experiments we modified the limiting primer by adding AT-rich tails, and we extended the amplification reaction from 65 cycles to 80-90 cycles. With these modifications, all twelve intended products were successfully made in amounts needed for sequencing when additive mixture EP043 was included at strand concentrations of 50/600/550 nM and the starting amount of genomic mitochondrial DNA was only 100 copies or 10 copies. These results show that mispriming was prevented successfully prior to and during amplification, despite the fact that the extended length of the amplification presented a severe test for suppression of Type III mispriming.</p><p id="p0093" num="0093">In Example 12 we tested mixture EP043 at 600 nM total concentration in LATE-PCR amplification reactions that differed in the 3' end of the limiting primers. One reaction included a limiting primer having a GC-rich 3' end (GGC). The other reaction included a limiting primer having at AT-rich 3' end (AAG). As compared to a no-additive control, inclusion of additive EP013 (three Dabcyl modifiers, Tm 60°C) in the amplification with the primer having the GC-rich 3' end resulted in relatively little reduction in efficiency of polymerization (C<sub>T</sub> delay of 4 cycles). As compared to a no-additive control, however, inclusion of the same additive at the same concentration with the primer having the AT-rich 3' end resulted in a significantly greater reduction in efficiency (C<sub>T</sub> delay of 11 cycles). In both<!-- EPO <DP n="44"> --> reactions, which were continued for 70 cycles, additive EP013 significantly reduced scatter among four replicates as compared to the no-additive control.</p><heading id="h0012"><u>ColdStop Protocol and All Types of Mispriming</u></heading><p id="p0094" num="0094">The likelihood of Type II mispriming is enhanced by the inclusion of a low-temperature detection step in PCR cycles for real-time detection. Type III mispriming is enhanced by lengthening a LATE-PCR amplification to generate single-stranded product. We have tested a protocol that we refer to as "ColdStop" in which, as a replacement for real-time, low-temperature detection, the amplification reaction is interrupted at one or several intermediate points in order to perform an operation that may include a low-temperature step. Example 10 illustrates a "ColdStop" protocol in which that operation is a melt analysis. The amplification in Example 10 is a 2-step LATE-PCR amplification of 70 cycles using a hybridization probe for fluorescence detection. Additive EP010 was tested at a concentration of 600 nM. For purposes of comparison, an amplification was performed with real-time detection. For real-time detection a low-temperature detection step (60°C.) was added following each annealing/extension step of the amplification cycles. Probe fluorescence as a function of thermal cycles is shown in <figref idrefs="f0026">FIG. 14A</figref>, which shows a moderate scatter among replicates for the amplifications starting with 1000, 100, and 10 copies of the target sequence. <figref idrefs="f0026">FIG. 14A</figref> also shows the curves for the three amounts of initial target beginning to converge by cycle 70. The inclusion of real-time, low temperature detection increased the chance for Type II mispriming. We repeated the amplification for all three starting copy numbers with no real-time low-temperature detection but with an interruption after 40 cycles to perform a melt beginning at 45°C. Then we resumed amplification to conclusion after 70 cycles, at which time a second melt was performed. The melt curves for the first melt are presented in <figref idrefs="f0027">FIG. 14B</figref>. The replicates for the three different starting amounts of target are clearly distinguishable and show little scatter. The melt curves for the second melt are presented in <figref idrefs="f0028">FIG. 14C</figref>. By cycle 70 the curves for the three levels of initial target amount have converged, and little scatter is detected.</p><p id="p0095" num="0095">To interpret the results shown in <figref idrefs="f0027">FIGS. 14B</figref> and <figref idrefs="f0028">14C</figref>, the following are noted. If mispriming takes place due to a low-temperature interruption, single-stranded DNA will be converted into double-stranded DNA, and the amount of single-stranded product will decrease between cycles 40 and 70. That did not happen. If mispriming occurs during the<!-- EPO <DP n="45"> --> interruption after 40 cycles, scatter among the replicates will increase between cycle 40 and 70. That did not happen. If mispriming occurs during the interruption, the amount of single-stranded product generated from the differing amounts of initial target would fail to equalize after 70 cycles. That did not happen. Comparison of <figref idrefs="f0026">FIG. 14A</figref>, <figref idrefs="f0027">FIG 14B</figref> and <figref idrefs="f0028">FIG. 14C</figref> indicates that additive EP046 completely suppressed all types of mispriming in this "ColdStop" amplification. The "ColdStop" protocol with a single interruption eliminates any low-temperature step prior to cycle 40 and after cycle 41. This reduces the chances for Type II and Type III mispriming during all but cycle 41. The first melt includes a lengthy time at a temperature below the primer annealing temperature (in this example, about 15 minutes), and so increased the likelihood of mispriming during the melt (which would include one extension of misprimed 3' ends), in exchange for eliminating a low-temperature step in other cycles. That trade-off may help to reduce scatter among replicates. It will be appreciated a "ColdStop" protocol can be used to screen additive compositions and concentrations for their effects on mispriming.</p><heading id="h0013"><u>Inhibition of 5' Exonuclease Activity of DNA Polymerase</u></heading><p id="p0096" num="0096">Additives can be effective to inhibit the 5' exonuclease activity of DNA polymerases that possess that activity, for example Taq DNA polymerase and Tfi (+) DNA polymerase. (This effect is not applicable to DNA polymerases not having that activity, such as the Klenow fragment, which does not possess a 5'exonuclease domain, and Tfi(-) DNA polymerase, which contains a 5' exonuclease domain that is modified to render it inactive.) We developed the assay reported in Example 6 as a primer-independent means to gage the inhibitory effects of additives on the 5' exonuclease activity of DNA polymerases. In that assay, a non-extendable probe that is dual labeled with a fluorophore and a quencher is hybridized to a target without primers being included in the reaction mixture. The reaction mixture is then subjected to thermal oscillation in which the temperature is cycled between 45°C and 60°C forty-five times, during which probe fluorescence is detected in real time. Probe cleavage leads to increased fluorescence indicative of 5' exonuclease activity of the polymerase. Several additives were tested in this assay at a concentration of 300 nM and compared to a control assay that included probe but no target. In the control assay no hybrid was formed, and the probe was not cleaved. In an assay containing probe and target but no additive, a large increase in fluorescence resulted. In assays containing probe, target and an<!-- EPO <DP n="46"> --> additive, fluorescence increase was markedly reduced compared to the assay with target but no additive, showing substantial inhibition of 5' nuclease activity. Additives EP004 and EP001, that have three and four covalently linked Dabcyl groups respectively, completely inhibited primer-independent 5'exonuclease cleavage of the probe. Additive EP008, that has a covalently linked Dabcyl group on each of its 5'nucleotides, also completely inhibited primer-independent 5'exonuclease activity in this assay. In comparison, additive EP009, that has a covalently linked Dabcyl group on each of its 3'nucleotides, only partially inhibited primer-independent 5'exonuclease activity in this assay. The Results show that the Dabcyl modifier groups on double-stranded oligonucleotides can enhance inhibition of the 5'exonuclease activity in a position-dependent manner. Dabcyl groups on both 5'ends of the additive are preferred, and three and four Dabcyl groups are preferred over two Dabcyl groups. Addition experiments demonstrated consistent results for Tfi(+) DNA polymerase.</p><p id="p0097" num="0097">As reported in Example 18, we performed the temperature-oscillation assay of Example 6 with various amounts of three additives having a single-stranded region of 22 base pairs and single-stranded overhangs six nucleotides in length. The sequences of the additives are given in Example 16. The additives comprised two strands that were hairpin-forming, as shown in <figref idrefs="f0041">FIG. 18C</figref>. Such additives included two, three or four Dabcyl groups as modifiers. As shown in <figref idrefs="f0044">FIG 20</figref>, the additive with two Dabcyl modifiers inhibited primer-independent 5' exonuclease activity of Taq DNA polymerase in a concentration-dependent manner, with concentrations of 200 nM and 400 nM largely inhibiting activity and a concentration of 600 nM nearly completely inhibiting activity. The tested additives with three and four modifiers also inhibited primer-independent 5' exonuclease activity of the polymerase in a concentration-dependent manner but to a somewhat lesser degree than the results shown in <figref idrefs="f0044">FIG. 20</figref>.</p><p id="p0098" num="0098">To gage inhibition of 5' nuclease activity during PCR amplification, we subjected probes and amplicons resulting from the LATE-PCR amplification described in Example 5 to hybridizing conditions followed by melt analysis. A reaction mixture of probe alone was also subjected to melt analysis. The experiment is reported in Example 7, and melt curves are presented in <figref idrefs="f0022 f0023">FIGS. 11 A and 11B</figref>. Comparison of fluorescence from the probe alone and the amplification with no additive in <figref idrefs="f0022">FIG 11A</figref> shows some probe molecules were cleaved:<!-- EPO <DP n="47"> --> fluorescence from the amplification reaction did not fall to the level of probe fluorescence after melting was completed. <figref idrefs="f0023">FIG. 11B</figref> shows probe cleavage due to 5' nuclease activity of the polymerase (in this case Taq DNA polymerase) was inhibited when the amplification reaction mixture included additive EP013 at a concentration of 600 nM: fluorescence from the amplification reaction fell to the level of probe fluorescence after melting was completed.</p><heading id="h0014"><u>Additive as a PCR Primer</u></heading><p id="p0099" num="0099">Example 14 demonstrates an additive in the form of a PCR primer. To convert a typical excess primer for a LATE-PCR amplification into an additive that suppresses Type I mispriming, two things were done: first, a modifying group, in this case a Dabcyl group, was added to the 5' terminus of the primer; and second, a reverse complement strand that was partially complementary to the excess primer and that had both a 5' terminal abcyl group and a 3' terminal Dabcyl group was included in the reaction mixture at a concentration of 100, 200 or 300 nM. The Tm of the hybrid formed by the excess primer and the reverse complement strand was reduced relative to the Tm of the hybrid formed by the excess primer and the target sequence by introducing several mismatches into the reverse complement strand (alternatively, the length of the reverse complement strand could have been reduced). The hybrid formed by the excess primer and the reverse complement strand included three modifying groups. Melt analysis of double-stranded amplification products showed that inclusion of the reverse complement sequence in the reaction mixture at a concentration of 200 nM or 300 nM resulted in the expected amplicon with little-to-no other products, and the melt curves showed little scatter among replicates. In contrast, amplification without the reverse complement sequence in the reaction mixture resulted in a mixture of intended amplicon and lower Tm products, and the melt curves showed scatter among replicates.</p><p id="p0100" num="0100">The foregoing examples are meant to illustrate certain preferred embodiments of additives, reaction mixtures, and methods according and should not be construed as exhaustive or limiting. Numerous variations are possible and would be apparent to one of skill in the art. For example, amplification methods other than PCR may be utilized, and additives may be modified versions of molecules other than double-stranded DNA molecules. Other variations will be apparent to persons skilled in the art.<!-- EPO <DP n="48"> --></p><heading id="h0015"><b>EXAMPLES</b></heading><heading id="h0016">Example 1. <u>Suppression of Type I Mispriming.</u></heading><p id="p0101" num="0101">LATE-PCR assays were performed using a single pair of primers and a single target to generate double-stranded and single-stranded amplicons. Double-stranded products were characterized by melting analysis at the end of amplification. Reaction components other than double-stranded oligonucleotides, and reaction conditions were as follows.
<tables id="tabl0001" num="0001"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="137mm"/><tbody><row><entry>Limiting Primer.</entry><entry>5' CCTGGATTATGCCTGGCACCAT (SEQ ID No. 1)</entry></row><row><entry>Excess Primer.</entry><entry>5' CCTTGATGACGCTTCTGTATCTA (SEQ ID No. 2)</entry></row><row><entry>Target.</entry><entry><img id="ib0001" file="imgb0001.tif" wi="132" he="20" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0102" num="0102">LATE-PCR amplifications were carried out in 25 ul volume consisting of 1X PCR buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl<sub>2</sub>, 250 nM dNTPs, 50 nM of limiting primer, 1000nM of excess primer, 0.24X SYBR Green (Invitrogen, Carlsbad, CA), 1.25 units of Taq DNA polymerase (Invitrogen, Carlsbad, CA) with approximately 1000 genomes of human genomic DNA (Sigma-Aldrich, St. Louis, MO). Amplification reactions were run in a triplicate set for each additive, utilizing the additive at concentrations of 30, 100, 300, 600, and 1000 nM, along with a no-additive reaction.</p><p id="p0103" num="0103">The thermal profile conditions for these reactions were as follows.: 95°C/10s-55°C/30s-70°C/30s for 10 cycles followed by 95°C/10s-50°C/30s-70°C/30s for 40 cycles followed by a melt starting at 55°C with 1°C increments at 30s intervals to 97°C.</p><p id="p0104" num="0104">Reactions were analyzed at the end of 50 cycles by a melt curve analysis using the first derivative of SYBR Green fluorescence (-dF/dT, SYBR) of double-stranded DNA product. In addition, the kinetics of production of double-stranded product (SYBR intensity reading as a function of thermal cycles) was analyzed for certain reactions.</p><heading id="h0017">A. 16mers</heading><p id="p0105" num="0105">Each of the following additives that were 16 nucleotides long was included in the starting reaction mixture (terminal blocker C<sub>3</sub> is a three-carbon linker chain):<!-- EPO <DP n="49"> -->
<tables id="tabl0002" num="0002"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="17mm"/><colspec colnum="2" colname="col2" colwidth="99mm"/><tbody><row><entry>16merA.</entry><entry><img id="ib0002" file="imgb0002.tif" wi="91" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>16merB.</entry><entry><img id="ib0003" file="imgb0003.tif" wi="93" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>EP048:</entry><entry>16merB with one Dabcyl at 3' end of top strand (SEQ. ID No. 6)</entry></row><row><entry>EP049:</entry><entry>16merB with one Dabcyl at 3' end of bottom strand (SEQ ID No. 7)</entry></row><row><entry>EP027:</entry><entry>16merB with two Dabcyls - one at 3' end of each strand (SEQ ID No. 8)</entry></row></tbody></tgroup></table></tables></p><p id="p0106" num="0106">With no additive, the amplification generated products other than the "correct" product, that is, other than the double-stranded product (amplicon) defined by the primers. The melt curves for the three replicate amplification reactions containing additive 16merA at 300 nM concentration is shown in <figref idrefs="f0001">FIG. 1</figref>, with the intended product identified by the downward-pointing arrow. Circle 11 is the curves for the three replicates. This amplification was judged to be very good, because (1) the correct product was made to the general exclusion of incorrect products, and (2) the three replicates were quite consistent (overlapping curves). The same result was obtained with higher concentrations of 16merA. At lower concentrations (50 nM, 100 nM), large amounts of incorrect products were found, and the three replicates were inconsistent.</p><p id="p0107" num="0107">The melt curve for additive 16merB at 300 nM concentration is shown in <figref idrefs="f0002">FIG 2</figref>. Circle 21 is the curves for the three replicates. This amplification was judged quite unacceptable, because large amounts of incorrect products were found, and the three replicates were inconsistent. At none of the concentrations utilized was the amplification found to generate correct product to the general exclusion of incorrect products, and in none were the replicates highly consistent. The incorrect products differed significantly from the incorrect products obtained with no additive, indicating that additive 16merB caused mispriming.</p><p id="p0108" num="0108">The melt curve for additive EP049 at 600 nM concentration is shown in <figref idrefs="f0003">FIG. 3</figref>, with the intended product identified by the downward-pointing arrow. Circle 31 is the curves for the three replicates. This amplification was judged to be very good, because (1) the correct product was made to the general exclusion of incorrect products, and (2) the three replicates were quite consistent (overlapping curves). The same result was obtained with higher<!-- EPO <DP n="50"> --> concentrations, but lower concentrations were not consistent among the replicates and yielded incorrect products. Additive EP048 showed more consistent product at concentrations of 100 and 600nM, indicating that both strands were capable of mispriming.</p><p id="p0109" num="0109">The melt curve for additive EP027 at 100 nM concentration is shown in <figref idrefs="f0004">FIG 4</figref>, with the intended product identified by the downward-pointing arrow. Circle 41 is the curves for the three replicates. This amplification was judged to be good rather than very-good, because (1) the correct product was made to the general exclusion of incorrect products, and (2) the three replicates were reasonably consistent, with minor variability among the curves. At higher concentration of this additive, the results were judged very good, because the three replicates were quite consistent. At 50 nM, however, significant incorrect products were made, and the replicates were not consistent.</p><p id="p0110" num="0110">Kinetic analysis of amplifications with EP027 are shown in <figref idrefs="f0005">FIG 5</figref>. Circle 51 is the three replicates at a concentration of 100 nM; circle 52 is the three replicates at a concentration of 300 nM; circle 53 is the three replicates at a concentration of 600 nM; and circle 54 is the three replicates at a concentration of 1000 nM. At 100 nM concentration, there was scatter among the three replicates in the plateau region. The three reactions containing 300 nM had entirely overlapping kinetics and higher efficiency than reactions containing 600 or 1000 nM. Therefore, 300 nM of EP027 was the optimal amount in this assay.</p><heading id="h0018">B. Other Additives</heading><p id="p0111" num="0111">Several additives consisting of double-stranded oligonucleotides without added modifiers, and having lengths of 12, 18, 20, 22 and 24 nucleotides were tested in the assay of this example at concentrations of 50, 100, 300, 600 and 1000 nM. As with the 16mers discussed in Part A, results were inconsistent. Of three different 12mer's tested, for example, one failed to produce the correct product at all concentrations, one produced the correct product only at 1000 nM concentration, and one produced correct product at concentrations of 600 nM and higher. Of eight longer oligonucleotides tested, half produced significant amounts of incorrect products even at the highest concentrations of 600 and 1000 nM. Only three produced the correct product to the general exclusion of incorrect products at 300 nM<!-- EPO <DP n="51"> --> concentration, and none did so at lower concentrations. We judged additive 22merA to be the best in this assay (terminal blocker p is a phosphate):
<tables id="tabl0003" num="0003"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="17mm"/><colspec colnum="2" colname="col2" colwidth="111mm"/><tbody><row><entry>22merA.</entry><entry><img id="ib0004" file="imgb0004.tif" wi="106" he="12" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0112" num="0112">Several additives consisting of double-stranded oligonucleotides that included either two or four terminal modifiers and had lengths of 8, 11 and 22 nucleotides were also tested, The modifiers were either Dabcyl or digoxigenin (DIG):
<tables id="tabl0004" num="0004"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="114mm"/><tbody><row><entry>Additive EP010.</entry><entry><img id="ib0005" file="imgb0005.tif" wi="101" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP018.</entry><entry><img id="ib0006" file="imgb0006.tif" wi="91" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP020.</entry><entry><img id="ib0007" file="imgb0007.tif" wi="99" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP021.</entry><entry><img id="ib0008" file="imgb0008.tif" wi="94" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP022.</entry><entry><img id="ib0009" file="imgb0009.tif" wi="94" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP023</entry><entry><img id="ib0010" file="imgb0010.tif" wi="102" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP024.</entry><entry><img id="ib0011" file="imgb0011.tif" wi="101" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP026.</entry><entry><img id="ib0012" file="imgb0012.tif" wi="92" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP028.</entry><entry><img id="ib0013" file="imgb0013.tif" wi="101" he="12" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="52"> --><row><entry/><entry><img id="ib0014" file="imgb0014.tif" wi="31" he="5" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP029.</entry><entry><img id="ib0015" file="imgb0015.tif" wi="110" he="12" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0113" num="0113">All of this group of additives produced the correct product to the general exclusion of other products at a concentration equal to or less than 600 nM. All but one (EP021) did so at a concentration of 300 nM or less. Additive EP028 did so at a concentration of 100 nM, and additive EP010 did so at a concentration or 50 nM.</p><heading id="h0019">Example 2. <u>Suppression of Type I Mispriming.</u></heading><p id="p0114" num="0114">Unmodified double-stranded oligonucleotide 22merA, which was judged to be the best unmodified additive in Example 1, and several Dabcyl-modified oligonucleotides were used in an assay for a different target with different primers. Each additive was separately added to a LATE-PCR amplification reaction mixture prior to the start of amplification at concentrations of 100 and 300 nM. Reactions were analyzed at the end of 50 cycles by a melt curve analysis using the first derivative of SYBR Green fluorescence (-dF/dT, Sybr) of double-stranded DNA product. In addition, the kinetics of production of double-stranded product (Sybr intensity reading as a function of thermal cycles) was analyzed for certain reactions. Reaction components other than double-stranded oligonucleotides, and reaction conditions were as follows.
<tables id="tabl0005" num="0005"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="26mm"/><colspec colnum="2" colname="col2" colwidth="140mm"/><tbody><row><entry>Limiting Primer.</entry><entry>5' AAATTGCGTCATTGTTTCACAGGGCCA (SEQ ID No. 20)</entry></row><row><entry>Excess Primer.</entry><entry>5' AATCTGGGTGGTGGTCATAC (SEQ ID No. 21)</entry></row><row><entry>Target.</entry><entry><img id="ib0016" file="imgb0016.tif" wi="136" he="34" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0115" num="0115">LATE-PCR amplifications were carried out in 25 ul volume consisting of 1X Invitrogen PCR buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl<sub>2</sub>, 250 nM dNTPs, 50 nM of limiting primer, 1000 nM of excess primer, 0.24X SYBR Green (Invitrogen, Carlsbad, CA),<!-- EPO <DP n="53"> --> 1.25 units of Taq DNA polymerase (Invitrogen, Carlsbad, CA) with approximately 1000 genomes of human genomic DNA (Sigma-Aldrich, St. Louis, MO). The thermal profile conditions for these reactions were as follows: 25°C for 30 minutes followed by 95°C/10s-62°C/20s-70°C/20s for 50 cycles followed by a melt starting at 55°C/30s with 1°C increments for 42 cycles. (The abbreviation "s", as in 20s, is "seconds".) All reactions analyzed at the end of 50 cycles using the first derivative of SYBR Green fluorescence (melt curve analysis) of double-stranded DNA product.</p><p id="p0116" num="0116">The following additives were tested:
<tables id="tabl0006" num="0006"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="29mm"/><colspec colnum="2" colname="col2" colwidth="104mm"/><tbody><row><entry>Additive 22merA.</entry><entry><img id="ib0017" file="imgb0017.tif" wi="75" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP001.</entry><entry><img id="ib0018" file="imgb0018.tif" wi="100" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP002.</entry><entry><img id="ib0019" file="imgb0019.tif" wi="99" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP003.</entry><entry><img id="ib0020" file="imgb0020.tif" wi="95" he="19" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP004.</entry><entry><img id="ib0021" file="imgb0021.tif" wi="95" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP005.</entry><entry><img id="ib0022" file="imgb0022.tif" wi="99" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP006.</entry><entry><img id="ib0023" file="imgb0023.tif" wi="88" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP007.</entry><entry><img id="ib0024" file="imgb0024.tif" wi="86" he="12" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="54"> -->
<tables id="tabl0007" num="0007"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="103mm"/><tbody><row><entry/><entry><img id="ib0025" file="imgb0025.tif" wi="31" he="5" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP008.</entry><entry><img id="ib0026" file="imgb0026.tif" wi="88" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP009.</entry><entry><img id="ib0027" file="imgb0027.tif" wi="86" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP020.</entry><entry><img id="ib0028" file="imgb0028.tif" wi="99" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP052.</entry><entry><img id="ib0029" file="imgb0029.tif" wi="99" he="19" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP053.</entry><entry><img id="ib0030" file="imgb0030.tif" wi="94" he="20" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0117" num="0117">The double-stranded oligonucleotide 22merA at 300 nM concentration was judged to be very good, because (1) the correct product was made to the general exclusion of incorrect products, and (2) the three replicates were quite consistent (overlapping curves). That was not the case for 22merA at 100 nM concentration, however, because one of the replicates did not generally exclude incorrect products. All of the Dabcyl-containing additives were judged to be very good at 300 nM as well. Five of them (EP001, EP002, EP003, EP004 and EP005) were also judged to be very good at 100 nM concentration. <figref idrefs="f0006">FIG. 6</figref> shows the melt curves for the three replicate reactions with additive EP003 and with additive 22merA at 100 nM concentration. Circle 61 is the three replicates of additive 22merA. Circle 62 is the three replicates of additive EP003.</p><heading id="h0020">Example 3. <u>Type II Mispriming and Polymerase Selectivity.</u></heading><p id="p0118" num="0118">We performed a LATE-PCR assay in which we amplified a target that was complementary to both primers (matched target), and in which we separately amplified a<!-- EPO <DP n="55"> --> target that was complementary to the excess primer but that contained a single mismatch to the 3' terminal nucleotide of the limiting primer. We detected double-stranded product in real time, that is, during the primer annealing portion of every PCR cycle, by a DNA dye, in this case SYBR Green. Selectivity against a 3' terminal mismatch in the presence of an additive at any concentration is the difference between the threshold cycle (C<sub>T</sub>) of the signal from amplification of the mismatched target and the C<sub>T</sub> of the signal from amplification of the matched target (Δ C<sub>T</sub>). Amplification reactions were run in triplicate. The C<sub>T</sub> differences are calculated using averages of the three replicates. The effectiveness of an additive for improving selectivity of a DNA polymerase is the C<sub>T</sub> difference with the additive minus the C<sub>T</sub> difference without any additive. Under the heading "Selectivity" in this and subsequent Examples, we report the improvement in the C<sub>T</sub> difference resulting from the use of an additive, in C<sub>T</sub> units, that is, as a ΔC<sub>T</sub>.</p><p id="p0119" num="0119">The sequences of the primers and single-stranded targets are as follows:
<tables id="tabl0008" num="0008"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="82mm"/><colspec colnum="2" colname="col2" colwidth="126mm"/><tbody><row><entry>Limiting Primer.</entry><entry>5'CGTAAGATTACAATGGCAGGCTCCAGT (SEQ ID NO. 34)</entry></row><row><entry>Excess Primer.</entry><entry>5'-GCCCAAGTTTTATCGTTCTTCTCA (SEQ ID NO. 35)</entry></row><row><entry>Matched Target (A).</entry><entry><img id="ib0031" file="imgb0031.tif" wi="122" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry namest="col1" nameend="col2" align="center"><img id="ib0032" file="imgb0032.tif" wi="155" he="20" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0120" num="0120">The underlined and bolded nucleotide is the nucleotide whose complement in the excess primer strand will either match or mismatch the 3' terminal nucleotide of the limiting primer.</p><p id="p0121" num="0121">The LATE-PCR amplifications were carried out in triplicate (three replicate assays) in 25 ul volume consisting of 1X Invitrogen PCR buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl<sub>2</sub>, 250 nM dNTPs, 50 nM of limiting primer, 1000nM of excess primer, 0.24X SYBR Green (Invitrogen, Carlsbad, CA), 1.25 units of Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA) with approximately 1000 single-stranded target A (matched) or T (mismatched). The thermal profile conditions for these reactions were: 95°C for 3 minutes<!-- EPO <DP n="56"> --> followed by 95°C/5s-62°C/20s-72°C/30s for 60 cycles. For this and other assays containing two targets, we run a control amplifications using the excess primer, which is perfectly complementary to both targets, and a control limiting primer that is also perfectly complementary to both targets, to ensure that the starting copy numbers of both targets are the same, in which case the C<sub>T</sub>'s for both targets is the same. (If the control amplifications reveal that the starting copy numbers are not the same, one has two choices: either reformulate or, if the C<sub>T</sub> difference is slight --as was the case in all Examples reported here, correct the observed C<sub>T</sub> values to adjust for the difference.)</p><p id="p0122" num="0122">Where Tm is reported, that is the calculated melting temperature of the double-stranded additive without modifiers. Tm's of double-stranded additives presented in this specification were calculated according to <nplcit id="ncit0019" npl-type="s"><text>Markhan and Zuker (2005) DINAMELT web server for nucleic acid melting prediction, Nucleic Acids Res. 33:W577-W581</text></nplcit>, and <nplcit id="ncit0020" npl-type="b"><text>Markham and Zuker (2008) UNFOLD: software for nucleic acid folding and hybridization. In Keith, J.M., ed., BIOINFORMATICS, vol. II, Structure, Functions and Applications, No. 45 3</text></nplcit> in <nplcit id="ncit0021" npl-type="b"><text>Methods in Molecular Biology, Ch. 1, pages 3-31 (Humana Press, Totowa, New Jersey. ISBN 978-1-60327-428-9</text></nplcit>.</p><heading id="h0021">A. No additive</heading><p id="p0123" num="0123">This assay was run with no additive. SYBR Green signals were detected in real time, that is, during the primer annealing portion of all PCR cycles. The fluorescence intensity readings as a function of amplification cycle number show that the enzyme has a modest inherent selectivity for the matched target. When additives were tested in this assay, a no-additive control was also included, and the C<sub>T</sub> difference between matched and mismatched target sequences for the no-additive control was subtracted from the C<sub>T</sub> difference between matched and mismatched target sequences for the additive to arrive at the selectivity improvement numbers (Δ C<sub>T</sub>) presented.</p><heading id="h0022">B. Double-Stranded Additive with No Modifier.</heading><p id="p0124" num="0124">The following 22-nucleotide long double-stranded oligonucleotide, denominated "22merA", in which the 3' terminus of each strand was capped with a phosphate (p) to<!-- EPO <DP n="57"> --> prevent extension by the DNA polymerase, was utilized as the additive at three different concentrations:
<tables id="tabl0009" num="0009"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="18mm"/><colspec colnum="2" colname="col2" colwidth="110mm"/><tbody><row><entry>22mer A.</entry><entry><img id="ib0033" file="imgb0033.tif" wi="105" he="12" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0125" num="0125">The results for selectivity (C<sub>T</sub> for mismatched target minus C<sub>T</sub> for matched target) are shown in Table 1.
<tables id="tabl0010" num="0010"><table frame="all"><title>Table 1</title><tgroup cols="5"><colspec colnum="1" colname="col1" colwidth="16mm"/><colspec colnum="2" colname="col2" colwidth="25mm"/><colspec colnum="3" colname="col3" colwidth="14mm"/><colspec colnum="4" colname="col4" colwidth="31mm"/><colspec colnum="5" colname="col5" colwidth="27mm"/><thead><row><entry align="center" valign="top"><u>Additive</u></entry><entry align="center" valign="top"><u>Length (NT's)</u></entry><entry align="center" valign="top"><u>Tm, °C</u></entry><entry align="center" valign="top"><u>Concentration, nM</u></entry><entry align="center" valign="top"><u>Selectivity, Δ C</u><sub><u>T</u></sub></entry></row></thead><tbody><row><entry align="center">22merA</entry><entry align="center">22</entry><entry align="center">63.1</entry><entry align="center">100</entry><entry align="char" char="." charoff="7">0.1</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">200</entry><entry align="char" char="." charoff="7">1.2</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">300</entry><entry align="char" char="." charoff="7">1.8</entry></row></tbody></tgroup></table></tables></p><heading id="h0023">C. Double-Stranded Additives with Two Dabcyl Modifiers.</heading><p id="p0126" num="0126">The double-stranded oligonucleotide 16mer B described in Example 1 (SEQ ID No. 5) was modified with two Dabcyls by placing a Dabcyl at the 5' end of the top strand and a Dabcyl at the 3' end of the bottom strand (additive EP050, SEQ ID No. 38); and by placing a Dabcyl at the 3' end of the top strand and a Dabcyl at the 5' end of the bottom strand (additive EP051, SEQ ID No. 39). The double-stranded oligonucleotide 22merA described in part B above (SEQ ID No. 9) was modified by placing a Dabcyl on the 5' end of the top strand and a Dabcyl on the 3' end of the bottom strand (additive EP006, SEQ ID No. 28); by placing a Dabcyl on the 3' end of the top strand and a Dabcyl on the 5'end of the bottom strand (additive EP007, SEQ ID No. 29); by placing a Dabcyl on the 5' end of each strand (additive EP008, SEQ ID No. 30); by placing a Dabcyl on the 3' end of each strand (additive EP009, SEQ ID No. 31); by placing a Dabcyl on each end of the top strand (additive EP052, SEQ ID No. 32); and by placing a Dabcyl on each end of the bottom strand (additive EP053, SEQ ID No. 33). Sequences of these additives are given below, and results for selectivity are presented in Table 2.
<tables id="tabl0011" num="0011"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="130mm"/><tbody><row><entry>Additive EP050.</entry><entry><img id="ib0034" file="imgb0034.tif" wi="105" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP051.</entry><entry><img id="ib0035" file="imgb0035.tif" wi="67" he="5" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="58"> --><row><entry/><entry><img id="ib0036" file="imgb0036.tif" wi="104" he="5" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP006.</entry><entry><img id="ib0037" file="imgb0037.tif" wi="118" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP007.</entry><entry><img id="ib0038" file="imgb0038.tif" wi="121" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP008.</entry><entry><img id="ib0039" file="imgb0039.tif" wi="126" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP009.</entry><entry><img id="ib0040" file="imgb0040.tif" wi="116" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP052.</entry><entry><img id="ib0041" file="imgb0041.tif" wi="123" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP053.</entry><entry><img id="ib0042" file="imgb0042.tif" wi="125" he="12" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables>
<tables id="tabl0012" num="0012"><table frame="all"><title>Table 2</title><tgroup cols="5"><colspec colnum="1" colname="col1" colwidth="16mm"/><colspec colnum="2" colname="col2" colwidth="25mm"/><colspec colnum="3" colname="col3" colwidth="14mm"/><colspec colnum="4" colname="col4" colwidth="31mm"/><colspec colnum="5" colname="col5" colwidth="27mm"/><thead><row><entry align="center" valign="top"><u>Additive</u></entry><entry align="center" valign="top"><u>Length (NT's)</u></entry><entry align="center" valign="top"><u>Tm, °C</u></entry><entry align="center" valign="top"><u>Concentration, nM</u></entry><entry align="center" valign="top"><u>Selectivity, Δ C</u><sub><u>T</u></sub></entry></row></thead><tbody><row><entry align="center">EP050</entry><entry align="center">16</entry><entry align="char" char="." charoff="26">62.8</entry><entry align="center">200</entry><entry align="center">1.6</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">300</entry><entry align="center">2.9</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">400</entry><entry align="center">5.5</entry></row><row><entry align="center">EP051</entry><entry align="center">16</entry><entry align="char" char="." charoff="26">62.8</entry><entry align="center">200</entry><entry align="center">1.1</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">300</entry><entry align="center">2.7</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">400</entry><entry align="center">1.8</entry></row><row><entry align="center">EP006</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">100</entry><entry align="center">3.5</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">300</entry><entry align="center">8.3</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">600</entry><entry align="center">12.0</entry></row><row><entry align="center">EP007</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">100</entry><entry align="center">3.5</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">300</entry><entry align="center">7.3</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">600</entry><entry align="center">11.5</entry></row><row><entry align="center">EP008</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">100</entry><entry align="center">1.7</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">300</entry><entry align="center">5.8</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">600</entry><entry align="center">9.7</entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="59"> --></p><heading id="h0024">D. Additives with Three Dabcyl Modifiers.</heading><p id="p0127" num="0127">The double-stranded oligonucleotide 22merA described in part B above (SEQ ID No. 9) was modified by placing a Dabcyl on each end of the top strand and on the 5' end of the bottom strand (additive EP002, SEQ ID No. 24); by placing a Dabcyl on the 3' end of the top strand and on each end of the bottom strand (additive EP003, SEQ ID No. 25); by placing a Dabcyl on the 5' end of the top strand and on each end of the bottom strand (additive EP004, SEQ ID No. 26); and by placing a Dabcyl on each end of the top strand and on the 3' end of the bottom strand (additive EP005, SEQ ID No. 27). Sequences of the additives are given below and results are presented in Table 3.
<tables id="tabl0013" num="0013"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="27mm"/><colspec colnum="2" colname="col2" colwidth="139mm"/><tbody><row><entry>Additive EP002.</entry><entry><img id="ib0043" file="imgb0043.tif" wi="135" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP003.</entry><entry><img id="ib0044" file="imgb0044.tif" wi="130" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP004.</entry><entry><img id="ib0045" file="imgb0045.tif" wi="135" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP005.</entry><entry><img id="ib0046" file="imgb0046.tif" wi="121" he="12" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables>
<tables id="tabl0014" num="0014"><table frame="all"><title>Table 3</title><tgroup cols="5"><colspec colnum="1" colname="col1" colwidth="16mm"/><colspec colnum="2" colname="col2" colwidth="25mm"/><colspec colnum="3" colname="col3" colwidth="14mm"/><colspec colnum="4" colname="col4" colwidth="31mm"/><colspec colnum="5" colname="col5" colwidth="27mm"/><thead><row><entry align="center" valign="top"><u>Additive</u></entry><entry align="center" valign="top"><u>Length (NT's)</u></entry><entry align="center" valign="top"><u>Tm, °C</u></entry><entry align="center" valign="top"><u>Concentration, nM</u></entry><entry align="center" valign="top"><u>Selectivity, Δ C</u><sub><u>T</u></sub></entry></row></thead><tbody><row><entry align="center">EP002</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">100</entry><entry align="center">4.2</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">200</entry><entry align="center">7.1</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">300</entry><entry align="center">9.2</entry></row><row><entry align="center">EP003</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">100</entry><entry align="center">2.1</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">200</entry><entry align="center">5.6</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">300</entry><entry align="center">8.2</entry></row><row><entry align="center">EP004</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">100</entry><entry align="center">5.0</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">200</entry><entry align="center">6.6</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">300</entry><entry align="center">11.9</entry></row><row><entry align="center">EP005</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">100</entry><entry align="center">5.9</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">200</entry><entry align="center">9.3</entry></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center">300</entry><entry align="center">7.8</entry></row></tbody></tgroup></table></tables></p><heading id="h0025">E. Additives with Four Dabcyl Modifiers.</heading><!-- EPO <DP n="60"> --><p id="p0128" num="0128">Several double-stranded oligonucleotides were modified with four terminal Dabcyl modifiers:
<tables id="tabl0015" num="0015"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="138mm"/><tbody><row><entry>Additive EP022.</entry><entry><img id="ib0047" file="imgb0047.tif" wi="93" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP020.</entry><entry><img id="ib0048" file="imgb0048.tif" wi="133" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP001.</entry><entry><img id="ib0049" file="imgb0049.tif" wi="133" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP028.</entry><entry><img id="ib0050" file="imgb0050.tif" wi="134" he="12" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0129" num="0129">Results are shown in Table 4.
<tables id="tabl0016" num="0016"><table frame="all"><title>Table 4</title><tgroup cols="5"><colspec colnum="1" colname="col1" colwidth="16mm"/><colspec colnum="2" colname="col2" colwidth="25mm"/><colspec colnum="3" colname="col3" colwidth="14mm"/><colspec colnum="4" colname="col4" colwidth="31mm"/><colspec colnum="5" colname="col5" colwidth="27mm"/><thead><row><entry align="center" valign="top"><u>Additive</u></entry><entry align="center" valign="top"><u>Length (NT's)</u></entry><entry align="center" valign="top"><u>Tm, °C</u></entry><entry align="center" valign="top"><u>Concentration, nM</u></entry><entry align="center" valign="top"><u>Selectivity, Δ C</u><sub><u>T</u></sub></entry></row></thead><tbody><row><entry align="center">EP0022</entry><entry align="center">8</entry><entry align="char" char="." charoff="26">42.8</entry><entry align="center">600</entry><entry align="center">1.2</entry></row><row><entry align="center">EP0020</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">47.7</entry><entry align="center">600</entry><entry align="center">0.9</entry></row><row><entry align="center">EP001</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">100</entry><entry align="center">7.1</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="26"/><entry align="center">200</entry><entry align="center">9.5</entry></row><row><entry align="center">EP028</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">60.6</entry><entry align="center">300</entry><entry align="center">10.0</entry></row></tbody></tgroup></table></tables></p><heading id="h0026">F. Additives with Different Modifiers.</heading><p id="p0130" num="0130">Several double-stranded oligonucleotides were modified with modifiers other than Dabcyl. Three modifiers, digoxigenin (DIG), coumarin (CMN), QSY 21 (QSY), were shown to be useful in additives, and one, fluorescein (FAM), was not. Sequences of the oligonucleotides were as follows:
<tables id="tabl0017" num="0017"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="136mm"/><tbody><row><entry>Additive EP026.</entry><entry><img id="ib0051" file="imgb0051.tif" wi="125" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP029.</entry><entry><img id="ib0052" file="imgb0052.tif" wi="123" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP031.</entry><entry><img id="ib0053" file="imgb0053.tif" wi="131" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP033.</entry><entry><img id="ib0054" file="imgb0054.tif" wi="93" he="5" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="61"> --><row><entry/><entry><img id="ib0055" file="imgb0055.tif" wi="122" he="5" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive F032.</entry><entry><img id="ib0056" file="imgb0056.tif" wi="130" he="12" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0131" num="0131">Results are shown in Table 5.
<tables id="tabl0018" num="0018"><table frame="all"><title>Table 5</title><tgroup cols="5"><colspec colnum="1" colname="col1" colwidth="16mm"/><colspec colnum="2" colname="col2" colwidth="25mm"/><colspec colnum="3" colname="col3" colwidth="14mm"/><colspec colnum="4" colname="col4" colwidth="31mm"/><colspec colnum="5" colname="col5" colwidth="27mm"/><thead><row><entry align="center" valign="top"><u>Additive</u></entry><entry align="center" valign="top"><u>Length (NT's)</u></entry><entry align="center" valign="top"><u>Tm, °C</u></entry><entry align="center" valign="top"><u>Concentration, nM</u></entry><entry align="center" valign="top"><u>Selectivity, Δ C</u><sub><u>T</u></sub></entry></row></thead><tbody><row><entry align="center">EP026</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">300</entry><entry align="char" char="." charoff="7">3.8</entry></row><row><entry align="center">EP029</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">300</entry><entry align="char" char="." charoff="7">0.9</entry></row><row><entry align="center">EP031</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">200</entry><entry align="char" char="." charoff="7">3.2</entry></row><row><entry align="center">EP033</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">200</entry><entry align="char" char="." charoff="7">3.4</entry></row><row><entry align="center">F032</entry><entry align="center">22</entry><entry align="char" char="." charoff="26">63.1</entry><entry align="center">200</entry><entry align="char" char="." charoff="7">0.9</entry></row></tbody></tgroup></table></tables></p><heading id="h0027">Example 4. <u>Type II Mispriming and Polymerase Selectivity with Additive Mixtures.</u></heading><p id="p0132" num="0132">Combinations of two additives can be added to the reaction mixture as four strands, that is, as a mixture of two different double-stranded oligonucleotides. Alternatively, two additives can share a common strand and, thus, be added to the reaction mixtrue as three strands. This example reports results obtained in the assay reported in Example 3 using three-strand versions of mixtures, including a control mixture having no modifiers. For two additives that share a common strand, we write the common strand in the middle, the strand whose hybrid with the middle strand has the higher melting temperature on top, and the strand whose hybrid with the middle strand has the lower melting temperature on the bottom. We write the strand concentrations, in nM, as top/middle/bottom. We write the Tm's of the two hybrids (°C) as upper/lower. Melting temperatures were adjusted either by shortening the bottom strand or introducing mismatches into the bottom strand (mismatched nucleotides are underlined). The additives tested were:
<tables id="tabl0019" num="0019"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="106mm"/><tbody><row><entry>Additive 041.</entry><entry><img id="ib0057" file="imgb0057.tif" wi="79" he="27" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP041.</entry><entry><img id="ib0058" file="imgb0058.tif" wi="96" he="12" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="62"> --><row><entry/><entry><img id="ib0059" file="imgb0059.tif" wi="90" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive 042.</entry><entry><img id="ib0060" file="imgb0060.tif" wi="80" he="27" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP042.</entry><entry><img id="ib0061" file="imgb0061.tif" wi="96" he="27" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP043.</entry><entry><img id="ib0062" file="imgb0062.tif" wi="95" he="27" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP045.</entry><entry><img id="ib0063" file="imgb0063.tif" wi="102" he="27" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0133" num="0133">Results are shown in Table 6, along with the strand concentratons and the Tm's of the unmodified hybrid of the upper two strands and the lower two strands. Numbers for improvement in selectivity over a no-additive control (ΔCT) were calculated as described in Example 3.
<tables id="tabl0020" num="0020"><table frame="all"><title>Table 6</title><tgroup cols="4"><colspec colnum="1" colname="col1" colwidth="16mm"/><colspec colnum="2" colname="col2" colwidth="36mm"/><colspec colnum="3" colname="col3" colwidth="32mm"/><colspec colnum="4" colname="col4" colwidth="27mm"/><thead><row><entry align="center" valign="top"><u>Additive</u></entry><entry align="center" valign="top"><u>Tm(Upper/Lower,(°C)</u></entry><entry align="center" valign="top"><u>Concentrations, nM</u></entry><entry align="center" valign="top"><u>Selectivity, ΔCT</u></entry></row></thead><tbody><row><entry align="center">041</entry><entry align="center">67.4/59.0</entry><entry align="center">Top 75</entry><entry align="center">1.7</entry></row><row><entry align="center"/><entry align="center"/><entry align="center">Mid. 400</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Bot. 325</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/></row><row><entry align="center">EP041</entry><entry align="center">67.4/59.0</entry><entry align="center">Top 75</entry><entry align="center">4.8</entry></row><row><entry align="center"/><entry align="center"/><entry align="center">Mid. 400</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Bot. 325</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/></row><row><entry align="center">042</entry><entry align="center">67.4/57.4</entry><entry align="center">Top 75</entry><entry align="center">1.9</entry></row><!-- EPO <DP n="63"> --><row><entry align="center"/><entry align="center"/><entry align="center">Mid. 400</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Bot. 325</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/></row><row><entry align="center">EP042</entry><entry align="center">67.4/57.4</entry><entry align="center">Top 75</entry><entry align="center">6.8</entry></row><row><entry align="center"/><entry align="center"/><entry align="center">Mid. 400</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Bot. 325</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/></row><row><entry align="center">EP043</entry><entry align="center">67.4/59.1</entry><entry align="center">Top 25</entry><entry align="center">2.4</entry></row><row><entry align="center"/><entry align="center"/><entry align="center">Mid. 600</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Bot. 575</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Top 50</entry><entry align="center">2.9</entry></row><row><entry align="center"/><entry align="center"/><entry align="center">Mid. 600</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Bot. 550</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Top 75</entry><entry align="center">2.2</entry></row><row><entry align="center"/><entry align="center"/><entry align="center">Mid. 600</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Bot. 525</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Top 100</entry><entry align="center">3.3</entry></row><row><entry align="center"/><entry align="center"/><entry align="center">Mid. 600</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Bot. 500</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/></row><row><entry align="center">EP045</entry><entry align="center">67.4/59.1</entry><entry align="center">Top 25</entry><entry align="center">5.0</entry></row><row><entry align="center"/><entry align="center"/><entry align="center">Mid. 600</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Bot. 575</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Top 50</entry><entry align="center">6.9</entry></row><row><entry align="center"/><entry align="center"/><entry align="center">Mid. 600</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Bot. 550</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Top 75</entry><entry align="center">7.7</entry></row><row><entry align="center"/><entry align="center"/><entry align="center">Mid. 600</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Bot. 525</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center"/><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Top 100</entry><entry align="center">10.8</entry></row><row><entry align="center"/><entry align="center"/><entry align="center">Mid. 600</entry><entry align="center"/></row><row><entry align="center"/><entry align="center"/><entry align="center">Bot. 500</entry><entry align="center"/></row></tbody></tgroup></table></tables></p><p id="p0134" num="0134">Kinetic analysis of amplification reactions with additives EP043 and EP045 are shown in <figref idrefs="f0007 f0008 f0009 f0010">FIGS. 7A-7D</figref> and <figref idrefs="f0011 f0012 f0013 f0014">FIGS. 8A-8D</figref>, respectively. These figures present fluorescence intensity readings from SYBR Green dye as a function of LATE-PCR cycle number for different concentrations of additive. <figref idrefs="f0007">FIG. 7A</figref> presents the results with additive EP043 having strand concentrations (upper/middle/lower strands) of 25/600/575 nM. In <figref idrefs="f0007">FIG. 7A</figref>, circle 71<!-- EPO <DP n="64"> --> is the three replicates for the matched target, and circle 72 is the three replicates for the mismatched target. <figref idrefs="f0008">FIG. 7B</figref> presents the results with additive EP043 having strand concentrations (upper/middle/lower strands) of 50/600/550 nM. In <figref idrefs="f0008">FIG 7B</figref>, circle 73 is the three replicates for the matched target, and circle 74 is the three replicates for the mismatched target. <figref idrefs="f0009">FIG. 7C</figref> presents the results with additive EP043 having strand concentrations (upper/middle/lower strands) of 75/600/525 nM. In <figref idrefs="f0009">FIG 7C</figref>, circle 75 is the three replicates for the matched target, and circle 76 is the three replicates for the mismatched target. <figref idrefs="f0010">FIG. 7D</figref> presents the results with additive EP043 having strand concentrations (upper/middle/lower strands) of 100/600/500 nM. In <figref idrefs="f0010">FIG. 7D</figref>, circle 77 is the three replicates for the matched target, and circle 78 is the three replicates for the mismatched target.</p><p id="p0135" num="0135"><figref idrefs="f0011">FIG. 8A</figref> presents the results with additive EP045 having strand concentrations (upper/middle/lower strands) of 25/600/575 nM. In <figref idrefs="f0011">FIG. 8A</figref>, circle 81 is the three replicates for the matched target, and circle 82 is the three replicates for the mismatched target. <figref idrefs="f0012">FIG. 8B</figref> presents the results with additive EP045 having strand concentrations (upper/middle/lower strands) of 50/600/550 nM. In <figref idrefs="f0012">FIG. 8B</figref>, circle 83 is the three replicates for the matched target, and circle 84 is the three replicates for the mismatched target. <figref idrefs="f0013">FIG. 8C</figref> presents the results with additive EP045 having strand-concentrations (upper/middle/lower strands) of 75/600/525 nM. In <figref idrefs="f0013">FIG. 8C</figref>, circle 85 is the three replicates for the matched target, and circle 86 is the three replicates for the mismatched target. <figref idrefs="f0014">FIG. 8D</figref> presents the results with additive EP045 having strand concentrations (upper/middle/lower strands) of 100/600/500 nM. In <figref idrefs="f0014">FIG. 8D</figref>, circle 87 is the three replicates for the matched target, and-circle 88 is the three replicates for the mismatched target.</p><heading id="h0028">Example 5. <u>Suppression of Type I and Type III Misprimins in a Duplex Reaction.</u></heading><p id="p0136" num="0136">A duplex LATE-PCR reaction was run in triplicate with two DNA targets, a primer pair for each target, and a molecular beacon hybridization probe for each target. Each reaction mixture contained the following primers and probes
<tables id="tabl0021" num="0021"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="46mm"/><colspec colnum="2" colname="col2" colwidth="102mm"/><thead><row><entry namest="col1" nameend="col2" align="left" valign="top">For First Target Sequence:</entry></row></thead><tbody><row><entry>Excess primer.</entry><entry>5' TGTCATCTTCTGTCCCTTCCCAGAAA (SEQ ID No. 50)</entry></row><row><entry>Limiting primer.</entry><entry><img id="ib0064" file="imgb0064.tif" wi="93" he="12" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="65"> --><row><entry>Probe for First Amplicon.</entry><entry>5' BHQ-1 CCGTAGCTGCCCTGG' Cal Red 610 (SEQ ID No. 52)</entry></row><row><entry/><entry/></row></tbody></tgroup><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="46mm"/><colspec colnum="2" colname="col2" colwidth="102mm"/><thead><row><entry valign="top">For Second Target Sequence:</entry><entry valign="top"/></row></thead><tbody><row><entry>Excess primer. 5'</entry><entry>GCACAGTTACAGTATTCCAGCAGACTCA (SEQ ID No. 53)</entry></row><row><entry>Limiting primer. 5'</entry><entry>TCAGTGGTGGCAGTGGTAGTGGTGGC (SEQ ID No. 54)</entry></row><row><entry>Probe for Second Amplicon.</entry><entry>5' BHQ-2 TCAGTGGTGGCAGTGGTAGA Quasar 670 (SEQ ID No.55)</entry></row></tbody></tgroup></table></tables>
.</p><p id="p0137" num="0137">LATE-PCR reaction mixtures included 1X Platinum Taq buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl2, 0.25 nM dNTPs, 50 nM each limiting primer, 1000 nM each excess primer, and 500 nM each detection probe, 1.25 units Platinum Taq polymerase (Invitrogen, Carlsbad, CA) and 1000 genomes equivalents of human DNA in a volume of 25 ul. Different reaction mixtures contained no additive, additive EP020 at 400 nM concentration, or additive EP013 at 300 nM concentration.</p><p id="p0138" num="0138">The LATE-PCR amplification reaction thermal profile conditions were 20 cycles of 95 °C/10s, annealing at the temperature specified below for 10s, and 72 °C/10s; followed by 50 cycles at 95 °C/10s, 65 °C110s, 72 °C/10s, and fluorescent signal detection at 54 °C/20s. Amplification was carried out in a Bio-Rad IQ-5 Multicolor Real-Time PCR Detection System (Bio-Rad, Hercules, CA) using the temperature gradient function that permits multiple amplification temperature profiles with different annealing temperatures to be run in the same instrument.
<tables id="tabl0022" num="0022"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="106mm"/><tbody><row><entry>Additive EP020.</entry><entry><img id="ib0065" file="imgb0065.tif" wi="99" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP013.</entry><entry><img id="ib0066" file="imgb0066.tif" wi="102" he="20" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="66"> --></p><p id="p0139" num="0139">Six assays were run. They had the following additives and initial annealing temperature (first 20 cycles):
<ul><li>Reaction 1: No additive, annealing temperature: 65 °C</li><li>Reaction 2: additive EP020, annealing temperature 65 °C</li><li>Reaction 3: additive EP020, annealing temperature 60.7 °C</li><li>Reaction 4: additive EP013, annealing temperature 66.5 °C</li><li>Reaction 5: additive EP013, annealing temperature 64.2 °C</li><li>Reaction 6: additive EP013, annealing temperature 60.7 °C</li></ul></p><p id="p0140" num="0140"><figref idrefs="f0015 f0016 f0017 f0018 f0019 f0020">FIG. 9</figref> presents the fluorescence readings from the probes as a function of the LATE-PCR thermal cycle number. <figref idrefs="f0015">FIG. 9A</figref> shows the readings from Reaction 1, wherein circle 911 is the readings from the first probe in the four replicates of amplification of the first target, and circle 912 is the readings from the second probe in the four replicates of amplification of the second target. <figref idrefs="f0016">FIG. 9B</figref> shows the readings from Reaction 2, wherein circle 913 is the readings from the first probe in the four replicates of amplification of the first target, and circle 914 is the readings from the second probe in the four replicates of amplification of the second target. <figref idrefs="f0017">FIG. 9C</figref> shows the readings from Reaction 3, wherein circle 915 is the readings from the first probe in the four replicates of amplification of the first target, and circle 916 is the readings from the second probe in the four replicates of amplification of the second target. <figref idrefs="f0018">FIG. 9D</figref> shows the readings from Reaction 4, wherein circle 917 is the readings from the first probe in the four replicates of amplification of the first target, and circle 918 is the readings from the second probe in the four replicates of amplification of the second target. <figref idrefs="f0019">FIG. 9E</figref> shows the readings from Reaction 5, wherein circle 919 is the readings from the first probe in the four replicates of amplification of the first target, and circle 920 is the readings from the second probe in the four replicates of amplification of the second target. <figref idrefs="f0020">FIG. 9F</figref> shows the readings from Reaction 6, wherein circle 921 is the readings from the first probe in the four replicates of amplification of the first target, and circle 922 is the readings from the second probe in the four replicates of amplification of the second target.<!-- EPO <DP n="67"> --></p><heading id="h0029">Example 6. <u>A Primer-Independent Oscillating-Temperature Assay for Evaluating Inhibition of 5'Exonuclease Activity.</u></heading><p id="p0141" num="0141">Many DNA polymerases, including Taq and Tfi(+) have the capacity to cleave the fluorescently labeled nucleotide on the 5' end of an oligonucleotide probe that is hybridized to its target strand. This 5'exonuclease cleavage even occurs under isothermal conditions in the absence of extension of an upstream primer. It is therefore primer-independent cleavage in contrast to primer-dependent cleavage that takes place in standard 5' nuclease amplification reactions. The rate of primer-independent 5'exonuclease cleavage can be increased by oscillating the temperature of the reaction mixture over a limited temperature range above and below the Tm of the probe/target hybrid.</p><p id="p0142" num="0142">Oscillation reactions were carried out in 25 ul volume consisting of 1X PCR buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl<sub>2</sub>, 200 nM dNTPs, 1.25 units of Taq DNA polymerase (Invitrogen, Carlsbad, CA), 200 nM of a probe having a 5'FAM and a 3' Black Hole Quencher 1 (BHQ1), and 100 nM of a complementary 41 nucleotide target. This reaction mixture was used with and without any additive and with each of the additives identified below at a concentration of 300 nM. A control reaction was run with the probe as the only oligonucleotide in the reaction mixture. The additives included PS060, a single-stranded additive that forms a stem-loop structure (complementary nucleotides forming the stem are underlined), as well as double-stranded additives. Reaction mixtures were oscillated using the following thermal profile: 45°C/20s, 60°C/10s for 45 cycles, followed by a melt starting at 45°C/30secs with 1°C increments for 30 cycles. The FAM fluorescence was acquired during the 45°C/10s segment of the thermal profile. Sequences for the probe, target and additives were:
<tables id="tabl0023" num="0023"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="120mm"/><tbody><row><entry>Probe.</entry><entry>5' FAM CCATGATACAAGCTTCC BHQ1 (SEQ ID No. 57)</entry></row><row><entry>Target.</entry><entry>5' ACTTAGTAATTGGGAAGCTTGTATCATGGCACTTAGAACCT (SEQ ID No. 58)</entry></row><row><entry>Additive EP001.</entry><entry><img id="ib0067" file="imgb0067.tif" wi="100" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP004.</entry><entry><img id="ib0068" file="imgb0068.tif" wi="88" he="5" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="68"> --><row><entry/><entry><img id="ib0069" file="imgb0069.tif" wi="94" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP008.</entry><entry><img id="ib0070" file="imgb0070.tif" wi="100" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP009.</entry><entry><img id="ib0071" file="imgb0071.tif" wi="91" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive PS060.</entry><entry><img id="ib0072" file="imgb0072.tif" wi="107" he="12" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0143" num="0143">Exonuclease cleavage activity separates the probe's fluorophore from the probe, thereby resulting in an increase in fluorescence (FAM). Results are reported in <figref idrefs="f0021">FIG. 10</figref>. In <figref idrefs="f0021">FIG. 10</figref>, curve 101 for the probe-only reaction shows that in the absence of target, the probe is not cleaved. Curve 102 for the reaction containing probe and target but no additive, shows the highest probe cleavage. Curve 103 for PS060 shows higher probe cleavage than the curves for additives; that is, curve 104, EP009; curve 105, the same curve for EP004 and for EP008; and curve 106, EP001.</p><heading id="h0030">Example 7. <u>Inhibitor of 5'Exonuclease Activity During PCR.</u></heading><p id="p0144" num="0144">After the LATE-PCR amplification as described in Example 5, the detection probe for the first target was hybridized to its complementary amplification products at 50°C for 1 minute. The probe-target hybrids were then subjected to melting curve analysis by monitoring probe fluorescent intensities at 1°C intervals of 30 seconds each between 50°C and 80°C as the probe was being melted from the amplicon. A no-template control containing only the probe was also subjected to melting regimen (fluorescence increases slightly with temperature in the absence of probe cleavage, because fluorescence intensity from the fluorophore is temperature dependent). Two samples were subjected to melting: one containing no additive and one containing additive EP013 (SEQ ID No. 47) at 600 nM concentration.</p><p id="p0145" num="0145">Results are presented in <figref idrefs="f0022">FIG. 11A</figref> and <figref idrefs="f0023">11B</figref>. In <figref idrefs="f0022">FIG. 11A</figref>, curve 111 is for the probe alone, and curve 112 is for the amplification product of the reaction containing no additive.<!-- EPO <DP n="69"> --> In <figref idrefs="f0023">FIG. 11B</figref>, curve 113 is for the probe alone, and curve 114 is for the amplification product containing the additive EP013. Inhibition of primer-dependent Taq DNA polymerase 5' exonuclease activity is evidenced by fluorescence signals from the probe melted off the amplification targets matching the fluorescence signals of control samples containing the probe alone when melting is completed.</p><heading id="h0031">Example 8. <u>Large Multiplexed Reactions.</u></heading><p id="p0146" num="0146">Twelve pairs of primers, each for a different sequence within genes of the human mitochondrial genome, were combined into a single multiplex amplification mixture for a multiplex amplification of twelve different target sequences. The 25ul reaction mixtures contained 1x PCR Buffer, 400 nM dNTPs, 3 mM MgCl2, 0.24x SYBR Green, 50 nM Limiting Primer, 1000 nM Excess Primer, and 3.75 units of Tfi(-) DNA polymerase, with either no additive, additive EP011 at 300 nM concentration, or additive EP011 at 600 nM concentration.</p><p id="p0147" num="0147">Reaction mixtures were subjected to the following LATE-PCR thermal cycling protocol: 95°C for 3 minutes followed by 65 cycles of 95°C/5s, 58°C/20s, and 68°C/2m; followed by a melt starting at 45°C with 1°C increments at 30s intervals to 95°C. Reactions were analyzed at the end of 65 cycles by a melt curve analysis using the first derivative of SYBR Green fluorescence (-dF/dT, SYBR) of double-stranded DNA product. In addition, the kinetics of production of double-stranded product (SYBR Green intensity reading as a function of thermal cycles) was analyzed for reactions.</p><p id="p0148" num="0148">The sequence of additive EP011, and the sequences of the 12 targets and the primers used to amplify each were are as follows:
<tables id="tabl0024" num="0024"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="29mm"/><colspec colnum="2" colname="col2" colwidth="132mm"/><tbody><row><entry>Additive EP011.</entry><entry><img id="ib0073" file="imgb0073.tif" wi="100" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Target HV1.</entry><entry><img id="ib0074" file="imgb0074.tif" wi="128" he="26" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="70"> --><row><entry/><entry><img id="ib0075" file="imgb0075.tif" wi="126" he="71" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer.</entry><entry>5' GCCCGGAGCGAGGAGAGTAGCACTCTTG (SEQ ID No. 62)</entry></row><row><entry>Excess Primer.</entry><entry>5' CACCAGTCTTGTAAACCGGAGATGAA (SEQ ID No. 63)</entry></row><row><entry/><entry/></row><row><entry>Target HV2.</entry><entry><img id="ib0076" file="imgb0076.tif" wi="127" he="99" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer.</entry><entry>5' AGCGGTGTGTGTGTGCTGGGTAGGAT (SEQ ID No. 65)</entry></row><row><entry>Excess Primer.</entry><entry>5' ACAGGTCTATCACCCTATTAACCACTCA (SEQ ID No. 66)</entry></row><row><entry/><entry/></row><row><entry>Target CO1-1.</entry><entry><img id="ib0077" file="imgb0077.tif" wi="120" he="4" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="71"> --><row><entry/><entry><img id="ib0078" file="imgb0078.tif" wi="121" he="114" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer.</entry><entry>5' AGGTTGCGGTCTGTTAGTAGTATAGTGATGCCAGCA (SEQ ID No. 68)</entry></row><row><entry/><entry>5' ACCGTTGACTATTCTCTACAAACCACA (SEQ ID No. 69)</entry></row><row><entry>Excess Primer.</entry><entry/></row><row><entry>Target CO1-2.</entry><entry><img id="ib0079" file="imgb0079.tif" wi="126" he="77" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="72"> --><row><entry/><entry><img id="ib0080" file="imgb0080.tif" wi="120" he="56" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer.</entry><entry>5' ATGGAGGGTTCTTCTACTATTAGGACTTTTCGCT (SEQ ID No. 71)</entry></row><row><entry>Excess Primer.</entry><entry>5' ATCCTACCAGGCTTCGGAATAATCTC (SEQ ID No. 72)</entry></row><row><entry/><entry/></row><row><entry>Target CO2.</entry><entry><img id="ib0081" file="imgb0081.tif" wi="127" he="106" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer.</entry><entry>5' AGGGTAAATACGGGCCCTATTTCAAAGATTTTTAGGGGA (SEQ ID No. 74)</entry></row><row><entry>Excess Primer.</entry><entry>5' TCCTTATCTGCTTCCTAGTCCTGTATGC (SEQ ID No. 75)</entry></row><!-- EPO <DP n="73"> --><row><entry>Target 12srRNA.</entry><entry><img id="ib0082" file="imgb0082.tif" wi="122" he="165" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer.</entry><entry>5' TCCAGTACACTTACCATGTTACGACTTGTCTCCTCTA (SEQ ID No. 77)</entry></row><row><entry>Excess Primer.</entry><entry>5' CCTCTAAATCACCACGATCAAAAGGAAC (SEQ ID No. 78)</entry></row><row><entry/><entry/></row><row><entry>Target Cytb-1.</entry><entry><img id="ib0083" file="imgb0083.tif" wi="126" he="19" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="74"> --><row><entry/><entry><img id="ib0084" file="imgb0084.tif" wi="119" he="63" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer.</entry><entry>5' TGTGAGGGTGGGACTGTCTACTGAGTAGCC (SEQ ID No. 80)</entry></row><row><entry>Excess Primer.</entry><entry>5' TCCGCATGATGAAACTTCGGCTC (SEQ ID No. 81)</entry></row><row><entry/><entry/></row><row><entry>Target Cytb-2.</entry><entry><img id="ib0085" file="imgb0085.tif" wi="127" he="77" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer.</entry><entry>5' CGATTCAGGTTAGAATGAGGAGGTCTGCGGCTAG (SEQ ID No. 83)</entry></row><row><entry>Excess Primer.</entry><entry>5' ACTCCACCTCCTATTCTTGCACGA (SEQ ID No. 84)</entry></row><row><entry/><entry/></row><row><entry>Target ND1.</entry><entry><img id="ib0086" file="imgb0086.tif" wi="125" he="19" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="75"> --><row><entry/><entry><img id="ib0087" file="imgb0087.tif" wi="123" he="100" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer.</entry><entry>5' CATAAGAACAGGGAGGTTAGAAGTAGGGTCTTGGT (SEQ ID No. 86)</entry></row><row><entry>Excess Primer.</entry><entry>5' CCCCTAAAACCCGCCACAT (SEQ ID No. 87)</entry></row><row><entry/><entry/></row><row><entry>Target ND2.</entry><entry><img id="ib0088" file="imgb0088.tif" wi="125" he="91" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="76"> --><row><entry/><entry><img id="ib0089" file="imgb0089.tif" wi="123" he="63" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer</entry><entry><img id="ib0090" file="imgb0090.tif" wi="106" he="12" img-content="dna" img-format="tif"/></entry></row><row><entry>Excess Primer.</entry><entry>5' TGCAGGCACACTCATCACAGCGCTAAGCT (SEQ ID No. 90)</entry></row><row><entry/><entry/></row><row><entry>Target ND4-1.</entry><entry><img id="ib0091" file="imgb0091.tif" wi="126" he="92" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer.</entry><entry>5' GCTCAGGAGTTTGATAGTTCTTGGGCAGTGAGAG (SEQ ID No. 92)</entry></row><row><entry>Excess Primer.</entry><entry>5' AACACAACCACCCACAGCCTAATTATTAG (SEQ ID No. 93)</entry></row><row><entry/><entry/></row><row><entry>Target ND4-2.</entry><entry><img id="ib0092" file="imgb0092.tif" wi="120" he="5" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="77"> --><row><entry/><entry><img id="ib0093" file="imgb0093.tif" wi="121" he="85" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer.</entry><entry>5' GTGGTGGGTGAGTGAGCCCCATTGTGT (SEQ ID No. 95)</entry></row><row><entry>Excess Primer.</entry><entry>5' CTACCCCTTCCTTGTACTATCCCTATGAG (SEQ ID No. 96)</entry></row></tbody></tgroup></table></tables></p><p id="p0149" num="0149">The amplified products were then analyzed using a 5% Polyacrylamide gel, loaded with 1 ul of PCR product combined with 1 ul of loading dye. The gel was run for eight hours at 30 volts at 4 °C. The gel was developed for ten minutes using SYBR Gold. A photograph of the gel is presented in <figref idrefs="f0024">FIG. 12</figref>. The first lane is the reaction with no additive. The second lane is the reaction with additive EP011 at 300 nM concentration. The third lane is the reaction with additive EP011 at 600 nM concentration. As can be seen from <figref idrefs="f0024">FIG. 12</figref>, the reaction without additive failed to generate the expected set of twelve products. From lane 2 it can be seen that 300 nM of additive EP011 suppressed most mispriming (one band of light weight product can be seen at the bottom). From lane 3 it can be seen that additive EP011 at 600 nM concentration suppressed all mispriming.</p><p id="p0150" num="0150">The reaction containing 600 nM additive EP011 was subjected to the sequencing sample preparation known as the Dilute-'N'-Go method. See, <nplcit id="ncit0022" npl-type="s"><text>Rice, J.E. et al. (2007), Monoplex/Multiplex Linear-After-The-Exponential PCR Assay Combined with PrimeSafe and Dilute-'N'-Go Sequencing, Nature Protocols 2: 2429-2438</text></nplcit>. The prepared sample was divided into twelve aliquots, and each aliquot was subjected to dideoxy sequencing utilizing one of the twelve limiting primers as the sequencing primer. Sequencing results demonstrated that the amplification reaction generated a sufficient single-stranded DNA for<!-- EPO <DP n="78"> --> each amplicon to permit sequencing of each of the 12 different Limiting Primer strands from a single reaction via the Dilute'N'Go dideoxy sequencing protocol.</p><p id="p0151" num="0151">The above results were obtained using 1000 copies of mitochondrial genomic DNA in each reaction. Additional samples in this experiment (results not shown) demonstrated that complete amplification of all 12 products was not obtained when each reaction contained only 100 or 10 copies of mitochondrial genomic DNA. This is consistent with the fact that Type 1 and Type 3 mispriming increase with decreasing numbers of targets.</p><p id="p0152" num="0152">But, 100 and 10 copies of mitochondrial genomic DNA can be successfully amplified with the multiplex reaction described above after making the following adjustments: 1) use EP043 with a combination of strands at 50/600/550 nM; 2) increase the number of amplification cycles to 80-90; and 3) in accord with Example 14 alter the limiting primers for the following targets by addition of at least two mismatched A's or T's to their 5' ends (indicated by underlining).
<tables id="tabl0025" num="0025"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm"/><colspec colnum="2" colname="col2" colwidth="123mm"/><thead><row><entry namest="col1" nameend="col2" align="left" valign="top">For target HV1:</entry></row></thead><tbody><row><entry>Limiting Primer.</entry><entry>5' <u>TAAA</u>GCCCGGAGCGAGGAGAGTAGCACTCTTG (SEQ ID No. 97)</entry></row></tbody></tgroup><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm"/><colspec colnum="2" colname="col2" colwidth="123mm"/><thead><row><entry valign="top">For target HV2:</entry><entry valign="top"/></row></thead><tbody><row><entry>Limiting Primer.</entry><entry>5' <u>AA</u>AGCGGTGTGTGTGTGCTGGGTAGGAT (SEQ ID No. 98)</entry></row></tbody></tgroup><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm"/><colspec colnum="2" colname="col2" colwidth="123mm"/><thead><row><entry valign="top">For target CO1-1:</entry><entry valign="top"/></row></thead><tbody><row><entry>Limiting Primer.</entry><entry>5' <u>AA</u>AGGTTGCGGTCTGTTAGTAGTATAGTGATGCCAGCA (SEQ ID No. 99)</entry></row></tbody></tgroup><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm"/><colspec colnum="2" colname="col2" colwidth="123mm"/><thead><row><entry valign="top">For target CO1-2:</entry><entry valign="top"/></row></thead><tbody><row><entry>Limiting Primer.</entry><entry>5' <u>AA</u>ATGGAGGGTTCTTCTACTATTAGGACTTTTCGCT (SEQ ID No. 100)</entry></row></tbody></tgroup><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm"/><colspec colnum="2" colname="col2" colwidth="123mm"/><thead><row><entry valign="top">For target CO2:</entry><entry valign="top"/></row></thead><tbody><row><entry>Limiting Primer.</entry><entry>5' <u>TAA</u>GGGTAAATACGGGCCCTATTTCAAAGATTTTT AGGGGA (SEQ ID No. 101)</entry></row></tbody></tgroup><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm"/><colspec colnum="2" colname="col2" colwidth="123mm"/><thead><row><entry valign="top">For target 12srRNA:</entry><entry valign="top"/></row></thead><tbody><row><entry>Limiting Primer.</entry><entry>5' <u>AA</u>TCCAGTACACTTACCATGTTACGACTTGTCTCCTCTA (SEQ ID No. 102)</entry></row></tbody></tgroup><!-- EPO <DP n="79"> --><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm"/><colspec colnum="2" colname="col2" colwidth="123mm"/><thead><row><entry valign="top">For target Cytb-1:</entry><entry valign="top"/></row></thead><tbody><row><entry>Limiting Primer.</entry><entry>5' <u>AA</u>TGTGAGGGTGGGACTGTCTACTGAGTAGCC (SEQ ID No. 103)</entry></row></tbody></tgroup><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm"/><colspec colnum="2" colname="col2" colwidth="123mm"/><thead><row><entry valign="top">For target Cytb-2:</entry><entry valign="top"/></row></thead><tbody><row><entry>Limiting Primer.</entry><entry>5' <u>AA</u>CGATTCAGGTTAGAATGAGGAGGTCTGCGGCTAG (SEQ ID No. 104)</entry></row></tbody></tgroup><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm"/><colspec colnum="2" colname="col2" colwidth="123mm"/><thead><row><entry valign="top">For target ND 1:</entry><entry valign="top"/></row></thead><tbody><row><entry>Limiting:</entry><entry>5'<u>AA</u>CATAAGAACAGGGAGGTTAGAAGTAGGGTCTTGGT (SEQ ID No. 105)</entry></row></tbody></tgroup><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm"/><colspec colnum="2" colname="col2" colwidth="123mm"/><thead><row><entry valign="top">For target ND2:</entry><entry valign="top"/></row></thead><tbody><row><entry>Limiting Primer.</entry><entry><img id="ib0094" file="imgb0094.tif" wi="101" he="12" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm"/><colspec colnum="2" colname="col2" colwidth="123mm"/><thead><row><entry valign="top">For target ND4-1:</entry><entry valign="top"/></row></thead><tbody><row><entry>Limiting Primer.</entry><entry>5' <u>AA</u>GCTCAGGAGTTTGATAGTTCTTGGGCAGTGAGAG (SEQ ID No. 107)</entry></row></tbody></tgroup><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="33mm"/><colspec colnum="2" colname="col2" colwidth="123mm"/><thead><row><entry valign="top">For target ND4-2:</entry><entry valign="top"/></row></thead><tbody><row><entry>Limiting Primer.</entry><entry>5' <u>TA</u>GTGGTGGGTGAGTGAGCCCCATTGTGT (SEQ ID No. 108)</entry></row></tbody></tgroup></table></tables></p><heading id="h0032">Example 9. <u>Direct Quantitative Measure of Suppression of Type 1 Mispriming.</u></heading><p id="p0153" num="0153">The assay reported in this example was developed to measure Type I mispriming and the effect of additives and hot-start reagents in suppressing Type I mispriming. In this assay, two overlapping oligonucleotides that can anneal and extend are first incubated at a temperature (50 °C) below a LATE-PCR annealing temperature for an extended period (10minutes). If extension occurs, priming sites for a pair of LATE-PCR primers are created, that is, the extended overlapping nucleotides include the priming sites but the oligonucleotides themselves contain only the complements of the priming sites. The reaction mixture is then subjected to LATE-PCR amplification using the primer pair. Under these conditions, the number of cycles required to generate a detectable level of product (observed with either SYBR Green or a probe to the Excess-Primer-Strand) will depend on how many extended (or full length) strands are generated during the initial isothermal incubation of the<!-- EPO <DP n="80"> --> partially complementary oligomers. This, in turn, will depend on how active the DNA polymerase is during isothermal incubation. By comparing the threshold cycles (C<sub>T</sub>) of a reaction with an inhibitor to a reaction with no inhibitor, one obtains a quantitative measure of the effect of the inhibitor in suppressing the initial, isothermal extension, which is considered to be a mispriming event in this assay. The lowest C<sub>T</sub> value is observed when all oligomers present initially are fully extended prior to the first round of amplification. Higher and higher C<sub>T</sub> values are observed with greater and greater inhibition of DNA polymerase. After the respective combinations of reactions were mixed and prior to the isothermal incubation at 50°C all reactions had the overlap oligonucleotides 1 and 2 added at approximately 100,000 copies each.</p><p id="p0154" num="0154">The following oligonucleotides were used. For the overlapping oligonucleotides, the sequences complementary to priming sites are underlined, and overlapping sequences are italicized.
<ul><li>Overlapping oligonucleotide 1:
<img id="ib0095" file="imgb0095.tif" wi="136" he="13" img-content="dna" img-format="tif"/></li><li>Overlapping oligonucleotide 2
<img id="ib0096" file="imgb0096.tif" wi="139" he="13" img-content="dna" img-format="tif"/></li></ul>
<tables id="tabl0026" num="0026"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="111mm"/><tbody><row><entry>Limiting Primer:</entry><entry>5' TTGCACGAGAGCCAGCTCGTCAGGTAGTCACCAGT (SEQ ID No. 111)</entry></row><row><entry>Excess Primer:</entry><entry>5' CAGCAGCAGACAGTGCACTCGTCAC (SEQ ID No. 112)</entry></row><row><entry>Additive EP046.</entry><entry><img id="ib0097" file="imgb0097.tif" wi="101" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP020.</entry><entry><img id="ib0098" file="imgb0098.tif" wi="99" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP022.</entry><entry><img id="ib0099" file="imgb0099.tif" wi="62" he="20" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="81"> --></p><p id="p0155" num="0155">Each reaction was carried out in triplicate in a 25 ul reaction. Each reaction mixture contained 1X PCR buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl<sub>2</sub>, 250 nM dNTPs, 0.24X SYBR Green (Invitrogen, Carlsbad, CA), and 1.25 units ofTaq DNA polymerase (Invitrogen, Carlsbad, CA). One reaction mixture contained only Taq DNA polymerase. A second reaction mixture contained Taq DNA polymerase and additive EP046 at 600 nM concentration. A third reaction mixture contained "hot start" Taq DNA polymerase with antibody (Invitrogen, Carlsbad, CA). A fourth reaction mixture contained Taq DNA polymerase with antibody and additive EP046 at 600 nM concentration. After the respective combinations of reaction ingredients were mixed and prior to the isothermal incubation at 50°C, all reactions had the overlapping oligonucleotides 1 and 2 added at approximately 100,000 copies each.</p><p id="p0156" num="0156">The thermal profile conditions for these reactions were as follows: 50°C for 10 minutes followed by incubation on ice for long enough to add the primers, followed by rapid heating to 98°C, then 60 cycles at 98 °C/10s and 72°C/40s. The melting temperature of the hybrid formed by the overlapping oligonucleotides was about 60 °C, that is, well above the temperature of the initial 10-minute incubation. The annealing/extension temperature of the two-step PCR protocol was below the concentration-adjusted melting temperatures of the limiting and excess primers, which were 75.1°C and 73.6°C, respectively, calculated according to the method given in Example 1. Each of the samples was analyzed by (SYBR Green fluorescence in real-time, and at the end of the run each was subjected to melt curve analysis to confirm that the reaction generated a single product peak of 88 °C as expected for the double-stranded product of the amplification reaction (not shown).</p><p id="p0157" num="0157">SYBR Green fluorescence as a function of amplification cycle is shown in <figref idrefs="f0025">FIG. 13</figref>, where circle 131 identifies the replicates from the sample with Taq DNA polymerase only, circle 132 identifies the replicates from the sample with Taq DNA polymerase and the additive EP046, circle 133 identifies the replicates from the sample with Taq DNA polymerase-plus-antibody and circle 134 identifies the replicates from the sample with Taq DNA polymerase-plus-antibody and additive EP046.<!-- EPO <DP n="82"> --></p><heading id="h0033">Example 10. <u>Mispriming and "ColdStop" Detection.</u></heading><p id="p0158" num="0158">To determine whether or not it is possible to interrupt a PCR amplification to perform some low-temperature operation. Mispriming effects of doing so need to be determined. We have developed the assay reported in this example for that purpose. The assay is a LATE-PCR amplification assay in which we have utilized the following target strand, primers and hybridization probe (labeled on one end with the fluorophore Quasar670 (Biosearch Technologies, Novato, CA) and on the other end with the quencher BHQ2 (Biosearch Technologies, Novato, CA):
<tables id="tabl0027" num="0027"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="130mm"/><tbody><row><entry>Limiting Primer.</entry><entry>5' CTCCAGCCCGGCACGCTCACGTGACAGACCG (SEQ ID No. 114)</entry></row><row><entry>Excess Primer.</entry><entry>5' CCGGTGGTCGCCGCGATCAAGGAG (SEQ ID No. 115)</entry></row><row><entry>Probe.</entry><entry>5' Quasar670 GCGGGTTGTTCTGGTCCATGA BHQ2 (SEQ ID No. 116)</entry></row><row><entry>Target.</entry><entry><img id="ib0100" file="imgb0100.tif" wi="126" he="27" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0159" num="0159">The reaction mixture included 1X PCR buffer (Invitrogen, Carlsbad, CA), 2 mM MgCl<sub>2</sub>, 200 nM dNTPs, 50 nM of limiting primer, 1000 nM of excess primer, 200 nM of probe, 1.25 units of Taq DNA polymerase (Invitrogen, Carlsbad, CA), and an additive to be tested, in this case additive EP010 at 600 nM concentration. In addition, each reaction contained 10 million copies of human genomic DNA (Sigma-Aldrich, St. Louis, MO). The sequence of the tested additive was:
<tables id="tabl0028" num="0028"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="105mm"/><tbody><row><entry>Additive EP010.</entry><entry><img id="ib0101" file="imgb0101.tif" wi="101" he="20" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0160" num="0160">Three control assays were first performed with the test additive included in the reaction mixture but without any interruption of the thermal cycling protocol to establish that the uninterrupted protocol was both sensitive and robust. The control assays were begun with 1000, 100 and 10 copies of the target strand in the amplification reaction mixture. Thermal<!-- EPO <DP n="83"> --> cycling regimen was 98°C for 3 minutes, followed by 70 cycles of 98°C/10s. 75°C/40s. 60°C/30s, with fluorescence reading at 60°C. <figref idrefs="f0026">FIG. 14A</figref> presents the fluorescence readings from the probe as a function of PCR cycle number, with circle 141 being the readings from the four replicate amplifications of the sample with 1000 copies of target, circle 142 (dashed lines) being the readings from the replicates of the sample with 100 copies of target, and circle 143 being from the replicates of the sample with 10 copies of target.</p><p id="p0161" num="0161">A separate reaction mixture was subjected to a thermal cycling protocol that was interrupted. The thermal profile was 1 minute at 98°C followed by 40 cycles of 98°C/ 10s, 75°C/40s, then a melt starting at 45°C and increasing in 1°C steps every 30 seconds (data acquisition for each step) for 40 steps, followed by 30 more cycles of 98°C/10s, 75°C/40s, at the conclusion of which the melt was repeated.</p><p id="p0162" num="0162">Results from the two melts are presented in <figref idrefs="f0027">FIG. 14B</figref> and <figref idrefs="f0028">FIG. 14C</figref>. These figures present melt curves in which the fluorescent values at each temperature are normalized by being divided by the fluorescent value at 75°C, a temperature at which the probe is not bound to the single-stranded product. Normalized melts were determined after 40 amplification cycles (<figref idrefs="f0027">FIG 14B</figref>) and after 70 cycles, following the conclusion of amplification (<figref idrefs="f0028">FIG 14C</figref>). In <figref idrefs="f0027">FIG 14B</figref>, circle 144 is the replicates for 1000 copies of the target, circle 145 is the replicates of the sample with 100 copies of target, and circle 146 is the replicates of the sample with 10 copies of target. Similarly, in <figref idrefs="f0028">FIG. 14C</figref>, circle 147 (solid black lines) is the three replicate amplifications of the sample with 1000 copies of target, circle 148 (dashed lines) is the replicates of the sample with 100 copies of target, and circle 149 (solid gray lines) is the replicates of the sample with 10 copies of target.</p><heading id="h0034">Example 11. <u>Type II Mispriming in Symmetric PCR Reactions.</u></heading><p id="p0163" num="0163">To demonstrate the effect of additives on the specificity of conventional symmetric PCR, allele-discriminating primers, the following assay was performed. Equal concentrations of two DNA target sequences differing at a single nucleotide position were amplified in parallel under symmetric PCR conditions in the presence or absence of additive EP043 (SEQ ID No. 45) using a primer pair in which one primer is specific (allele-specific primer) for one those DNA targets DNA (designated as the "matched target"). As suggested in the literature (<nplcit id="ncit0023" npl-type="s"><text>Newton et al., Analysis of any point mutation in DNA. The amplification<!-- EPO <DP n="84"> --> refractory mutation system (ARMS). 1989, Nucleic Acids Res. 17:2503-2516</text></nplcit>), a pair of symmetric PCR primers for preferential amplification of the matched target was constructed such that 3' end of one of the primers is complementary to the nucleotide unique to the intended DNA target and the penultimate 3' end position is mismatched to both the intended and the unintended DNA targets. Thus, the primer specific for the intended target is mismatched only once at its 3' end to the intended DNA target, but it is mismatched twice at its 3' end to the mismatched target. This primer design results in preferential amplification of the matched target. Prior to this experiment, genomic DNA samples containing the matched and mismatched targets were quantified with primers fully complementary to both targets to normalize the data for differences in target genome concentration. In this instance, the C<sub>T</sub> for the mismatched target was lower than the C<sub>T</sub> for the matched target by 1.52, so for assays using the allele-specific primer, any noted delay in the C<sub>T</sub> of the mismatched target had to be corrected by adding 1.52 to the observed ΔC<sub>T</sub> to account for target concentration difference.</p><p id="p0164" num="0164">The target and primer sequences for preferential amplification, and the additive sequence were:
<tables id="tabl0029" num="0029"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="36mm"/><colspec colnum="2" colname="col2" colwidth="129mm"/><tbody><row><entry>Allele-Specific Primer.</entry><entry>5' TATCGTCAAGGCACTCTTGCCTACGCCTT (SEQ ID No. 118)</entry></row><row><entry>Common Primer.</entry><entry>5' GTACTGGTGGAGTATTTGATAGTGTATTAACC (SEQ ID No. 119)</entry></row><row><entry>Matched Target.</entry><entry><img id="ib0102" file="imgb0102.tif" wi="125" he="34" img-content="dna" img-format="tif"/></entry></row><row><entry>Mismatched Target.</entry><entry><img id="ib0103" file="imgb0103.tif" wi="116" he="34" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP043.</entry><entry><img id="ib0104" file="imgb0104.tif" wi="96" he="12" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="85"> --><row><entry/><entry><img id="ib0105" file="imgb0105.tif" wi="83" he="12" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0165" num="0165">Symmetric PCR amplification were carried out in 1X Platinum Taq buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl<sub>2</sub>, 0.2 mM dNTP, 1 uM of primer pair, 0.24X SYBR Green (Invitrogen, Carlsbad, CA), 1 unit Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA) and 1000 genomes equivalents of human DNA containing either the matched or the mismatched target sequence in a final reaction volume of 25 ul. The reaction mixture either contained no additive or contained additive EP043 at a total concentration of 300 nM, with the top strand at 100 nM, the middle strand at 300 nM, and the bottom strand at 200 nM concentration.</p><p id="p0166" num="0166">The amplification conditions were 94°C for 5 minutes; followed by 60 cycles of 94°C/1 minute (m), 64°C/1 m, 72°C/1 m, with data acquisition at the 72°C step; and a final extension step of 72°C/10 m. Amplification was carried out in a Bio-Rad IQ-5 Multicolor Real-Time PCR Detection System (Bio-Rad, Hercules, CA).</p><p id="p0167" num="0167">From SYBR green real-time fluorescence signals it was determined that in the assay containing no additive, signal from the mismatched target was delayed relative to signal from the matched target, giving a corrected ΔC<sub>T</sub> of 7.84. Similarly, in the assay containing additive EP043 at a total of 300 nM concentration signal from the mismatched target was even more delayed relative to signal from the matched target, giving a corrected ΔC<sub>T</sub> of 12.59. Accordingly, increased polymerase specificity due to the presence of EP043 was 4.75 cycles.</p><heading id="h0035">Example 12. <u>Inhibition of Taq DNA Polymerase Activity and AT Content of Limiting Primer 3' End.</u></heading><p id="p0168" num="0168">LATE-PCR assays utilizing a limiting primer GC rich at its 3' end and a limiting primer AT rich at its 3' end were compared as to the delay caused by the presence of an additive as described herein. Four amplification reactions were performed: one using the primer having the GC rich 3' end and no additive, a second using the same primer and additive EP013; a third using the primer having the AT rich 3' end and no additive; and a fourth using the same primer and additive EP013.<!-- EPO <DP n="86"> --></p><p id="p0169" num="0169">Each 25ul amplification reaction mixture included 1X Platinum Taq buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl<sub>2</sub>, 250 nM dNTP, 1.25 units Platinum Taq polymerase (Invitrogen, Carlsbad, CA), 1000 genomes equivalents of human DNA, excess primer at 1000 nM concentration, limiting primer at 50 nM concentration, and detection probe at 500 nM concentration. For the two assays that included additive EP013 (SEQ ID No. 47) was included in the reaction mixture at 600 nM concentration.</p><p id="p0170" num="0170">The thermal cycling regimen was 95°C for 10 seconds., 66.5°C for 10 seconds, and 72°C for 10 seconds for 20 cycles, followed by 50 cycles at 95°C for 10 seconds, 65°C for 10 seconds, 72°C for 10 seconds, and fluorescent signal detection at 54°C for 20 seconds. Fluorescence detection from each probe when bound to its target was measured during the annealing phase of the PCR cycles.</p><p id="p0171" num="0171">Sequences of target, primers and probe utilized in assays with limiting primer having GC rich 3' end were:
<tables id="tabl0030" num="0030"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="39mm"/><colspec colnum="2" colname="col2" colwidth="105mm"/><tbody><row><entry>Excess primer.</entry><entry>5' GCACAGTTACAGTATTCCAGCAGACTCA (SEQ ID No. 122)</entry></row><row><entry>Limiting primer.</entry><entry>5' TCAGTGGTGGCAGTGGTAGTGGTGGC (SEQ ID No. 123)</entry></row><row><entry>Target for GC rich primer.</entry><entry><img id="ib0106" file="imgb0106.tif" wi="97" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Detection probe.</entry><entry>5' BHQ-2 TCAGTGGTGGCAGTGGTAGA Quasar 670 (SEQ ID No. 125)</entry></row></tbody></tgroup></table></tables></p><p id="p0172" num="0172">Sequences for target, primers, and probe utilized in assays with limiting primer having AT rich 3' end were:
<tables id="tabl0031" num="0031"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="39mm"/><colspec colnum="2" colname="col2" colwidth="99mm"/><tbody><row><entry>Excess primer.</entry><entry>5' CTTTGGCACCAGAGGTGAGC (SEQ ID No. 126)</entry></row><row><entry>Limiting primer.</entry><entry>5' GGTGCGTGGGTCCCAGTCTGCAGTTAAG (SEQ ID No. 127)</entry></row><row><entry>Target for AT rich primer.</entry><entry><img id="ib0107" file="imgb0107.tif" wi="94" he="12" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="87"> --><row><entry/><entry><img id="ib0108" file="imgb0108.tif" wi="59" he="5" img-content="dna" img-format="tif"/></entry></row><row><entry>Detection probe.</entry><entry>5' BHQ-2 GCAGGAGTGGCGCT Quasar 670 (SEQ ID No. 129)</entry></row></tbody></tgroup></table></tables></p><p id="p0173" num="0173">Sequence of additive EP013 was as follows:
<tables id="tabl0032" num="0032"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="28mm"/><colspec colnum="2" colname="col2" colwidth="105mm"/><tbody><row><entry>Additive EP013.</entry><entry><img id="ib0109" file="imgb0109.tif" wi="101" he="20" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0174" num="0174">In the assays using the limiting primer having the GC rich 3' end, addition of additive EP013 to the reaction mixture at 600 nM concentration resulted in a delay in the threshold cycle (C<sub>T</sub>) of 4 cycles as compared to amplification with no additive. In the assays using the limiting primer having the AT rich 3' end, addition of additive EP013 to the reaction mixture at 600 nM concentration resulted in a C<sub>T</sub> delay of 11 cycles.</p><heading id="h0036">Example 13. <u>Modification of 5' End of Primers and Type III Mispriming.</u></heading><p id="p0175" num="0175">We used additional nucleotides to form a non-complementary tail on the 5'end of one of the PCR amplification primers. In this example we used LATE-PCR amplification, and we modified the limiting primer. We compared modified and unmodified primers to discriminate between fully bound and partially bound 3'ends. Two adenines were added to the 5'-end of the limiting primer used to amplify the human mitochondrial cytochrome b gene (denoted by the underlined bases). We tested two additives: additive EP047, target, primer, and additive sequences were as follows:
<tables id="tabl0033" num="0033"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="36mm"/><colspec colnum="2" colname="col2" colwidth="130mm"/><tbody><row><entry>Target Cytb-1.</entry><entry><img id="ib0110" file="imgb0110.tif" wi="126" he="48" img-content="dna" img-format="tif"/></entry></row><!-- EPO <DP n="88"> --><row><entry/><entry><img id="ib0111" file="imgb0111.tif" wi="119" he="34" img-content="dna" img-format="tif"/></entry></row><row><entry>Limiting Primer.</entry><entry>5' <u>AA</u>TGTGAGGGTGGGACTGTCTACTGAGTAGCC (SEQ ID No. 80)</entry></row><row><entry>Excess Primer.</entry><entry>5' TCCGCATGATGAAACTTCGGCTC (SEQ ID No. 81)</entry></row><row><entry>Modified Limiting Primer.</entry><entry>5' <u>AA</u>TGTGAGGGTGGGACTGTCTACTGAGTAGCC (SEQ ID No. 130)</entry></row><row><entry>Additive EP047.</entry><entry><img id="ib0112" file="imgb0112.tif" wi="95" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP043.</entry><entry><img id="ib0113" file="imgb0113.tif" wi="95" he="27" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0176" num="0176">Additive EP047 includes a strand 22 nucleotides long and a strand 17 nucleotides long that form a double-stranded region that is 17 nucleotides long, and it has four terminal Dabcyl modifiers. The Tm of additive EP047 is 59.1°C. Additive EP043 is a mixture of additives. It includes as one component additive EP047 (which comprises the two bottom strands), which was included in this test at a concentration of 550 nM. Mixture EP043 also includes another double-stranded oligonucleotide shown as the top two strands. This second oligomer includes two complementary strands that are 22 nucleotides long, and it has three terminal Dabcyl modifiers. It has a Tm of 67.4 °C, and it was included in this test at a concentration of 50 nM. Because the two additives in the mixture share a common strand, the strand concentrations were 50/600/550 for the top/middle//bottom strands.</p><p id="p0177" num="0177">LATE-PCR reaction mixtures included 1x PCR buffer, 250 nM dNTPs, 3 mM MgCl<sub>2</sub>, 0.24x SYBR Green, 50 nM limiting primer, 1000 nM excess primer, 1000 copies of human mitochondrial DNA, and 2.5 units of TFi(-) DNA polymerase, an antibody-bound, 5'<!-- EPO <DP n="89"> --> exonuclease (-) polymerase (Invitrogen, Carlsbad CA) in 25ul volume. Six assays were performed, with additives and limiting primers in the reaction mixture as follows:
<ol><li>(1) no additive, untailed limiting primer (SEQ ID No. 80)</li><li>(2) no additive, tailed limiting primer (SEQ ID No. 133)</li><li>(3) additive EP047 at 600 nM concentration, untailed limiting primer</li><li>(4) additive EP047 at 600 nM concentration, tailed primer</li><li>(5) three-strand additive mixture EP043 at strand concentrations of 50/600/550, untailed primer</li><li>(6) three-strand additive mixture EP043 at strand concentrations of 50/600/550, tailed primer</li></ol></p><p id="p0178" num="0178">The six reaction mixtures were amplified under the following conditions: 95°C for 3 minutes followed by 65 cycles of 95°/5s, 58°C/20s, and 68°C/2m. Melt analysis of the products was then conducted, starting at 45°C with 1 °C increments at 30s intervals to 95°C. PCR amplification as well as the melt analysis was monitored by the use of SYBR Green.</p><p id="p0179" num="0179">For the reactions with no additive, product evolution resulted in an amplicon having a Tm above the Tm of the desired product, no matter which limiting primer was used. Including additive EP047 in the reaction mixture delayed the onset of detectable product evolution by several amplification cycles and resulted in a portion of the amplification product being the correct product. With additive EP047, more correct product was made using the tailed primer than was made using the untailed primer. Additive EP047 has a calculated Tm based on its unmodified strands of 59.1 °C. Including additive EP043 in the reaction mixture also delayed the onset of detectable product evolution and resulted in the most correct product being generated. With additive EP043, more correct product was made using the tailed primer than was made using the untailed primer. Additive EP043 is a mixture having calculated Tm's base on the unmodified strands of 67.4 °C and 59.1 °C.</p><p id="p0180" num="0180">Real-time kinetic curves the six replicates with additive EP043, tailed limiting primer and untailed limiting primer, are shown in <figref idrefs="f0029">FIG 15A</figref>. In <figref idrefs="f0029">FIG. 15A</figref> circle 151 (gray lines) identifies the curves for the three replicates with the untailed primer, and circle 152 (black lines) identifies the curves for the replicates with the tailed primer. Melt curves of the six amplification products with additive EP043 are shown in <figref idrefs="f0030">FIG 15B</figref>, where the downward<!-- EPO <DP n="90"> --> pointing arrow indicates the melting temperature, 86°C, of the correct double-stranded DNA product. In <figref idrefs="f0030">FIG. 15B</figref> circle 153 identifies the one replicate with untailed primer that showed the correct peak with no product evolution (flat plateau) in <figref idrefs="f0029">FIG. 15A</figref>, and circle 154 identifies the two replicates with tailed primer also showed no product evolution (flat plateau) in <figref idrefs="f0029">FIG. 15A</figref>.</p><heading id="h0037">Example 14: <u>Additive as Primer for Suppressing Mispriming.</u></heading><p id="p0181" num="0181">A primer that is an additive is a double-stranded oligonucleotide in which one strand is an amplification primer having an extendable 3' end. Its 5' end has a modifier substituent. The other strand, which we refer to as the reverse complement sequence has two, and its 3' end is non-extendable. Because the amplification assay of this example is a LATE-PCR assay in which the limiting primer is included in the reaction mixture a very low concentration, only the excess primer is made an additive. The strand having the free 3' end serves as an amplification primer when it hybridizes to and extends on its target strand, and it serves as an inhibitor of mispriming when it hybridizes to its modified complementary strand. In this example, the primer-reverse complement sequence additive has three terminal Dabcyl modifiers. The primer strand is modified by covalent linkage of a modifying group, here a Dabcyl group, to its 5' terminal nucleotide. The reverse complement sequence is modified by covalent linkage of a modifying group, here a Dabcyl group, to each of its 5' and 3' ends. The Tm of the reverse complement sequence to the primer strand is designed to be 5-30 °C, preferably 15-25 °C, lower than the Tm of the primer strand to its amplification target sequence. To achieve the difference in Tm's, the reverse complement sequence may be rendered partially complementary to the primer strand by making it either shorter or mismatched at one or more nucleotides. In this example, several mismatched nucleotides were included. In multiplex reactions having more than one pair of primers at least one primer is converted to an additive with its corresponding partially complementary reverse complement sequence. In both monoplex and multiplex reactions the concentration of said at least one oligonucleotide is titrated and optimized empirically to achieve suppression of mispriming together with the lowest scatter among replicate reactions. Typically, said optimum concentration is close to that of a double-stranded additive that is not a primer added to the same reaction to suppress mispriming. As one skilled in the art will understand,<!-- EPO <DP n="91"> --> reactions utilizing an additive-primer can be further supplemented with an additive that is not a primer, provided the latter does not cross hybridize with the former.</p><p id="p0182" num="0182">LATE-PCR reactions were carried out in triplicate using the following sequences:
<tables id="tabl0034" num="0034"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="24mm"/><colspec colnum="2" colname="col2" colwidth="142mm"/><tbody><row><entry>Limiting Primer.</entry><entry>5' TCCAGTACACTTACCATGTTACGACTTGTCTCCTCTA (SEQ ID No. 132)</entry></row><row><entry>Excess Primer.</entry><entry>5' Dabcyl AGTTCACCCTCTAAATCACCACGAT (SEQ ID No. 133)</entry></row><row><entry>Reverse Complement Sequence.</entry><entry>5' Dabcyl ATCGT<u>T</u>GTG<u>G</u>T<u>A</u>TAGAGGGTGAACT-Dabcyl (SEQ ID No. 134)</entry></row><row><entry>Target.</entry><entry><img id="ib0114" file="imgb0114.tif" wi="136" he="150" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables><!-- EPO <DP n="92"> --></p><p id="p0183" num="0183">LATE PCR amplifications were carried out in 25 ul volume consisting of 1X Platinum Tfi(-) buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl<sub>2</sub>, 250 nM dNTPs, 50 nM of limiting primer, 1000 nM of excess primer, 0.24X SYBR Green (Invitrogen, Carlsbad, CA), 2.5 units of Platinum Tfi(-) DNA polymerase (Invitrogen, Carlsbad, CA) with approximately 1000 mitochondrial genomes from human genomic DNA. The concentrations of the reverse complement that created the additive were 100, 200 and 300 nM. In this instance we lowered the Tm of the primer-reverse complement hybrid relative to the primer-target hybrid by introducing mismatches into the reverse complement strand (mismatched nucleotides are underlined).</p><p id="p0184" num="0184">The thermal profile conditions for these reactions were as follows: 95°C for 3 minutes followed by 95°C/5s-58°C/20s-68°C/2m for 60 cycles, followed by a melt starting at 45°C/45s with 1°C increments for 51 cycles. All reactions were analyzed in real time during the extension phase (68°C) of thermal cycles. At the end of 60 cycles the amplification products were analyzed using the first derivative of SYBR Green fluorescence (melt curve analysis) of double-stranded DNA product.</p><p id="p0185" num="0185">The melt curves are presented in <figref idrefs="f0031 f0032 f0033 f0034">FIGS. 16A-16D</figref>. <figref idrefs="f0031">FIG. 16A</figref> is the melt curves for the three replicates with no reverse complement sequence. Curves 161 show that in the absence of the complementary oligonucleotide only one of three reactions generated the expected product having a melting temperature of 86°C (arrow). <figref idrefs="f0032">FIG 16B</figref> is the melt curves for the three replicates that included the reverse complement sequence at 100 nM concentration. Curves 162 show that two of three reactions generated the expected product. <figref idrefs="f0033">FIGS 16C</figref> and <figref idrefs="f0034">16D</figref> are the melt curves for the replicates with the reverse complement sequence at concentrations of 200 nM and 300 nM, respectively. Curves 163 and 164 show that all three replicates in each set of reactions generated the correct product (as judged by the presence of a melting peak of 86°C).</p><heading id="h0038">Example 15: <u>Mispriming, with RNA Target.</u></heading><p id="p0186" num="0186">This example describes a series of LATE-PCR assays in which the starting target sequence was RNA rather than DNA, so the initial reaction mixtures included reverse transcriptase, and the protocol included an initial incubation to convert RNA to cDNA prior to amplification of the cDNA. The RNA utilized in this series was a sequence within an<!-- EPO <DP n="93"> --> Enterovirus Armored RNA (EV, Catalog #42050 from Asuragen, Austin, TX, USA) containing the a portion of the 5' untranslated region (UTR) from the Enterovirus RNA. Samples include primer pairs for both EV and Foot and Mouth Disease Virus (FMDV), but no FMDV targets are included in this example. Amplification reactions were followed in real time by the use of a molecular beacon probe having a fluorophore (Cal Red 610) and a quencher (Black Hole Quencher No. 2). All sets of all reactions were run in triplicate, and products were analyzed via melt curve analysis at end-point.</p><p id="p0187" num="0187">Several additives, including mixtures, were compared to a no-additive control. Sequences of the EV primers, EV probe and additives were as follows:
<tables id="tabl0035" num="0035"><table frame="none"><tgroup cols="2" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="32mm"/><colspec colnum="2" colname="col2" colwidth="105mm"/><tbody><row><entry>EV Limiting Primer.</entry><entry>5' GACTTGCGCGTTACGACAGGCCAATC (SEQ ID No. 136)</entry></row><row><entry>EV Excess Primer.</entry><entry>5' TGAATGCGGCTAATCCCAAC (SEQ ID No. 137)</entry></row><row><entry>EV Probe.</entry><entry>5' Cal Red 610-AACCACCTGCCCCTT-BHQ2 (SEQ ID No. 138)</entry></row><row><entry>Additive EP020.</entry><entry><img id="ib0115" file="imgb0115.tif" wi="99" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP010.</entry><entry><img id="ib0116" file="imgb0116.tif" wi="101" he="20" img-content="dna" img-format="tif"/></entry></row><row><entry>Additive EP003.</entry><entry><img id="ib0117" file="imgb0117.tif" wi="94" he="20" img-content="dna" img-format="tif"/></entry></row></tbody></tgroup></table></tables></p><p id="p0188" num="0188">EV Armored RNA was diluted in 10 mM TRIS, pH 8.3 to about 25,000 particles per µl and heated at 75°C for 3 minutes to denature the coat protein and release the RNA. The RNA (2 µl per sample) was mixed with a solution containing the concentrated primers (3 µl per sample) and was incubated at room temperature for 5 minutes, then a concentrated reagent mix was added to yield the following concentrations in a final volume of 25 µl per sample: 3 mM magnesium chloride, 400 nM each deoxynucleotide, 500 nM each probe, 50 nM each limiting primer, 500 nM each excess primer, 1X Tfi (exo-) reaction buffer, 2 Units Tfi (exo-) polymerase per sample (Invitrogen, Cat. No. 60684-050), and 100 Units per<!-- EPO <DP n="94"> --> sample SuperScript III Reverse Transcriptase (Invitrogen, Cat. No. 18080-044). EV RNA was at about 50,000 copies per sample. Additives were included at the following concentrations:
<ul><li>Reaction A - Additive EP020 at 2000 nM</li><li>Reaction B - Additive EP010 at 200 nM</li><li>Reaction C - Additive EP003 at 400 nM</li><li>Reaction D - Additive EP010 at 400 nM and Additive EP020 at 1000 nM</li><li>Reaction E - Additive EP003 at 400 nM and Additive EP020 at 1000 nM</li><li>Reaction F - no additive control</li></ul></p><p id="p0189" num="0189">Samples were placed in a Stratagene MX3005P thermal cycler and incubated at 50 °C for 6 minutes, 95 °C for 1 minute, then 25 cycles of 95 °C/10s, 64 °C/10s, and 68 °C/20s, followed by 35 cycles of 95 °C/10s, 64 °C/10s, 68 °C/20s, and 50 °C/30s with fluorescence detection for probe at 50 °C.</p><p id="p0190" num="0190"><figref idrefs="f0035 f0036 f0037 f0038 f0039 f0040">FIGS. 17A-17F</figref> show the real-time results for probe fluorescence during the low-temperature (50°C) detection step in cycles 26-60. In <figref idrefs="f0035">FIG. 17A</figref>, circle 171 is the curves for the three replicates for Reaction A. In <figref idrefs="f0036">FIG. 17B</figref>, circle 172 is the curves for the three replicates for Reaction B. In <figref idrefs="f0037">FIG. 17C</figref>, circle 173 is the curves for the three replicates for Reaction C. In <figref idrefs="f0038">FIG. 17D</figref>, circle 174 is the curves for the three replicates for Reaction D. In <figref idrefs="f0039">FIG. 17E</figref>, circle 175 is the curves for the three replicates for Reaction E. In <figref idrefs="f0040">FIG. 17F</figref>, circle 176 is the curves for the three replicates for Reaction F.</p><p id="p0191" num="0191">The curves of circle 176 show that the no-additive control exhibited Type III mispriming (severe product evolution), shown by the reduction of single-stranded product in later amplification cycles (roughly cycles 42-60). The curves ofcircle 171 for Reaction A, which contained a low-Tm additive (Tm 47.7 °C, which was some 16 °C below the annealing temperature and 2.3 °C below the low-temperature detection temperature) in very high concentration, showed suppression of Type 1 mispriming but only partial suppressionn of Type III mispriming, with high scatter among replicates by cycle 60. The curves of circle 172 for Reaction B, which contained an additive having a somewhat higher Tm (Tm 60 °C, which was 4 °C below the annealing temperature but above the low-temperature detection temperature) at very low concentration totally supppressed Type I mispriming and only partially suppressed Type III mispriming (two of three replicates showed some reduction in<!-- EPO <DP n="95"> --> probe signal by cycle 60), but significantly reduced scatter at cycle 60 nonetheless. Reactions C, D, and E, all of which contained additives showed no reduction in probe signal through cycle 60. Because curves of circle 174 show suppression of Type III mispriming with high signal, indicating minimal reduction in efficiency of the reaction, Reaction D was judged to be optimal for this set of reactions.</p><heading id="h0039">Example 16. <u>Direct Quantitative Measure of Suppression of Type I Mispriming by Additives with Overhangs.</u></heading><p id="p0192" num="0192">The assay reported here was carried out as described in Example 9 with the following exceptions: (a) a Taq polymerase antibody was present in all samples during the 50 °C incubation step; (b) the incubation step at 50 °C was for 1 minute.</p><p id="p0193" num="0193">Each additive was comprised of the same two hairpin-forming 34-nucleotide long single-stranded oligomers having the structure of oligomers 194,195 depicted in <figref idrefs="f0041">FIG. 18C</figref>, with 1, 2, 3 or 4 ends modified by addition of a Dabcyl moiety. All oligos in which the 3' ends were not blocked by a quencher were blocked by either a phosphate (P) or a three-carbon modifier (C<sub>3</sub>) to prevent extension. The six nucleotides on the 5' and 3' ends of each single-stranded oligomer were complementary, such that when these ends hybridized to each other they formed a 6-base-pair stem and a 22-nucleotide loop structure. With reference to <figref idrefs="f0041">Figure 18C</figref>, the two 22-nucleotide loops of said additive were complementary, such that when hybridized to each other formed an additive 196 having a 22-base-pair long double-stranded portion 197 with four non-complementary single-stranded 6-base-pair long ends 198, 199, 200, 201. The sequences of the single-stranded oligomers were not randomly assigned but required careful consideration due to the inherent complementarity in the design. The consideration is not to allow the oligomers to form other structures at the temperature in which the loops are engaged, in particular to prevent the arm sequences to remain disengaged from each other as well as not binding to any of the complementary loop sequences of either oligonucleotide. These additive sequences have the ability to remain in a predesigned conformation over a range of temperatures.</p><p id="p0194" num="0194">In the case of additives in which one or both of the component oligonucleotide strands has the capacity to form a stem-loop structure (see <figref idrefs="f0041">FIGS. 18B, 18C</figref>) it is desirable that the melting temperature (Tm) of said stem be higher than the melting temperature of the double-strand<!-- EPO <DP n="96"> --> of the additive, but not so much higher as to prevent formation of the double-stranded conformation of the additive in a reasonable period of time when the temperature of the reaction is decreased. In this case the calculated Tm of the double-stranded portion of the additives was 59 °C, and the calculated Tm of the stem nucleotides was 65 °C. These calculations are based on reagent concentrations of 70mM Na+, 3mM Mg++ at 50 °C. For the double-stranded portion the website <u>(http://dinamelt.bioinfo.rpi.edu/twostate.php)</u> was used, and for the stem the website <u>(http://frontend.bioinfo.rpi.edu/applications/mfold/cgi-bin/dna-form1.cgi)</u> was used. In practice the actual Tm depends on the number of interacting Dabcyls and can increase from the calculated Tm by approximately 4° C.</p><p id="p0195" num="0195">The following additives were used and sequences that are complementary are underlined.
<ul><li>Additive SL02.
<img id="ib0118" file="imgb0118.tif" wi="123" he="20" img-content="dna" img-format="tif"/></li><li>Additive SL03.
<img id="ib0119" file="imgb0119.tif" wi="126" he="20" img-content="dna" img-format="tif"/></li><li>Additive SL04.
<img id="ib0120" file="imgb0120.tif" wi="133" he="20" img-content="dna" img-format="tif"/></li><li>Additive SL05.
<img id="ib0121" file="imgb0121.tif" wi="131" he="13" img-content="dna" img-format="tif"/><!-- EPO <DP n="97"> -->
<img id="ib0122" file="imgb0122.tif" wi="33" he="5" img-content="dna" img-format="tif"/></li><li>Additive SL06.
<img id="ib0123" file="imgb0123.tif" wi="124" he="20" img-content="dna" img-format="tif"/></li><li>Additive SL07.
<img id="ib0124" file="imgb0124.tif" wi="131" he="20" img-content="dna" img-format="tif"/></li><li>Additive SL08.
<img id="ib0125" file="imgb0125.tif" wi="133" he="20" img-content="dna" img-format="tif"/></li><li>Additive SL09.
<img id="ib0126" file="imgb0126.tif" wi="133" he="20" img-content="dna" img-format="tif"/></li></ul></p><p id="p0196" num="0196">Each reaction was carried out in 25 µl volume in triplicate. The final reaction mixture contained 1X PCR buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl<sub>2</sub>, 250 nM dNTPs, 0.24X SYBR Green (Invitrogen, Carlsbad, CA), 1.25 units of both Taq DNA polymerase and Taq DNA polymerase antibody (Invitrogen, Carlsbad, CA). Separate reaction mixtures contained 300 nM of each additive and no additive. After the respective combinations of reaction ingredients were mixed and prior to the isothermal incubation at 50 °C, all reactions had the overlapping oligonucleotides 1 and 2 (Example 9) added at approximately 100,000 copies each.<!-- EPO <DP n="98"> --></p><p id="p0197" num="0197">The thermal profile conditions for these reactions were as follows: 50 °C for 1 minute followed by incubation on ice then the addition of primers to all reaction mixtures for final concentrations of 50 nM limiting primer and 1 µM excess primer. This was followed by rapid heating to 95 °C for 3min, then 50 cycles at 98 °C/10s and 72 °C/40s. Each of the samples was analyzed by SYBR Green fluorescence in real-time, and at the end of the run each was subjected to melt curve analysis to confirm that the reaction generated a single product peak of 88 °C as expected for the double-stranded product of the amplification reaction.</p><p id="p0198" num="0198">The melt-curve analysis with additives SL04, SL07, SL08 and SL09 is shown in <figref idrefs="f0042 f0043">FIGS. 19A-19D</figref>. The lines identified by circle 210 in each figure are the replicates from the sample with Taq DNA polymerase-plus-antibody. The lines identified by circles 211, 212, 213 and 214 are the replicates with additive SL04, SL07, SL08 and SL09, respectively.</p><p id="p0199" num="0199">The results (see <figref idrefs="f0042">FIG. 19A</figref>) confirm that the antibody (circle 210) did not reduce mispriming, because of the presence of two peaks, a low melting peak (i.e., incorrect product, 85 °C) and the correct product at higher peak (88 °C). The results with additives SL04, SL05, SL07 and SL08 show that each additive greatly reduced the amount of incorrect product but did not completely suppress it. <figref idrefs="f0043">FIG 19D</figref> shows that additive SL09, which has 4 Dabcyls, was able to completely suppress the production of the incorrect product.</p><heading id="h0040">Example 17. <u>Type II Mispriming and Polymerase Selectivity with Additives Having Overhangs.</u></heading><p id="p0200" num="0200">We performed a LATE-PCR assay described in Example 3 using the additives SL06, SL07, and SL09 (Example 16) at 200 nM, 400 nM, and 600 nM concentrations. These additives contain two, three or four Dabcyl modifiers, respectively.</p><p id="p0201" num="0201">The LATE-PCR amplifications were carried out in triplicate in 25 µl volume consisting of 1X Invitrogen PCR buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl<sub>2</sub>, 25 0 nM dNTPs, 50 nM limiting primer, 1000 nM excess primer, 0.24X SYBR Green (Invitrogen, Carlsbad, CA), 1.25 units Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA) with approximately 10000 single-stranded target A (matched) or T (mismatched). The thermal profile conditions for these reactions were: 95 °C for 3 minutes followed by 95 °C/5s-62 °C/20s-72 °C/30s for 60 cycles. For this and other assays containing two targets, a control<!-- EPO <DP n="99"> --> amplification is done using the excess primer, which is perfectly complementary to both targets, and a control limiting primer that is also perfectly complementary to both targets, to ensure that the starting copy numbers of both targets are the same, in which case the C<sub>T</sub> for both targets is the same. (If the control amplifications reveal that the starting copy numbers are not the same, one has two choices: either reformulate or, if the C<sub>T</sub> difference is slight --as was the case in all examples reported here, correct the observed C<sub>T</sub> values to adjust for the difference.)</p><p id="p0202" num="0202">The results for selectivity (Δ C<sub>T</sub> equals C<sub>T</sub> for mismatched target minus C<sub>T</sub> for matched target) are shown in Table 7.
<tables id="tabl0036" num="0036"><table frame="all"><title>Table 7</title><tgroup cols="3"><colspec colnum="1" colname="col1" colwidth="35mm"/><colspec colnum="2" colname="col2" colwidth="31mm"/><colspec colnum="3" colname="col3" colwidth="27mm"/><thead><row><entry align="center" valign="top"><u>Additive</u></entry><entry align="center" valign="top"><u>Concentration, nM</u></entry><entry align="center" valign="top"><u>Selectivity, Δ C</u><sub><u>T</u></sub></entry></row></thead><tbody><row><entry align="center"/><entry align="center"/><entry align="center"/></row><row><entry align="center">SL06 (two Dabcyls)</entry><entry align="center">200</entry><entry align="char" char="." charoff="7">1.3</entry></row><row><entry align="center"/><entry align="center">400</entry><entry align="char" char="." charoff="7">0.8</entry></row><row><entry align="center"/><entry align="center">600</entry><entry align="char" char="." charoff="7">3.2</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="7"/></row><row><entry align="center">SL07 (three Dabcyls)</entry><entry align="center">200</entry><entry align="char" char="." charoff="7">0.8</entry></row><row><entry align="center"/><entry align="center">400</entry><entry align="char" char="." charoff="7">2.4</entry></row><row><entry align="center"/><entry align="center">600</entry><entry align="char" char="." charoff="7">2.6</entry></row><row><entry align="center"/><entry align="center"/><entry align="char" char="." charoff="7"/></row><row><entry align="center">SL09 (four Dabcyls)</entry><entry align="center">200</entry><entry align="char" char="." charoff="7">2.8</entry></row><row><entry align="center"/><entry align="center">400</entry><entry align="char" char="." charoff="7">4.2</entry></row><row><entry align="center"/><entry align="center">600</entry><entry align="char" char="." charoff="7">6.8</entry></row></tbody></tgroup></table></tables></p><heading id="h0041">Example 18. <u>Inhibition of Primer-Independent 5' Exonuclease Activity by Additives with Overhangs.</u></heading><p id="p0203" num="0203">We performed a LATE-PCR assay as described in detail in Example 6 to determine the efficacy of inhibition of primer-independent 5' exonuclease activity of DNA Taq polymerase using additives with single-stranded overhangs of the type shown in <figref idrefs="f0041">FIG. 18C</figref>.</p><p id="p0204" num="0204">Oscillation reactions were carried out in 25 µl volume consisting of 1X PCR buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl<sub>2</sub>, 200 nM dNTPs, 1.25 units of Taq DNA polymerase (Invitrogen, Carlsbad, CA), 200 nM of probe (Example 6), and 100 nM of target (Example 6). This reaction mixture was used without any additive and with each additive at<!-- EPO <DP n="100"> --> 200 nM, 400 nM, and 600 nM concentrations. A control reaction was run with the probe as the only oligonucleotide in the reaction mixture. The additives (see Example 16) included SL06, which has two Dabcyls; SL07, which has 3 Dabcyls; and SL09, which has 4 Dabcyls. Reaction mixtures were oscillated using the following thermal profile: 45 °C/20s, 60 °C/10s for 45 cycles, followed by a melt starting at 45 °C/30 secs with 1°C increments for 25 cycles. During cycling FAM fluorescence was acquired during the 60°C/10s segment of the thermal profile.</p><p id="p0205" num="0205">Exonuclease cleavage activity separates the probe's fluorophore from the probe, thereby resulting in an increase in fluorescence (FAM). Results with additive SL06 are reported in <figref idrefs="f0044">FIG. 20</figref>, wherein circle 220 identifies the probe-only control; circle 221 identifies the samples with probe and target but no additive; circle 222 identifies the samples with probe, target and additive SL06 at 200 nM concentration; circle 223 identifies the samples with probe, target and additive SL06 at 400 nM concentration; and circle 224 identifies the samples with probe, target and additive SL06 at 600 nM concentration.</p><heading id="h0042">Example 19. <u>Use of a Blocker to Create a 3' Terminal Mismatch.</u></heading><p id="p0206" num="0206">Example 4 above demonstrates the effect of additive mixtures on Type II mispriming and polymerase selectivity in LATE-PCR amplification for a target sequence that is perfectly complementary to the limiting primer as opposed to a mismatched target containing a single base-pair mismatch at the 3' terminal nucleotide of the limiting primer. The present example demonstrates the use of an oligonucleotide, referred to as a "blocker", to prevent the 3' terminus of the limiting primer from hybridizing to a target that is considered to be the mismatched target, that is, the one to be selected against, when the mismatched nucleotide or nucleotides are downstream from the limiting primer binding site. Targets, primers and blocker for the type of assay are depicted generally in <figref idrefs="f0045">FIGS. 2 1 A, 2 1 B</figref>.</p><p id="p0207" num="0207">LATE-PCR amplifications were performed using a limiting primer and an excess primer that were perfectly complementary to the strands of a double-stranded first target and also perfectly complementary to the strands of a double-stranded second target. It was desired that the second target be amplified selectively relative to the first target. The second target contained two base-pair differences from the first target. The first base-pair difference was downstream of the limiting primer binding site and was included in the binding site for a<!-- EPO <DP n="101"> --> blocker oligonucleotide that was utilized to create a 3' terminal mismatch. The second base-pair difference was downstream of both the limiting primer binding site and the blocker binding site, and the downstream of the excess primer binding site, and was used for probing. The blocker binding site overlapped the limiting primer binding site at the 3' end of the limiting primer, as shown in <figref idrefs="f0045">FIG 21A</figref>.</p><p id="p0208" num="0208">The blocker used in the LATE-PCR assays was allele-specific so that, due to the first base-pair difference between the targets, it preferentially hybridized to the strand of the first target to which the limiting primer hybridized (see <figref idrefs="f0045">FIG 21A</figref>) rather than the second target (see <figref idrefs="f0045">FIG. 21B</figref>). The 5' end of the blocker and the 3' end of the limiting primer were both complementary to the same bases on the first-target strand, but the melting temperature of the blocker, Tm(B), to said strand was higher so that it would bind first as the reaction temperature was lowered during amplification, preventing the 3' terminus of the primer from hybridizing to the first target, creating a 3' terminal mismatch with a perfectly complementary primer. The 3' end of the blocker was itself blocked to prevent extension during amplification. In this instance, the blocker was dual labeled with a fluorophore (Cal Orange 560) on its 5' end and a Dabcyl quencher on its 3' end.</p><p id="p0209" num="0209">Both LATE-PCR assays also contained an allele-specific probe that hybridizes to the excess primer strand generated from said first target (to the extent that such strands are generated) at a higher melting temperature, Tm(P1), than when hybridized to the excess primer stranded generated from said second target Tm(P2). In this instance the probe was a molecular beacon probe labeled on its 5' end with a Black Hole Quencher 2 (BHQ2) and on its 3' end with a fluorophore (Quasar 670).</p><p id="p0210" num="0210">The binding of the limiting primer, the allele-specific blocker, and the allele-specific probe to both said first and second targets is illustrated generally in <figref idrefs="f0045">FIGS. 21A and 21B</figref>. To effectively block the binding and extension of the limiting primer, the blocker must overlap with the 3' end of the primer at least one nucleotide. The 5' end of the blocker does not have to be a perfect match to the target as long as the blocker binds at a higher temperature than the limiting primer.</p><p id="p0211" num="0211">Reaction components and reaction conditions were as follows:
<ul><li>Limiting Primer: 5' GCACTCTTGCCTACGCC (SEQ ID NO. 147)</li><li>Excess Primer: 5' CTGGTGGAGTATTTGATAGTG (SEQ ID NO. 148)<!-- EPO <DP n="102"> --></li><li>Allele-Specific Blocker: 5' Cal Org 560-GCCTACGCCACCAGCTCC-Dabcyl (SEQ ID NO. 149)</li><li>Molecular Beacon Probe: 5' BHQ2-CAAGAACATGTCACACATAATG-Quasar 670 (SEQ ID NO. 150)</li></ul></p><heading id="h0043">Excess Primer Strand of Said First Target:</heading><p id="p0212" num="0212"><img id="ib0127" file="imgb0127.tif" wi="149" he="27" img-content="dna" img-format="tif"/>
Excess Primer Strand of Said Second Target (the first base pair change, the change in the blocker binding site, is underlined; the second base pair change, the change in the probe binding site, bolded:
<img id="ib0128" file="imgb0128.tif" wi="149" he="27" img-content="dna" img-format="tif"/></p><p id="p0213" num="0213">LATE-PCR amplifications were carried out in 25 ul volume consisting of 1X PCR buffer (Invitrogen, Carlsbad, CA), 3 mM MgCl<sub>2</sub>, 200 nM dNTPs, 50 nM limiting primer, 1000 nM excess primer, 0.24X SYBR Green (Invitrogen, Carlsbad, CA), 200 nM probe, 2 units of Taq DNA polymerase (Invitrogen, Carlsbad, CA) with different concentrations of plasmid DNA (Epoch Biolabs, Inc, Sugar Land, TX) that gave starting copy numbers in the range of 10<sup>0</sup> to 10<sup>6</sup>, obtained by serial dilution. Amplification reactions were run in a duplicate set for each condition in the presence or absence of 500 nM blocker and either with no additive or with additive EP043 (Example 4) whose strand concentrations (top/middle/bottom) were 33.3 nM, 200 nM and 166.7 nM.</p><p id="p0214" num="0214">The thermal profile conditions for these reactions were as follows: 95°C for 3 min followed by 70 cycles of 95 °C/10s,70 °C/30s, 62 °C/10s, 72 °C/20s, followed by a melt starting at 30 °C with 1 °C increments at 30s intervals to 90 °C. SYBR Green signals were detected in real time during the primer extension portion of all PCR cycles. and the C<sub>T</sub> values were determined. As the assays were run in duplicate, the two C<sub>T</sub> values at each concentration of target were averaged. <figref idrefs="f0046">FIG. 22A</figref> presents C<sub>T</sub> values as a function of target concentration for<!-- EPO <DP n="103"> --> assays performed without the blocker, both with and without the EP043 additive. <figref idrefs="f0046">FIG 22B</figref> presents C<sub>T</sub> values as a function of target concentration for assays performed with the blocker, both with and without the additive.</p><p id="p0215" num="0215">Turning to <figref idrefs="f0046">FIG. 22A</figref>, filled squares are C<sub>T</sub> values of samples with the first target (to be discriminated against through operation of the blocker) at various amounts of starting target (copy number), no blocker and no additive, and the C<sub>T</sub> values are connected by line 250; and filled triangles are C<sub>T</sub> values of samples with the second target (to be preferentially amplified, because it is mismatched to the blocker), no blocker and no additive, and the C<sub>T</sub> values are connected by line 251. Also in <figref idrefs="f0046">FIG. 22A</figref>, open squared are C<sub>T</sub> values of samples with the first target and additive but no blocker, and the C<sub>T</sub> values are connected by line 252; and open triangles are C<sub>T</sub> values of samples with the first target and additive but no blocker, and the C<sub>T</sub> values are connected by line 253.</p><p id="p0216" num="0216">Turning to <figref idrefs="f0046">FIG. 22B</figref>, filled squares are C<sub>T</sub> values of samples with the first target and blocker but no additive, and the C<sub>T</sub> values are connected by line 254 (which is extrapolated to low copy numbers); and open squares are C<sub>T</sub> values of samples with the second target and blocker but no additive, and the C<sub>T</sub> values are connected by line 255 (which is extrapolated to low copy numbers). Also in <figref idrefs="f0046">FIG 22B</figref>, filled circles are C<sub>T</sub> values of samples with the first target, blocker and additive, and the C<sub>T</sub> values are connected by line 256 (which is extrapolated); and open circles are C<sub>T</sub> values of samples with the second target, blocker and additive, and the C<sub>T</sub> values are connected by line 257 (which is extrapolated).</p><p id="p0217" num="0217">Selectivity against the created 3' terminal mismatch in the absence of additive, in this case additive EP043, is the difference between the threshold cycle (C<sub>T</sub>) of the signal from amplification of said first target at a first concentration and the C<sub>T</sub> of the signal from amplification of said second target at said first concentration, and is designated (AC<sub>TB</sub>). Selectivity due to additive Rep043 is the double-C<sub>T</sub> difference, designated (ΔΔC<sub>T</sub>), calculated as ΔC<sub>TA</sub>-ΔC<sub>TB</sub>, where ΔC<sub>TA</sub> is measured as the difference between the C<sub>T</sub> values of said first target and said second target at a second concentration in the presence of both the additive and the blocker, wherein the C<sub>T</sub> value of said second target is the same for the reaction containing just the blocker at said first concentration and the reaction containing both the blocker and the additive at said second concentration.<!-- EPO <DP n="104"> --></p><p id="p0218" num="0218"><figref idrefs="f0046">FIG. 22A</figref> shows that without the blocker there was no selectivity for either target, as we expected due to the lack of a 3' terminal mismatch between the limiting primer and either target. The data show that without additive EP043, the assay is efficient, as lines 250 and 251 both have slopes of about 3.5. With additive EP043, however, the slopes of lines 252 and 253 are both about 3.9, thereby demonstrating that EP043 decreased PCR amplification for both targets.</p><p id="p0219" num="0219">For the effect of the additive on selectivity, one turns to <figref idrefs="f0046">FIG. 22B</figref>. With the allele-specific blocker but no additive, a mismatched 3' end of the limiting primer is created to said first target, which gives a first selectivity that shows as a ΔC<sub>T</sub> between the C<sub>T</sub> of said first target and the C<sub>T</sub> of said second target. As shown by lines 254, 255, this ΔC<sub>T</sub> is a function of the concentration of target. With both the blocker and additive EP043, there is another selectivity due to the additive. Because of the inhibition of the PCR amplification reaction by EP043, the C<sub>T</sub> difference between the first target and the second target in the presence of EP043 actually includes two factors: 1) the selectivity due to the allele-specific blocker compounded with selectivity due to EP043; and 2) the progressive decrease in efficiency due to EP043 inhibition of PCR.</p><p id="p0220" num="0220">In order to distinguish and quantify the contribution of these two factors, we did the following with the information in <figref idrefs="f0046">FIG. 22B</figref>. At a certain target concentration (copy number), the C<sub>T</sub> of a sample with second target, blocker and additive has the value of point A on line 257, and the C<sub>T</sub> of a sample with first target, blocker and additive has the value of point D on line 256. These C<sub>T</sub> values are 35 and 62, respectively, giving sample a ΔC<sub>TA</sub> of 27. However, the C<sub>T</sub> value of point A is the C<sub>T</sub> value of point B on line 255 (same target, that is, second target, without additive EP043). The concentration of second target at point B is the effective target concentration in the presence of EP043 because of its inhibition of amplification. At the concentration of point B, the ΔC<sub>TB</sub> is the segment BC, which is 17. Without additive EP043, this selectivity between said first target and said second target is due to the allele-specific blocker. In order to remove the inhibitory effect of the additive EP043 from ΔC<sub>TA</sub>, the ΔC<sub>TB</sub> at said first concentration of target, 17, is subtracted from the ΔC<sub>TA</sub> at the said second concentration of target, 27. This gives the ΔΔCT of 10. The ΔΔCT of 10 is the selectivity effect of additive EP043 in the presence of induced-Type II mis-priming at the target concentration of point A. As can be seen from the <figref idrefs="f0046">FIG. 22B</figref>, the magnitude of the<!-- EPO <DP n="105"> --> selectivity effect of additive EP043 depends on the target concentration, because lines 254, 255, 256, 257 are not parallel to one another. The lower the target concentration, the greater is the selectivity effect of the additive. This is the case, because more thermal cycles are required to detect the product.</p><heading id="h0044">Example 20. <u>Suppression of Type I Mispriming on Ice Prior to Amplification.</u></heading><p id="p0221" num="0221">The assay reported here was carried out as described in Example 9 with the following exceptions: (a) the incubation step at 50 °C was for 1 minute; (b) the number of amplifications cycles was reduced to 50; (c) EP010, described in Example 10, was used as the additive; (d) the concentration of the additive was 300 nM.</p><p id="p0222" num="0222">SYBR Green fluorescence of the double-stranded products generated in these amplification reactions is shown in <figref idrefs="f0047">FIG. 23A</figref>, where circle 260 identifies the replicates from the sample with Taq DNA polymerase only, circle 261 identifies the replicates from the sample with Taq DNA polymerase and antibody added immediately after the isothermal extension step, circle 262 identifies the replicates from the sample with Taq DNA polymerase-plus-antibody present during the isothermal extension step.</p><p id="p0223" num="0223"><figref idrefs="f0047">FIG. 23A</figref> shows the effect of antibody on extension of the overlapping oligonucleotides. The replicate samples without any antibody (circle 260) had a C<sub>T</sub> value of 22, and, therefore, extension of the overlapping templates was efficient. In contrast, extension of the overlapping templates is extensively inhibited when the antibody is added prior to the 50 °C incubation step (circle 262). When addition of the antibody is delayed until the end of the 50°C incubation (circle 261), the C<sub>T</sub> is higher than in the no-antibody case (circle 260). This means that most, but not all, of the possible overlapping templates were extended during the 1-minute incubation at 50 °C. Additional overlapping templates are extended during the subsequent incubation on ice.</p><p id="p0224" num="0224"><figref idrefs="f0047">FIG. 23B</figref> shows the effect of additive EP010 on extension of the overlapping oligonucleotides. Replicates with EP10 (circle 263) received additive EP010 either prior to incubation at 50 °C or after incubation at 50°C. The results (combined as circle 263) show no difference in amplification when EP010 is added before or after the incubation step. This demonstrates that EP010 does not inhibit polymerization during the incubation at the 50°C<!-- EPO <DP n="106"> --> step. However, the C<sub>T</sub> values are slightly higher than C<sub>T</sub> replicates that received the antibody at the end of the 50°C step (circle 261). This demonstrates that addition of additive EP010 is slightly more effective than the antibody in inhibiting the extension of the overlapping oligonucleotides on ice.</p><p id="p0225" num="0225"><figref idrefs="f0048">FIG. 23C</figref> shows the SYBR Green melt curves of the double-strand product generated in replicates with Taq DNA polymerase only (circle 264) and in replicates with Taq DNA polymerase and antibody added immediately after the extension step (circle 265). <figref idrefs="f0048">FIG. 23D</figref> shows the SYBR Green melt curve of the double-stranded product generated in replicates with Taq DNA polymerase-plus-antibody during extension step (circle 266). <figref idrefs="f0049">FIG. 23E</figref> shows the SYBR Green melt curves (circle 267) of the double-stranded product generated in replicates that received additive EP010 either prior to incubation at 50 °C (circle 267) or after incubation at 50 °C (circle 268, only two replicates, as one was lost).</p><p id="p0226" num="0226"><figref idrefs="f0048">FIG. 23C</figref> demonstrates that omission of the antibody entirely (circle 264) or omission of the antibody during incubation of the templates at 50 °C (circle 265) results in extension and subsequent amplification of a fairly clean product that melts at 88°C. <figref idrefs="f0048">FIG. 23D</figref> demonstrates, in contrast, that inclusion of the antibody during the incubation at 50 °C (circle 266) results in a mixture of products with peaks at 88 °C and 85 °C. <figref idrefs="f0049">FIG. 23E</figref> demonstrates that addition of the EP010 additive either before or after the 50 °C step results amplification of a clean double-stranded product with a sharp melting peak at 88°C. The melt curves in <figref idrefs="f0049">FIG. 23E</figref> also show the presence of a small broad peak at 67-71 °C. This peak is due to melting of the double-stranded form of EP010. It shows that the double-stranded form is no longer present at 72°C, the temperature at which extension was carried out during the amplification phase of these reactions and in Example 9. In contrast, the additives used in Example 9 were found to have melt peaks (not shown) that are higher than that of EPO10.</p><p id="p0227" num="0227">The specific embodiments described above are not exhaustive and should not be construed as limiting the claims. Various modifications of these embodiments can be made without departing from the the concepts described herein. Such modifications are intended to fall within the scope of the claims.</p></description><claims mxw-id="PCLM56985461" lang="DE" load-source="patent-office"><!-- EPO <DP n="109"> --><claim id="c-de-01-0001" num="0001"><claim-text>Reaktionsgemisch zum Unterdrücken von Mispriming in einer Primer-abhängigen DNA-Amplifikationsreaktion, wobei das Reaktionsgemisch umfasst
<claim-text>(a) wenigstens ein Primerpaar,</claim-text>
<claim-text>(b) eine DNA-Polymerase,</claim-text>
<claim-text>(c) dNTPs und</claim-text>
<claim-text>(d) wenigstens ein doppelsträngiges Oligonucleotid-Additiv:
<claim-text>(i) das zwei Nucleinsäurestränge mit einer Länge von 6-50 Nucleotiden umfasst,</claim-text>
<claim-text>(ii) das bei 32°C zu wenigstens 50% doppelsträngig ist,</claim-text>
<claim-text>(iii) das stumpfe Enden oder Überhänge von 1-8 Nucleotiden hat,</claim-text>
<claim-text>(iv) das terminale Regionen an jedem seiner Stränge hat und 1-4 modifizierende Gruppen, jede kovalent an eine unterschiedliche terminale Region gebunden, hat, wobei die modifizierenden Gruppen polycyclische Gruppierungen sind, die keine voluminösen Teile, die nicht planar sind, haben, und</claim-text>
<claim-text>(v) wobei das wenigstens eine doppelsträngige Oligonucleotid-Additiv in dem Reaktionsgemisch mit einer Konzentration von bis zu 2000 nM eingeschlossen ist.</claim-text></claim-text></claim-text></claim><claim id="c-de-01-0002" num="0002"><claim-text>Amplifikationsreaktionsgemisch gemäß Anspruch 1, wobei die wenigstens eine modifizierende Gruppe 2-4 modifizierende Gruppen ist.</claim-text></claim><claim id="c-de-01-0003" num="0003"><claim-text>Amplifikationsreaktionsgemisch gemäß Anspruch 2, wobei das Additiv einen ersten Strang, der ein Primer oder eine Sonde für die wenigstens eine Targetsequenz ist, und einen<!-- EPO <DP n="110"> --> reversen Komplementstrang, der teilweise komplementär zu dem ersten Strang ist, umfasst.</claim-text></claim><claim id="c-de-01-0004" num="0004"><claim-text>Amplifikationsreaktionsgemisch gemäß einem der Ansprüche 1-3, wobei die modifizierenden Gruppen kovalent mit terminalen Nucleotiden des wenigstens einen doppelsträngigen Oligonucleotid-Additivs verknüpft sind.</claim-text></claim><claim id="c-de-01-0005" num="0005"><claim-text>Amplifikationsreaktionsgemisch gemäß einem der Ansprüche 1-4, wobei die modifizierenden Gruppen Dabcyl sind.</claim-text></claim><claim id="c-de-01-0006" num="0006"><claim-text>Amplifikationsreaktionsgemisch gemäß Anspruch 2, wobei das wenigstens eine Additiv ein Gemisch aus zwei Additiven ist.</claim-text></claim><claim id="c-de-01-0007" num="0007"><claim-text>Amplifikationsreaktionsgemisch gemäß Anspruch 6, wobei das Gemisch aus drei Strängen besteht.</claim-text></claim><claim id="c-de-01-0008" num="0008"><claim-text>Amplifikationsreaktionsgemisch gemäß einem der Ansprüche 1-7, wobei das wenigstens eine doppelsträngige Oligonucleotid-Additiv aus natürlichen Nucleotiden besteht.</claim-text></claim><claim id="c-de-01-0009" num="0009"><claim-text>Amplifikationsreaktionsgemisch gemäß einem der Ansprüche 1-7, wobei das wenigstens eine doppelstängige Oligonucleotid-Additiv DNA ist.</claim-text></claim><claim id="c-de-01-0010" num="0010"><claim-text>Amplifikationsreaktionsgemisch gemäß einem der Ansprüche 1-2 und 4-9, wobei das wenigstens eine Additiv kein Primer oder keine Sonde für die wenigstens eine Targetsequenz ist.</claim-text></claim><claim id="c-de-01-0011" num="0011"><claim-text>Amplifikationsreaktionsgemisch gemäß einem der Ansprüche 1-10, wobei die Konzentration des wenigstens einen doppelsträngigen Oligonucleotid-Additivs nicht mehr als 1000 nM ist.<!-- EPO <DP n="111"> --></claim-text></claim><claim id="c-de-01-0012" num="0012"><claim-text>Amplifikationsreaktionsgemisch gemäß einem der Ansprüche 1-11, das außerdem eine reverse Transkriptase umfasst.</claim-text></claim><claim id="c-de-01-0013" num="0013"><claim-text>Amplifikationsreaktionsgemisch gemäß Anspruch 1, wobei das wenigstens eine doppelsträngige Additiv ein bis vier einzelsträngige Überhänge umfasst.</claim-text></claim><claim id="c-de-01-0014" num="0014"><claim-text>Amplifikationsreaktionsgemisch gemäß Anspruch 13, wobei das wenigstens eine doppelsträngige Additiv wenigstens einen Strang umfasst, der, wenn er nicht hybridisiert ist, eine Stem-Loop-Struktur bildet.</claim-text></claim><claim id="c-de-01-0015" num="0015"><claim-text>Verfahren zum Amplifizieren wenigstens einer DNA-Targetsequenz, umfassend In-Kontakt-Bringen der wenigstens einen DNA-Targetsequenz mit einem Amplifikationsreaktionsgemisch gemäß einem der Ansprüche 1-14 und Unterwerfen des Reaktionsgemisches einer Primer-abhängigen DNA-Amplifikationsreaktion, die eine Primer-Anlagerungstemperatur und eine Primer-Extensionstemperatur hat.</claim-text></claim></claims><claims mxw-id="PCLM56985462" lang="EN" load-source="patent-office"><!-- EPO <DP n="107"> --><claim id="c-en-01-0001" num="0001"><claim-text>A reaction mixture for suppressing mispriming in a primer-dependent DNA amplification reaction, said reaction mixture comprising
<claim-text>(a) at least one primer pair,</claim-text>
<claim-text>(b) a DNA polymerase</claim-text>
<claim-text>(c) dNTP's, and</claim-text>
<claim-text>(d) at least one double-stranded oligonucleotide additive:
<claim-text>(i) comprising two nucleic acid strands of 6-50 nucleotides in length,</claim-text>
<claim-text>(ii) that is at least fifty percent double-stranded at 32°C,</claim-text>
<claim-text>(iii) having blunt ends or overhangs of 1-8 nucleotides,</claim-text>
<claim-text>(iv) that has terminal regions on each of its strands and includes 1-4 modifying groups, each covalently attached to a different terminal region, said modifying groups being polycyclic moieties that do not have bulky portions that are nonplanar, and</claim-text>
<claim-text>(v) wherein said at least one double-stranded oligonucleotide additive is included in said reaction mixture at a concentration of up to 2000 nM.</claim-text></claim-text></claim-text></claim><claim id="c-en-01-0002" num="0002"><claim-text>The amplification reaction mixture of claim 1 wherein the at least one modifying groups is 2-4 modifying groups.</claim-text></claim><claim id="c-en-01-0003" num="0003"><claim-text>The amplification reaction mixture of claim 2 wherein the additive includes a first strand that is a primer or probe for said at least one target sequence and a reverse complement strand that is partially complementary to the first strand.</claim-text></claim><claim id="c-en-01-0004" num="0004"><claim-text>The amplification reaction mixture of any of claims 1-3 wherein the modifying groups are covalently linked to terminal nucleotides of said at least one double- stranded oligonucleotide additive.</claim-text></claim><claim id="c-en-01-0005" num="0005"><claim-text>The amplification reaction mixture of any of claims 1-4 wherein the modifying groups are Dabcyl.</claim-text></claim><claim id="c-en-01-0006" num="0006"><claim-text>The amplification reaction mixture of claim 2 wherein the at least one additive is a mixture of two additives.<!-- EPO <DP n="108"> --></claim-text></claim><claim id="c-en-01-0007" num="0007"><claim-text>The amplification reaction mixture of claim 6 wherein the mixture consists of three strands.</claim-text></claim><claim id="c-en-01-0008" num="0008"><claim-text>The amplification reaction mixture of any of claims 1-7, wherein the at least one double-stranded oligonucleotide additive consists of natural nucleotides.</claim-text></claim><claim id="c-en-01-0009" num="0009"><claim-text>The amplification reaction mixture of any of claims 1-7 wherein the at least one double-stranded oligonucleotide additive is DNA.</claim-text></claim><claim id="c-en-01-0010" num="0010"><claim-text>The amplification reaction mixture according to any of claims 1-2 and 4-9 wherein the at least one additive is not a primer or probe for said at least one target sequence.</claim-text></claim><claim id="c-en-01-0011" num="0011"><claim-text>The amplification reaction mixture according to any of claims 1-10 wherein the concentration of said at least one double-stranded oligonucleotide additive is not more than 1000 nM.</claim-text></claim><claim id="c-en-01-0012" num="0012"><claim-text>The amplification reaction mixture according to any of claims 1-11, further including a reverse transcriptase.</claim-text></claim><claim id="c-en-01-0013" num="0013"><claim-text>The amplification reaction mixture of claim 1 wherein the at least one double-stranded additive includes from one to four single-stranded overhangs.</claim-text></claim><claim id="c-en-01-0014" num="0014"><claim-text>The amplification reaction mixture of claim 13 wherein the at least one double-stranded additive comprises at least one strand that, when not hybridized, forms a stem-loop structure.</claim-text></claim><claim id="c-en-01-0015" num="0015"><claim-text>A method for amplifying at least one DNA target sequence comprising contacting said at least one DNA target sequence with an amplification reaction mixture according to any one of claims 1 to 14 and subjecting the reaction mixture to a primer-dependent DNA amplification reaction having a primer annealing temperature and a primer extension temperature.</claim-text></claim></claims><claims mxw-id="PCLM56985463" lang="FR" load-source="patent-office"><!-- EPO <DP n="112"> --><claim id="c-fr-01-0001" num="0001"><claim-text>Mélange réactionnel permettant de supprimer tout mauvais amorçage dans une réaction d'amplification d'ADN dépendante d'amorces, lequel mélange réactionnel comprend :
<claim-text>a) au moins une paire d'amorces,</claim-text>
<claim-text>b) une ADN polymérase,</claim-text>
<claim-text>c) des dNTP,</claim-text>
<claim-text>d) et au moins un adjuvant oligonucléotidique double-brin qui :
<claim-text>i) comporte deux brins d'acide nucléique longs de 6 à 50 nucléotides,</claim-text>
<claim-text>ii) se trouve, pour au moins 50 %, sous forme de double-brin à 32 °C ;</claim-text>
<claim-text>iii) présente des extrémités franches, ou des bouts collants comportant de 1 à 8 nucléotides dépassants,</claim-text>
<claim-text>iv) et comporte des régions terminales sur chacun de ses brins et porte de 1 à 4 groupes modificateurs attachés par liaison covalente, chacun à une région terminale différente, qui sont des groupes polycycliques, sans parties volumineuses qui ne soient pas planes,</claim-text>
<claim-text>v) lequel adjuvant oligonucléotidique double-brin au nombre d'au moins un est contenu dans ledit mélange réactionnel en une concentration valant jusqu'à 2000 nM.</claim-text></claim-text></claim-text></claim><claim id="c-fr-01-0002" num="0002"><claim-text>Mélange réactionnel pour amplification, conforme à la revendication 1, dans lequel les groupes modificateurs, au nombre d'au moins 1, sont au nombre de 2 à 4.</claim-text></claim><claim id="c-fr-01-0003" num="0003"><claim-text>Mélange réactionnel pour amplification, conforme à la revendication 2, dans lequel l'adjuvant contient un premier brin qui est une amorce ou une sonde pour ladite séquence cible au nombre d'au moins une, et un brin complémentaire inverse qui est partiellement complémentaire du premier brin.<!-- EPO <DP n="113"> --></claim-text></claim><claim id="c-fr-01-0004" num="0004"><claim-text>Mélange réactionnel pour amplification, conforme à l'une des revendications 1 à 3, dans lequel les groupes modificateurs sont liés par liaison covalente aux nucléotides terminaux dudit adjuvant oligonucléotidique double-brin au nombre d'au moins un.</claim-text></claim><claim id="c-fr-01-0005" num="0005"><claim-text>Mélange réactionnel pour amplification, conforme à l'une des revendications 1 à 4, dans lequel les groupes modificateurs sont des groupes dabcyl.</claim-text></claim><claim id="c-fr-01-0006" num="0006"><claim-text>Mélange réactionnel pour amplification, conforme à la revendication 2, dans lequel l'adjuvant au nombre d'au moins un est un mélange de deux adjuvants.</claim-text></claim><claim id="c-fr-01-0007" num="0007"><claim-text>Mélange réactionnel pour amplification, conforme à la revendication 6, lequel mélange est constitué de trois brins.</claim-text></claim><claim id="c-fr-01-0008" num="0008"><claim-text>Mélange réactionnel pour amplification, conforme à l'une des revendications 1 à 7, dans lequel l'adjuvant oligonucléotidique double-brin au nombre d'au moins un est constitué de nucléotides naturels.</claim-text></claim><claim id="c-fr-01-0009" num="0009"><claim-text>Mélange réactionnel pour amplification, conforme à l'une des revendications 1 à 7, dans lequel l'adjuvant oligonucléotidique double-brin au nombre d'au moins un est un ADN.</claim-text></claim><claim id="c-fr-01-0010" num="0010"><claim-text>Mélange réactionnel pour amplification, conforme à l'une des revendications 1 à 2 et 4 à 9, dans lequel l'adjuvant au nombre d'au moins un n'est pas une amorce ou une sonde pour ladite séquence cible au nombre d'au moins une.</claim-text></claim><claim id="c-fr-01-0011" num="0011"><claim-text>Mélange réactionnel pour amplification, conforme à l'une des revendications 1 à 10, dans lequel la concentration dudit adjuvant oligonucléotidique double-brin au nombre d'au moins ne vaut pas plus de 1000 nM.</claim-text></claim><claim id="c-fr-01-0012" num="0012"><claim-text>Mélange réactionnel pour amplification, conforme à l'une des revendications 1 à 11, qui contient en outre une transcriptase inverse.<!-- EPO <DP n="114"> --></claim-text></claim><claim id="c-fr-01-0013" num="0013"><claim-text>Mélange réactionnel pour amplification, conforme à la revendication 1, dans lequel ledit adjuvant double-brin au nombre d'au moins un comporte de 1 à 4 bouts collants simple-brin.</claim-text></claim><claim id="c-fr-01-0014" num="0014"><claim-text>Mélange réactionnel pour amplification, conforme à la revendication 13, dans lequel ledit adjuvant double-brin au nombre d'au moins un comporte au moins un brin qui, lorsqu'il n'est pas hybridé, adopte une structure en tige et boucle.</claim-text></claim><claim id="c-fr-01-0015" num="0015"><claim-text>Procédé d'amplification d'au moins une séquence cible d'ADN, qui comporte le fait de mettre ladite séquence cible d'ADN au nombre d'au moins une en contact avec un mélange réactionnel pour amplification, conforme à l'une des revendications 1 à 14, et le fait de soumettre le mélange réactionnel à une réaction d'amplification d'ADN dépendante d'amorces, se déroulant à une température d'hybridation d'amorces et à une température d'allongement d'amorces.</claim-text></claim></claims><drawings mxw-id="PDW16672167" load-source="patent-office"><!-- EPO <DP n="115"> --><figure id="f0001" num="1"><img id="if0001" file="imgf0001.tif" wi="165" he="124" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="116"> --><figure id="f0002" num="2"><img id="if0002" file="imgf0002.tif" wi="165" he="132" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="117"> --><figure id="f0003" num="3"><img id="if0003" file="imgf0003.tif" wi="165" he="151" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="118"> --><figure id="f0004" num="4"><img id="if0004" file="imgf0004.tif" wi="165" he="151" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="119"> --><figure id="f0005" num="5"><img id="if0005" file="imgf0005.tif" wi="165" he="151" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="120"> --><figure id="f0006" num="6"><img id="if0006" file="imgf0006.tif" wi="165" he="151" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="121"> --><figure id="f0007" num="7A"><img id="if0007" file="imgf0007.tif" wi="165" he="103" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="122"> --><figure id="f0008" num="7B"><img id="if0008" file="imgf0008.tif" wi="165" he="103" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="123"> --><figure id="f0009" num="7C"><img id="if0009" file="imgf0009.tif" wi="165" he="103" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="124"> --><figure id="f0010" num="7D"><img id="if0010" file="imgf0010.tif" wi="165" he="104" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="125"> --><figure id="f0011" num="8A"><img id="if0011" file="imgf0011.tif" wi="165" he="104" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="126"> --><figure id="f0012" num="8B"><img id="if0012" file="imgf0012.tif" wi="165" he="104" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="127"> --><figure id="f0013" num="8C"><img id="if0013" file="imgf0013.tif" wi="165" he="104" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="128"> --><figure id="f0014" num="8D"><img id="if0014" file="imgf0014.tif" wi="165" he="104" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="129"> --><figure id="f0015" num="9A"><img id="if0015" file="imgf0015.tif" wi="159" he="94" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="130"> --><figure id="f0016" num="9B"><img id="if0016" file="imgf0016.tif" wi="159" he="106" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="131"> --><figure id="f0017" num="9C"><img id="if0017" file="imgf0017.tif" wi="159" he="106" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="132"> --><figure id="f0018" num="9D"><img id="if0018" file="imgf0018.tif" wi="159" he="106" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="133"> --><figure id="f0019" num="9E"><img id="if0019" file="imgf0019.tif" wi="159" he="106" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="134"> --><figure id="f0020" num="9F"><img id="if0020" file="imgf0020.tif" wi="159" he="94" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="135"> --><figure id="f0021" num="10"><img id="if0021" file="imgf0021.tif" wi="159" he="127" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="136"> --><figure id="f0022" num="11A"><img id="if0022" file="imgf0022.tif" wi="165" he="104" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="137"> --><figure id="f0023" num="11B"><img id="if0023" file="imgf0023.tif" wi="165" he="104" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="138"> --><figure id="f0024" num="12"><img id="if0024" file="imgf0024.tif" wi="106" he="142" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="139"> --><figure id="f0025" num="13"><img id="if0025" file="imgf0025.tif" wi="165" he="141" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="140"> --><figure id="f0026" num="14A"><img id="if0026" file="imgf0026.tif" wi="165" he="106" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="141"> --><figure id="f0027" num="14B"><img id="if0027" file="imgf0027.tif" wi="165" he="106" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="142"> --><figure id="f0028" num="14C"><img id="if0028" file="imgf0028.tif" wi="165" he="106" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="143"> --><figure id="f0029" num="15A"><img id="if0029" file="imgf0029.tif" wi="165" he="106" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="144"> --><figure id="f0030" num="15B"><img id="if0030" file="imgf0030.tif" wi="165" he="106" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="145"> --><figure id="f0031" num="16A"><img id="if0031" file="imgf0031.tif" wi="165" he="115" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="146"> --><figure id="f0032" num="16B"><img id="if0032" file="imgf0032.tif" wi="165" he="115" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="147"> --><figure id="f0033" num="16C"><img id="if0033" file="imgf0033.tif" wi="165" he="115" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="148"> --><figure id="f0034" num="16D"><img id="if0034" file="imgf0034.tif" wi="165" he="115" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="149"> --><figure id="f0035" num="17A"><img id="if0035" file="imgf0035.tif" wi="165" he="108" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="150"> --><figure id="f0036" num="17B"><img id="if0036" file="imgf0036.tif" wi="165" he="108" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="151"> --><figure id="f0037" num="17C"><img id="if0037" file="imgf0037.tif" wi="165" he="108" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="152"> --><figure id="f0038" num="17D"><img id="if0038" file="imgf0038.tif" wi="165" he="108" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="153"> --><figure id="f0039" num="17E"><img id="if0039" file="imgf0039.tif" wi="165" he="108" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="154"> --><figure id="f0040" num="17F"><img id="if0040" file="imgf0040.tif" wi="165" he="108" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="155"> --><figure id="f0041" num="18A,18B,18C"><img id="if0041" file="imgf0041.tif" wi="134" he="193" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="156"> --><figure id="f0042" num="19A,19B"><img id="if0042" file="imgf0042.tif" wi="134" he="210" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="157"> --><figure id="f0043" num="19C,19D"><img id="if0043" file="imgf0043.tif" wi="134" he="220" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="158"> --><figure id="f0044" num="20"><img id="if0044" file="imgf0044.tif" wi="128" he="96" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="159"> --><figure id="f0045" num="21A,21B"><img id="if0045" file="imgf0045.tif" wi="160" he="146" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="160"> --><figure id="f0046" num="22A,22B"><img id="if0046" file="imgf0046.tif" wi="142" he="221" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="161"> --><figure id="f0047" num="23A,23B"><img id="if0047" file="imgf0047.tif" wi="142" he="221" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="162"> --><figure id="f0048" num="23C,23D"><img id="if0048" file="imgf0048.tif" wi="142" he="221" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="163"> --><figure id="f0049" num="23E"><img id="if0049" file="imgf0049.tif" wi="123" he="87" img-content="drawing" img-format="tif"/></figure></drawings><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
